Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytokine receptor activity (GO:0004896),0.6284467589086882,1.9112140933347894,0.0,0.07707519106482837,0.071,24/83,10.90%,CD74;CCR2;CD44;IFNLR1;FLT3;IL27RA;IFNGR1;IL18RAP;XCR1;CCR1;IL10RA;ACKR2;CCR9;IL6R;IL2RG;IL17RA;CCRL2;CSF2RB;IFNAR1;IL6ST;IL1R2;IL1RAPL2;IL31RA;IL17RB
prerank,C-C chemokine binding (GO:0019957),0.7580082251720831,1.8402703548790458,0.0015360983102918587,0.1842285054720288,0.293,6/22,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,C-C chemokine receptor activity (GO:0016493),0.761733958385031,1.8258610867499196,0.0015600624024961,0.1648030508134135,0.367,6/21,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,microtubule minus-end binding (GO:0051011),-0.7281387813026643,-1.8027880386250152,0.005141388174807198,0.682949921254108,0.41,9/13,20.30%,CAMSAP1;NUMA1;TUBGCP5;CAMSAP2;MACF1;TUBGCP6;HAUS4;CEP290;TUBGCP2
prerank,chemokine binding (GO:0019956),0.6976327975156696,1.8022192926404361,0.0,0.18211363742451825,0.486,7/30,6.59%,CCR2;ITGA4;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6630413078969801,1.7938755640670734,0.001445086705202312,0.167873525904614,0.528,10/35,7.20%,FGR;HCK;LYN;FYN;SYK;SLA;ZAP70;STYK1;PTK2B;DYRK1A
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5657824455416276,-1.7746300009715188,0.0035087719298245615,0.46621209500487043,0.51,14/29,18.59%,GRIA4;GRIA2;GABRG3;GABRG2;GRID2;GRIK4;GLRA3;GABRB1;GRIK1;GLRA2;GABRA4;GABRB3;GABRA2;GABRA5
prerank,chemokine receptor activity (GO:0004950),0.7174876871572612,1.7701439858233223,0.0030257186081694403,0.20146076363692944,0.66,7/24,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;GPR35;CCRL2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.7764543025885982,1.7614871947291169,0.004792332268370607,0.19309080967112055,0.697,7/14,13.44%,KMO;CYBB;NOX1;CYB5R4;NCF2;AIFM1;NCF1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.8317994752334222,1.7514341756801737,0.0034423407917383822,0.19492033837888761,0.746,7/11,14.57%,MAP3K15;MAP3K5;MAP3K1;MAP3K4;MAP3K7;MAP3K20;MAP3K13
prerank,thioesterase binding (GO:0031996),0.831272276375123,1.7452678239872828,0.003436426116838488,0.18788383296155317,0.775,6/11,8.19%,TRAF1;CDC42;TRAF4;ADRA2A;TRAF3;RAC1
prerank,endodeoxyribonuclease activity (GO:0004520),0.7022681449424515,1.7316031004036496,0.0075075075075075074,0.2020873912065622,0.813,11/20,20.00%,DNA2;RBBP8;MRE11;FEN1;MBD4;RPS3;EXOG;ERCC4;ENDOV;SETMAR;APEX1
prerank,MHC protein binding (GO:0042287),0.7211329110761857,1.7267805787486024,0.012618296529968454,0.19584959858158163,0.831,4/20,6.29%,CD74;LILRB1;PILRA;TAP1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.7634585387813654,1.7236305925031603,0.0016750418760469012,0.18610838818092706,0.839,6/15,6.59%,CCR2;XCR1;CCR1;ACKR2;CCR9;CCRL2
prerank,N-methyltransferase activity (GO:0008170),-0.6100759286384568,-1.7093118196002883,0.0106951871657754,0.6073174506358845,0.747,7/20,9.10%,METTL15;TRMT1;ZCCHC4;SETD3;HNMT;TRMT1L;DIMT1
prerank,MHC class II protein complex binding (GO:0023026),0.8071767696024326,1.6966051905689776,0.006896551724137931,0.24185414081787138,0.924,1/11,0.02%,CD74
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7882323294258523,1.6776258733030747,0.016216216216216217,0.27983396895313994,0.959,2/11,3.31%,KCNE3;KCNQ1
prerank,sialyltransferase activity (GO:0008373),0.6863073871433504,1.6762991415658797,0.012519561815336464,0.2651261247116169,0.962,5/20,3.54%,ST3GAL1;ST8SIA4;ST3GAL4;ST8SIA1;ST8SIA6
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.6142561305444258,-1.673671150983797,0.010526315789473684,0.5255892286544012,0.869,9/16,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.6142561305444258,-1.673671150983797,0.010526315789473684,0.5255892286544012,0.869,9/16,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,protein serine/threonine kinase activity (GO:0004674),0.48971462689428735,1.6636730578449923,0.0,0.2843910060555138,0.979,102/335,14.86%,GRK3;LRRK2;GRK5;STK10;MAP4K1;MAP3K15;ALPK1;SGK3;PRKCE;SIK1;STK24;CDK13;VRK1;DAPK1;SLK;CAMK1D;CASK;MAP3K5;LMTK2;AKT3;MAP3K8;MAPKAPK3;SYK;PIM1;PKN1;PAK1;STK17B;STKLD1;MAP3K14;ERN1;PRKCH;RPS6KA3;BMPR2;CSNK1G1;MAPKAPK2;STK38;SBK3;EIF2AK2;BCR;IKBKB;VRK2;TAOK3;SIK3;HIPK2;MAPK14;IRAK4;RPS6KA5;CDK14;MAP3K1;HIPK1;STK4;PRKAB2;PTK2B;PDPK1;MKNK2;DYRK1A;PKN2;PAK2;MAPK12;SIK2;RIOK1;ACVR2A;STK38L;MINK1;CSNK1G3;LATS1;PIKFYVE;OXSR1;NEK8;CSNK2A2;CSNK2A1;MAP3K4;BRAF;TLK2;GRK6;RIPK1;DMPK;NLK;LATS2;MAP4K3;PRKAA1;RPS6KA1;MAP3K7;PIK3R4;SMG1;CDK12;MAP3K20;EIF2AK3;MAPK8;AKT1;PDK3;LIMK2;MARK3;STK39;PRKAA2;ROCK1;TLK1;RPS6KA2;MOK;MAP3K13;AURKB;BRSK1
prerank,FAD binding (GO:0071949),0.6675671981028976,1.66292968691906,0.008708272859216255,0.2695420060552642,0.981,8/24,11.18%,KMO;AGPS;CRY1;CRY2;NQO2;MTRR;CYB5R1;AIFM1
prerank,glutamate receptor activity (GO:0008066),-0.5845527134562728,-1.660398027414712,0.018518518518518517,0.49781969466621756,0.904,7/19,10.34%,GRIA4;GRIA2;GRIA1;GRID2;GRIK4;GRIK1;GRM5
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6677305747685088,-1.654484627977479,0.011848341232227487,0.45040829517419684,0.911,7/13,18.59%,GABRG3;GABRG2;GLRA3;GLRA2;GABRA4;GABRA2;GABRA5
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7093329412018217,1.6535414697892383,0.019169329073482427,0.2825045959760986,0.991,7/18,13.46%,PDLIM5;STXBP6;ANXA2;PDLIM1;ANXA1;S100A11;TMOD3
prerank,growth factor receptor binding (GO:0070851),0.5331731605423399,1.6534788022499605,0.0011933174224343676,0.26788328601800104,0.991,21/95,9.48%,IL1B;IL27RA;FYN;FGF5;FGF22;PLSCR1;JAK2;KL;ERN1;CCDC88A;IL6R;VEGFC;SNX1;GLMN;ARF4;GRB2;ADAM17;IL6ST;IL6;HIP1;PGF
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5811194158176444,-1.6444097268892306,0.01524390243902439,0.4323468096534271,0.93,8/19,18.59%,GABRG3;GABRG2;GRID2;GRIK4;GRIK1;GABRA4;GABRA2;GABRA5
prerank,nucleotidyltransferase activity (GO:0016779),0.6905507189534849,1.6260157661765071,0.013313609467455622,0.34011777910741636,0.998,9/19,14.81%,DNTT;PAPSS1;TUT1;PAPSS2;TENT2;MTPAP;TUT7;PNPT1;TENT4B
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7761574714589223,1.6180701641626005,0.028985507246376812,0.35037432964894105,0.998,3/10,5.83%,DPP4;PRCP;FAP
prerank,lysophospholipase activity (GO:0004622),-0.5830927430655967,-1.61583438077911,0.010810810810810811,0.48803639000913385,0.962,8/20,13.24%,ABHD12;PNPLA7;MGLL;GDE1;ENPP2;PLA2G4A;ABHD4;LYPLAL1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6274052360076685,-1.6155589721245867,0.013227513227513227,0.4400229409997542,0.962,10/15,26.40%,HS3ST5;HS3ST4;HS6ST3;NDST1;HS3ST3B1;HS6ST1;HS6ST2;HS3ST2;HS3ST1;HS3ST3A1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.5766047561019944,1.612160064425507,0.007792207792207792,0.35350339848691237,0.999,14/53,11.78%,KMO;CYBB;GSR;AGPS;CRY1;ACOX3;CRY2;NQO2;LDHD;DLD;MTRR;CYB5R1;AIFM1;FOXRED2
prerank,nuclease activity (GO:0004518),0.5591002858422587,1.609387565314798,0.007926023778071334,0.347001827853371,0.999,15/52,13.64%,DNA2;SAMHD1;STK31;PLSCR1;SND1;MRE11;FEN1;XRN2;WRN;RNASE1;RNASE6;DFFB;EXOG;RNASEH2A;RNASEH1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5822406713235986,1.600288483420436,0.01849217638691323,0.360428345208138,1.0,11/42,7.08%,FGR;HCK;PLCG2;STAP1;SYK;CRK;PTPN6;ZAP70;FBXW7;GRB2;SAMSN1
prerank,phosphotyrosine residue binding (GO:0001784),0.5905200641944182,1.5978390331013856,0.014534883720930232,0.3542075000106088,1.0,10/37,7.08%,FGR;HCK;PLCG2;STAP1;SYK;CRK;PTPN6;ZAP70;GRB2;SAMSN1
prerank,WW domain binding (GO:0050699),0.628635632002045,1.5929930818039246,0.024963289280469897,0.3560208637928845,1.0,8/26,15.39%,NFE2;RAPGEF2;TRAF4;TCEAL3;TCEAL6;PMEPA1;ENAH;WBP11
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.5396647596736691,1.5882596566730998,0.016414141414141416,0.35769990433202864,1.0,20/60,17.53%,LRRK2;CDC14A;LRRC2;PPP3CA;PTEN;MTMR3;SSU72;PPTC7;PHLPP1;CTDSPL2;PDP2;DUSP1;PGAM5;PPP1CB;PPM1D;TIMM50;ILKAP;PPM1G;LRRK1;TAB1
prerank,ligand-gated cation channel activity (GO:0099094),-0.41578327342246335,-1.5862713679169125,0.005025125628140704,0.5037717751219257,0.986,17/75,13.32%,GRIA4;KCNJ2;GRIA2;GRIA1;P2RX7;P2RX4;GRIK4;GRIK1;KCNN2;MCOLN1;CHRNA7;KCNJ6;KCNK6;SHROOM2;KCNN3;TRPM2;KCNJ9
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.6230498134654673,1.585347166336303,0.02643171806167401,0.35402219728644596,1.0,15/28,18.99%,LRRK2;MAPKAPK3;MAPK14;RPS6KA1;MAP2K5;MAP2K3;AKT1;PRKAA2;RPS6KA2;AURKB;RPS6KB1;MAP3K9;MAP2K4;PRKCG;MAP2K1
prerank,MAP kinase kinase activity (GO:0004708),0.7130363575610221,1.5830025668171004,0.022988505747126436,0.34823206593797984,1.0,8/15,18.99%,LRRK2;MAPKAPK3;MAPK14;MAP2K5;MAP2K3;MAP3K9;MAP2K4;MAP2K1
prerank,deoxyribonuclease activity (GO:0004536),0.709462326767762,1.5826650906929922,0.024875621890547265,0.3378462541674977,1.0,7/14,20.00%,MRE11;MBD4;RPS3;DFFB;ERCC4;DNASE1L1;APEX1
prerank,calcium channel inhibitor activity (GO:0019855),0.753666391605815,1.5782756330406795,0.02992957746478873,0.33919754620072184,1.0,4/11,11.64%,ITPR1;MCUB;SLC30A1;FKBP1B
prerank,fibroblast growth factor receptor binding (GO:0005104),0.6416735869975199,1.5716416546401528,0.02526002971768202,0.3474845694729115,1.0,4/21,3.56%,FGF5;FGF22;KL;NPTN
prerank,hexosaminidase activity (GO:0015929),-0.6574563198811414,-1.5686199117294566,0.023872679045092837,0.5350715085528053,0.994,5/12,20.21%,HEXB;HEXD;HEXA;CEMIP;HYAL1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.5827291582890217,1.5666803740157291,0.03536067892503536,0.35122475277915693,1.0,8/34,8.46%,MYO1G;IQGAP2;IQGAP1;DAPP1;RACGAP1;ARAP1;GBF1;CYTH3
prerank,mitogen-activated protein kinase binding (GO:0051019),0.6090272467819783,1.5664374419888834,0.032857142857142856,0.3416686823422575,1.0,10/29,14.37%,ACE;DUSP16;MAPKAPK3;MAPKAPK2;MAPK14;DUSP6;DIRAS1;DUSP1;PPM1D;PTPRJ
prerank,heme binding (GO:0020037),0.535926002649246,1.5616176241276274,0.012578616352201259,0.34643552778267805,1.0,12/65,8.76%,CYBB;JAK2;RSAD1;PTGIS;EIF2AK1;CYB5B;DGCR8;CYP27A1;CYB5R4;PTGES2;PXDN;BACH1
prerank,histone acetyltransferase activity (GO:0004402),0.6057297087422601,1.561065127565702,0.02653631284916201,0.33858776345822983,1.0,14/30,15.44%,BAZ1A;NCOA3;TAF9;KAT7;ATF2;TADA3;CLOCK;KAT6A;EPC2;TADA2A;SRCAP;KAT2B;CREBBP;TAF1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.431304353249738,-1.5610032964896532,0.0,0.5229147394522871,0.995,12/60,6.64%,MERTK;CSF1R;ERBB4;NRP1;FLT1;NTRK2;EPHA6;NTRK3;NRP2;EPHA5;FGFR2;RYK
prerank,protein phosphatase 1 binding (GO:0008157),0.6334489891419028,1.5578410465344488,0.03398058252427184,0.33848050288324755,1.0,6/21,8.85%,LILRB1;KCNQ1;AKAP11;PPP1R9B;SHOC2;PPP1R15A
prerank,retinoic acid binding (GO:0001972),0.7136869968649187,1.550252597187019,0.04040404040404041,0.349905536843088,1.0,1/12,0.51%,RARA
prerank,lipoprotein particle receptor binding (GO:0070325),-0.5047432756122223,-1.5491419682236316,0.027972027972027972,0.5307980320679803,0.997,10/27,16.90%,APOE;SYT1;LRP1;AP2A1;HSP90B1;CLU;AP2M1;SNX17;APBB1;APBB3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.643483808355214,-1.543982973097895,0.0412621359223301,0.5140750316349104,0.997,4/11,15.37%,SLC25A20;SLC22A5;SLC22A4;SLC25A47
prerank,CCR chemokine receptor binding (GO:0048020),0.5973025680547576,1.5368520123439224,0.039301310043668124,0.38017012628411595,1.0,3/28,10.17%,CCR2;CCRL2;CNIH4
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.5781002561263056,-1.523410065651419,0.04639175257731959,0.5637158957459011,0.999,5/15,11.23%,P2RY12;GPR34;P2RX7;P2RX4;P2RY13
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7177522711119515,1.5231961881056326,0.05414551607445008,0.4135506974237544,1.0,2/11,2.23%,SLC23A2;SLC23A1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.422961044701957,-1.5219623045002812,0.004405286343612335,0.5362003513978534,1.0,12/60,6.64%,MERTK;CSF1R;TGFBR2;ERBB4;FLT1;NTRK2;EPHA6;NTRK3;EPHA5;ACVR1;FGFR2;RYK
prerank,SH3 domain binding (GO:0017124),0.5197901526870625,1.5193479997941142,0.026143790849673203,0.4142619579242857,1.0,22/62,15.28%,WIPF1;PTPN22;PLSCR1;WASF2;CRK;GPX1;REPS1;CBLB;ABI1;CBL;CD2AP;PTPN12;GRB2;AFAP1L2;SYNJ1;CABYR;VASP;AFAP1;NCF1;ENAH;ADAM9;ELMO1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5623438237773664,1.518830910936102,0.03038674033149171,0.40585324911749776,1.0,11/42,13.46%,CD47;PDLIM5;EMB;STXBP6;ANXA2;PDLIM1;NPTN;IGSF9;ANXA1;S100A11;TMOD3
prerank,BMP binding (GO:0036122),0.703953070914697,1.5160277801375799,0.048027444253859346,0.4047431190460471,1.0,2/11,8.16%,BMPR2;ENG
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5994707792882367,1.5139482817886019,0.04727793696275072,0.40178220441998114,1.0,8/27,10.28%,ITPR1;SLC23A1;ATP2B1;ATP2A3;MMGT1;SLC4A8;ZDHHC13;MAGT1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.7177857382725048,1.5058227203802461,0.06208053691275168,0.4181276896302803,1.0,5/10,17.79%,CYBB;NOX1;NCF2;NCF1;CYBA
prerank,anion transmembrane transporter activity (GO:0008509),-0.6156668831379806,-1.5029079544490644,0.05152224824355972,0.5804133628289044,1.0,5/12,22.48%,SLCO2B1;ABCG2;SLC26A11;ABCC5;SLC4A2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6975609955295277,1.4990623318766254,0.059625212947189095,0.4289606272597938,1.0,4/12,7.46%,TRAF1;TRAF4;STAT1;TRAF3
prerank,nuclear export signal receptor activity (GO:0005049),0.7126108277248422,1.4945066235480435,0.04878048780487805,0.43325296814438036,1.0,4/11,5.77%,XPO1;XPO5;XPO6;XPO4
prerank,filamin binding (GO:0031005),-0.62431735618919,-1.4869565406491803,0.06053811659192825,0.6172393851160441,1.0,5/11,18.86%,NEBL;FBLIM1;DPYSL3;CRMP1;SYNPO2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6463123803994774,-1.4865235982772365,0.04883720930232558,0.5879577958433093,1.0,5/10,18.59%,GABRG3;GABRG2;GABRA4;GABRA2;GABRA5
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.5013304792391593,-1.4821436083558142,0.059880239520958084,0.5768386938195854,1.0,9/22,16.90%,APOE;SYT1;AP2A1;HSP90B1;CLU;AP2M1;SNX17;APBB1;APBB3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6419894468787681,1.480147885100475,0.06050955414012739,0.46687670359950156,1.0,6/16,8.66%,MTMR14;INPP5F;PTEN;MTMR3;MTMR4;SYNJ1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6657297969730479,1.4789703905992573,0.07291666666666667,0.46107000807222864,1.0,2/14,3.31%,KCNE3;KCNQ1
prerank,amyloid-beta binding (GO:0001540),0.49074902155793554,1.4729533207781484,0.030084235860409144,0.4704406479017878,1.0,15/79,6.89%,CD74;LILRB3;LILRB1;NGFR;LDLR;APBA1;CACNA1A;CD36;SORL1;APBA3;PICALM;ITGB2;HSPG2;PRNP;GSAP
prerank,exopeptidase activity (GO:0008238),0.5201005803458222,1.4719239729343927,0.031081081081081083,0.4646996335505936,1.0,7/50,5.83%,DPP4;ACE;LNPEP;ACE2;DPEP1;PRCP;FAP
prerank,ligand-gated ion channel activity (GO:0015276),-0.45871952593988086,-1.4707917691697248,0.030303030303030304,0.5929503598807266,1.0,7/30,6.91%,GRIA4;GRIA2;GRIA1;GRID2;GRIK4;GABRB1;GRIK1
prerank,chemorepellent activity (GO:0045499),0.5963046746916667,1.4700168146278976,0.05614567526555387,0.461926948325912,1.0,2/25,2.16%,DPP4;SEMA4A
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6842288529450308,1.4682837010679586,0.05733558178752108,0.4584076250905853,1.0,2/11,3.72%,ITPR1;RASA3
prerank,small GTPase binding (GO:0031267),0.44824248008394213,1.4681372440937235,0.007616974972796518,0.4502145024597529,1.0,54/170,16.39%,LRRK2;IQGAP2;IQGAP1;CYRIB;SRGAP2;RIN3;EPS8;NGFR;PKN1;PAK1;MYO1C;RCC2;SORL1;USP6NL;OCRL;UNC13D;PICALM;XPO5;FGD4;AFDN;ARHGDIB;MYO5B;RABGAP1L;RAB34;FLNA;CIB1;MYCBP2;PAK2;GCC2;RABGAP1;NOX1;RHOBTB3;FGD1;FGD3;BRAF;KIF3B;AP1G1;DVL3;SH3BP4;DNM1L;PEX5L;ANKFY1;STRN3;SGSM1;EVI5;MAPKAP1;TRIOBP;RAB29;EHD1;KCTD13;RNF41;EXOC2;HACE1;DAPK3
prerank,pyrophosphatase activity (GO:0016462),-0.4225259209809899,-1.4676973434599219,0.03225806451612903,0.5788509788911929,1.0,28/50,35.39%,ENTPD1;ENPP1;DHX29;PLPP1;PRUNE2;ENTPD5;TRPM2;DHX9;NUDT6;ITPA;DDX3X;ATCAY;PPA2;NUDT3;PLPP4;NUDT16L1;NUDT16;FITM2;PLPP5;ENTPD7;NUDT1;DOLPP1;ENPP3;ENTPD3;ENTPD6;NUDT14;NUDT4;NUDT11
prerank,ligand-gated calcium channel activity (GO:0099604),0.6039438521693561,1.4668562982143232,0.06885758998435054,0.4459765379218983,1.0,2/19,3.72%,ITPR1;RASA3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7191973426437644,1.466338160813766,0.06174957118353345,0.43967435321062265,1.0,5/10,11.05%,PRKAG2;PKIB;CXCL10;PRKAR2A;PRKAG1
prerank,CXCR chemokine receptor binding (GO:0045236),0.6944879026706283,1.460459744167825,0.08020477815699659,0.4503968107731402,1.0,2/11,3.59%,ITCH;CXCL10
prerank,transcription cis-regulatory region binding (GO:0000976),0.4248172271956637,1.4547919010322663,0.0,0.45971235175273056,1.0,65/406,12.31%,CIITA;TRPS1;NFE2;ZBTB46;FOXP1;RARA;SP3;RUNX3;GLI1;KLF4;PPARG;ETV6;LONP1;NFKB1;FOSL2;STAT3;FOXJ1;FOS;ZBTB20;TAF9;SPI1;SCX;TBL1XR1;ATF6;ATF2;IRF2;RFX3;DEAF1;XRN2;BBX;RFX5;TIPARP;KLF10;CDC5L;SETX;AHR;CREBRF;ARID4A;CREM;NFE2L2;PURB;THRA;CRY2;ZFP3;ZBED4;E2F2;GABPB1;GABPB2;CTCF;NFYC;RBAK;E4F1;SNAPC3;SMAD4;RPS3;BNC2;NR3C1;PBX1;FOXO3;IKZF5;TAF7;REST;ATF6B;NFYA;TFAM
prerank,inward rectifier potassium channel activity (GO:0005242),-0.48747835823046126,-1.4531596828613313,0.049586776859504134,0.6062826780279237,1.0,15/24,40.67%,KCNJ2;KCNN2;KCNJ6;KCNK6;KCNN3;KCNJ9;KCNK1;ABCC9;KCNJ3;KCNJ13;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1
prerank,voltage-gated ion channel activity (GO:0005244),-0.5651860507208236,-1.449821389452968,0.057356608478802994,0.5941325662057225,1.0,6/14,16.18%,KCND2;PKD2;HCN1;VDAC1;GPR89B;GPR89A
prerank,ligand-gated channel activity (GO:0022834),-0.4587238430976101,-1.4495101908678092,0.039603960396039604,0.5724535735368985,1.0,7/29,6.91%,GRIA4;GRIA2;GRIA1;GRID2;GRIK4;GABRB1;GRIK1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6235201174466145,1.4457608309907355,0.09180327868852459,0.47788848829509234,1.0,3/16,4.94%,HGD;ETHE1;HAAO
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6983008446616257,1.4440042730224758,0.08528428093645485,0.4673973951558255,1.0,3/10,11.47%,DUSP16;DUSP6;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6983008446616257,1.4440042730224758,0.08528428093645485,0.4673973951558255,1.0,3/10,11.47%,DUSP16;DUSP6;DUSP1
prerank,CARD domain binding (GO:0050700),0.6394201389993506,1.4425416197748429,0.09656301145662848,0.4643310290978685,1.0,3/14,13.47%,CARD11;CARD16;CARD19
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.66972141589134,1.4371870126766115,0.0762987012987013,0.4732380924090769,1.0,7/12,15.48%,TENT5A;TUT1;TENT2;PAPOLG;MTPAP;TENT4B;PAPOLA
prerank,MAP kinase phosphatase activity (GO:0033549),0.6706835221906673,1.434820291585664,0.08471760797342193,0.47264363545127797,1.0,3/12,11.47%,DUSP16;DUSP6;DUSP1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5215286003533169,-1.4345370265687833,0.07777777777777778,0.6024676073016036,1.0,5/17,6.91%,GRIA4;GRIA2;GRIA1;GRIK4;GRIK1
prerank,cytokine receptor binding (GO:0005126),0.4735988624142542,1.4344992149061868,0.04094292803970223,0.4661964511705444,1.0,19/83,16.20%,IL1B;IL27RA;SYK;JAK2;IL6R;VEGFC;CCRL2;ADAM17;PXDN;IL6ST;IL6;USP15;PGF;LIFR;TYK2;TIMM50;IL18;SPRED1;CD300LF
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.6128207157312566,-1.4299841105216453,0.08353808353808354,0.597399759925819,1.0,5/10,16.23%,ECHS1;ECHDC1;HADHB;HADHA;ECI1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5057890160267866,1.4280839367452969,0.05366492146596859,0.4782022848438298,1.0,13/49,15.09%,PTPN22;SAMHD1;DUSP16;PTPRO;ARMT1;SMPDL3B;SMPDL3A;PXYLP1;DUSP12;PGAM5;PPP1CB;PTPRJ;DUSP28
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.47970396448096997,1.4263641285365436,0.042027194066749075,0.4764240059267512,1.0,6/73,2.72%,CRHR2;CYSLTR2;FPR1;LTB4R;FPR3;RXFP2
prerank,GTPase binding (GO:0051020),0.43142059979440434,1.4251429889596785,0.01284796573875803,0.47321900396420363,1.0,56/195,16.39%,LRRK2;IQGAP2;IQGAP1;CYRIB;SRGAP2;LCP1;RIN3;EPS8;NGFR;PKN1;PAK1;MYO1C;RCC2;SORL1;USP6NL;OCRL;UNC13D;PICALM;XPO5;FGD4;AFDN;ARHGDIB;MYO5B;RABGAP1L;RAB34;FLNA;CIB1;MYCBP2;PAK2;GCC2;RABGAP1;NOX1;RHOBTB3;FGD1;GNB1;FGD3;BRAF;KIF3B;AP1G1;DVL3;SH3BP4;DNM1L;PEX5L;ANKFY1;STRN3;SGSM1;EVI5;MAPKAP1;TRIOBP;RAB29;EHD1;KCTD13;RNF41;EXOC2;HACE1;DAPK3
prerank,calcium channel regulator activity (GO:0005246),0.536999498639958,1.4237420969812413,0.08152173913043478,0.4706790388250177,1.0,5/37,8.42%,ITPR1;SGK3;MCUB;STIM2;SLC30A1
prerank,ribosomal large subunit binding (GO:0043023),-0.5913336819628777,-1.4194443477055245,0.08466819221967964,0.6156086067046861,1.0,6/11,12.75%,CPEB2;MRRF;LTN1;CPSF6;RBM3;NPM1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5455606191953665,1.418952987664794,0.09131075110456553,0.4775842021956011,1.0,5/32,5.68%,KCNE3;KCNG4;KCNA6;KCNQ1;KCNH1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5659881457322069,1.4183514884956436,0.09579100145137881,0.47259192212851997,1.0,7/25,9.68%,ZC3HAV1;PARP8;PARP4;TIPARP;PARP14;TNKS;PARP9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.6818754329529996,1.4164681894205757,0.09649122807017543,0.4716547388179512,1.0,4/11,17.81%,PADI1;ARG2;DDAH1;PADI2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5659169913808135,1.4142897995442738,0.09748892171344166,0.47151578630037005,1.0,4/25,10.45%,KMO;CYP27A1;MSMO1;MTRR
prerank,calcium activated cation channel activity (GO:0005227),-0.5224637766311762,-1.412701609026408,0.06896551724137931,0.6204872838281124,1.0,5/17,8.18%,KCNMA1;ANO10;KCNN2;TMEM63B;KCNMB2
prerank,GTPase activator activity (GO:0005096),0.4148602977234751,1.4089128789196044,0.007186858316221766,0.480525964596823,1.0,61/313,9.82%,ARHGAP15;LRRK2;VAV3;RIN2;RAP1GAP2;DOCK5;IQGAP2;IQGAP1;TIAM1;ARHGEF18;SRGAP2;RASGRP4;TBC1D1;RIN3;RAP1A;DOCK2;DENND3;TBC1D8;RACGAP1;DOCK10;SIPA1L3;TBC1D9;CCDC88C;ARHGAP18;RASGRP2;ARHGEF10L;ARHGAP30;DENND1A;RAPGEF2;RGS2;ARHGAP26;RGS3;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;DOCK11;OCRL;BCR;RP2;TAGAP;DLC1;ARAP1;FGD4;TBC1D8B;DENND1B;RABGAP1L;CCZ1;NUCB2;MYCBP2;RABGAP1;PLCB1;FGD1;CYTH3;SOS1;FGD3;CYTH2;DEPDC5;TBC1D5;ARHGEF6;ARFGEF1
prerank,lipase activity (GO:0016298),0.5166344736461383,1.4063131614299842,0.08401084010840108,0.48170114532808833,1.0,2/43,0.54%,PLBD1;PLA1A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.431236598746107,1.4037779272804982,0.02348993288590604,0.48244963546981545,1.0,30/147,9.82%,VAV3;RIN2;DOCK5;TIAM1;ARHGEF18;RASGRP4;RIN3;RAP1A;DOCK2;DENND3;DOCK10;CCDC88C;RASGRP2;DENND1A;RAPGEF2;CCDC88A;DOCK11;BCR;FGD4;DENND1B;CCZ1;NUCB2;MYCBP2;FGD1;CYTH3;SOS1;FGD3;CYTH2;ARHGEF6;ARFGEF1
prerank,cGMP binding (GO:0030553),0.6592171298230145,1.4005263470622724,0.12116040955631399,0.48551022714941694,1.0,2/11,7.50%,RAPGEF2;PDE2A
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6166924284192677,1.3958032556651792,0.12111292962356793,0.49346921108579145,1.0,5/14,8.66%,MTMR14;PTEN;MTMR3;MTMR4;SYNJ1
prerank,adenylyltransferase activity (GO:0070566),0.5707247674829498,1.3919806456143002,0.10773899848254932,0.49813322388255155,1.0,9/21,15.48%,OAS2;OASL;TUT1;TENT2;PAPOLG;MTPAP;NMNAT3;TENT4B;PAPOLA
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.6234164911384268,1.3918151481189704,0.10517799352750809,0.492353030727383,1.0,2/13,4.13%,DNA2;FEN1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5777346566281094,-1.3896719603893297,0.0951219512195122,0.6852076069442042,1.0,6/12,19.33%,IGF1;IRS1;PIK3R1;SOCS2;GNAS;YWHAH
prerank,ligand-gated anion channel activity (GO:0099095),-0.5116623894896195,-1.3875402854483139,0.1122715404699739,0.6714145584312726,1.0,9/17,18.59%,GABRG3;GABRG2;GLRA3;GABRB1;GLRA2;GABRA4;GABRB3;GABRA2;GABRA5
prerank,carbohydrate kinase activity (GO:0019200),-0.5809098719507391,-1.3871644779885106,0.13768115942028986,0.6523343350020455,1.0,4/11,3.49%,FGGY;HK3;NAGK;HK1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5516834097511293,1.3859087305719793,0.093841642228739,0.503889795484499,1.0,14/28,23.71%,TRAF1;TRAF4;STAT1;TRAF3;SIVA1;PIDD1;RIPK1;MYD88;TRAF2;FEM1B;BID;TNF;MADD;CASP8AP2
prerank,serine-type endopeptidase activity (GO:0004252),0.4573955770449188,1.3839795187866564,0.054086538461538464,0.5033042072091738,1.0,12/80,13.36%,DPP4;PRSS53;HP;HPR;FAP;PARL;C1RL;HGF;RHBDL2;MBTPS1;CORIN;PCSK5
prerank,retinoid binding (GO:0005501),0.5593653632676882,1.3815817889597004,0.0904836193447738,0.5039897594988425,1.0,1/22,0.51%,RARA
prerank,tropomyosin binding (GO:0005523),-0.52730593576642,-1.381150838806253,0.10112359550561797,0.6554592778511716,1.0,5/16,18.61%,NEBL;CALD1;PYCARD;TMOD1;TMOD2
prerank,chloride channel inhibitor activity (GO:0019869),-0.5890743372130408,-1.3804630440145929,0.11888111888111888,0.6394733453933978,1.0,7/10,21.63%,WNK1;WNK2;VTI1B;STX1A;VAMP8;STX8;WNK3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.47080675980293085,-1.380212149210074,0.07780979827089338,0.6229331099923833,1.0,10/22,12.66%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP2A2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,cholesterol transfer activity (GO:0120020),-0.510345571298952,-1.3744414443407722,0.10962566844919786,0.6258060658818075,1.0,4/16,16.71%,ABCA1;GRAMD1A;MTTP;STARD5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6343140858042694,1.3730116551473182,0.135,0.5225626339615976,1.0,6/13,13.09%,PIP4K2A;PIK3C2A;PIKFYVE;PIP4K2B;PIK3CA;PIP5K1A
prerank,intracellular chloride channel activity (GO:0061778),-0.5248504578451717,-1.3704920291717626,0.10160427807486631,0.6069701143758697,1.0,3/16,5.90%,TTYH3;ANO10;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5248504578451717,-1.3704920291717626,0.10160427807486631,0.6069701143758697,1.0,3/16,5.90%,TTYH3;ANO10;TTYH2
prerank,semaphorin receptor activity (GO:0017154),-0.5885200719041964,-1.369407854984816,0.10741687979539642,0.5954646007628793,1.0,5/11,6.67%,PLXNA4;NRP1;NRP2;PLXNB2;PLXNA2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5743191534016493,-1.3689543266890516,0.10476190476190476,0.5822626460262801,1.0,9/12,38.44%,ENTPD1;ENTPD5;SLC25A42;ENTPD7;ENTPD3;ENTPD6;CANT1;NUDT18;ENTPD2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.539062874782329,1.3672142883804872,0.11791730474732007,0.5335991778539781,1.0,8/25,14.35%,MYO1G;DAPP1;SESTD1;PLEKHA2;HIP1;AKT1;NCF1;MAPKAP1
prerank,transcription coregulator binding (GO:0001221),-0.3875850982994636,-1.3642274506642187,0.061068702290076333,0.5833698559945066,1.0,32/50,30.81%,VGLL4;LMO2;NEK6;EED;CTNNB1;THRB;CTBP1;PGR;MTF2;SMAD3;MED25;PER1;PHF1;PER3;ESR1;ZBTB49;AR;PER2;EHMT2;HDAC6;CDK9;HDGF;THAP7;CHD6;ZBTB17;CIT;RORA;PPARD;USP11;UBE2I;ZBTB7A;SUZ12
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.5160120581367725,1.3614736142000354,0.11510791366906475,0.5443025510804761,1.0,15/31,21.01%,BIRC6;UBE2E1;UBE2QL1;UBE2D3;UBE2N;UBE2W;UBE2Z;UBE2S;UBE2G1;UBE2J2;TAF1;UBE2Q2;AKTIP;UBE2E3;CDC34
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.413608759774302,1.3594274092007383,0.03879310344827586,0.5441828285315868,1.0,53/181,18.18%,KLF4;CREB1;PPARG;DTX3L;STAT3;FOS;MAD2L2;RBBP8;NCOA3;SPI1;NFKBIA;CRY1;MTA3;ATF2;RBPJ;STAT1;HIPK2;MAPK14;FAF1;ANXA4;BUD31;TADA3;NFE2L2;CPNE1;BCAS3;ID2;WWP2;NCOA2;SMARCE1;PARP9;NCOA1;SPEN;BAZ2A;TACC1;NRIP1;CHD4;HCLS1;HDAC3;DUSP26;CREBBP;RELA;MIER1;TAF1;BHLHE40;MED1;RBL2;RB1;PROX1;SIRT1;BBS10;SMARCD3;HDAC1;NCOA7
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5429640911058393,1.3571471563888686,0.12960235640648013,0.544717377206779,1.0,6/24,7.12%,DAPK1;CAMK1D;MAPKAPK3;MAPKAPK2;PTK2B;MKNK2
prerank,actinin binding (GO:0042805),0.5632589215339472,1.3564608562481426,0.13509316770186336,0.5405824513352021,1.0,4/21,2.11%,RARA;PDLIM5;PPARG;NFKB1
prerank,magnesium ion binding (GO:0000287),0.42758158210426467,1.3561945782632354,0.0464326160815402,0.5353488203229136,1.0,41/135,17.18%,LRRK2;SIK1;MAP3K5;PLSCR1;ERN1;STK38;FEN1;RP2;SIK3;STK4;GSS;IMPA1;WRN;PDE2A;MAPK12;SIK2;STK38L;MSH6;IDH1;PGM1;LATS1;OXSR1;NLRC4;TDG;MTPAP;NLK;RHEB;GNAI1;EXD2;XXYLT1;MAP3K20;NT5C3A;BRSK1;PAPOLA;SRR;ENDOV;IRAK3;DYRK2;MVK;ABL2;PI4K2A
prerank,ephrin receptor binding (GO:0046875),0.5520449401810034,1.3525420362632672,0.13707165109034267,0.53973291797126,1.0,7/21,10.52%,LYN;FYN;CRK;CBL;GRB2;EFNA2;PTPN1
prerank,monocarboxylic acid binding (GO:0033293),0.5798563909883521,1.3508178972257732,0.1390625,0.5385046620685278,1.0,2/18,7.60%,RARA;PSAP
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.40648069400367864,1.3437624070270746,0.04184549356223176,0.5525642336606735,1.0,33/188,12.31%,CIITA;GLI1;KLF4;PPARG;NFKB1;STAT3;FOXJ1;FOS;ZBTB20;TAF9;SPI1;TBL1XR1;ATF6;RFX3;AHR;ARID4A;NFE2L2;THRA;CRY2;ZBED4;GABPB1;GABPB2;CTCF;NFYC;SMAD4;BNC2;PBX1;FOXO3;TAF7;REST;ATF6B;NFYA;TFAM
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4083688969217958,-1.3433254907286425,0.0749063670411985,0.6367986254030712,1.0,8/37,7.13%,CACNA1D;CACNB2;CACNA2D3;CACNA2D1;PKD2;CACNA1C;CACHD1;TPCN2
prerank,protein kinase C activity (GO:0004697),0.6087110544418604,1.3430283797710392,0.1377551020408163,0.5489157516221786,1.0,3/14,2.88%,PRKCE;PKN1;PRKCH
prerank,sodium channel activity (GO:0005272),-0.41795354002898555,-1.341029467879174,0.08914728682170543,0.6293811971527339,1.0,9/37,12.12%,SCN1A;PKD2;SCN3A;GRIK4;GRIK1;HCN1;HCN2;SHROOM2;SCN1B
prerank,SUMO transferase activity (GO:0019789),-0.49887255113060214,-1.3389524677544016,0.11609498680738786,0.6215157850869341,1.0,8/16,30.08%,RANBP2;PIAS2;PIAS4;MDM2;HDAC4;EGR2;CBX4;UBE2I
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5262444257475515,1.3387807618768524,0.11416184971098266,0.5552381992523797,1.0,12/30,15.36%,RPS6KA3;BIRC6;DPEP1;BIRC3;CAST;SERPINB9;TNFAIP8;CARD16;UBE2Z;RPS6KA1;XIAP;PRDX5
prerank,transcription corepressor binding (GO:0001222),-0.43039491450284695,-1.3375481413726935,0.10869565217391304,0.6124217835004498,1.0,13/27,20.86%,NEK6;EED;CTBP1;MTF2;PER1;PHF1;PER3;ESR1;PER2;EHMT2;HDAC6;HDGF;THAP7
prerank,protein kinase binding (GO:0019901),0.3899277214627305,1.336744701437792,0.005035246727089627,0.5552311909177194,1.0,116/480,15.94%,FGR;PTPRC;RND3;NEDD9;GRK5;RARA;IQGAP1;CD226;PDLIM5;SIK1;PLCG2;ACE;VRK1;MARVELD3;STAP1;DUSP16;MAPKAPK3;UTRN;PKN1;PPP1R12A;MSN;RACGAP1;PRKAG2;JAK2;STAT3;CRK;BMPR2;MAD2L2;KCNQ1;KIF20A;RCC2;MAPKAPK2;STK38;PTPN6;CCDC88A;RAC2;BCL2L14;IKBKB;VRK2;SLC12A7;CDC42;AXIN1;IBTK;ATF2;CCND3;ADRA2A;BCAR1;ITGB2;CAV2;PRKRIP1;IRAK4;FAF1;TIRAP;TEX14;CDKN2C;AP2A2;MAP3K1;CCND1;PRKAB2;GRB2;NBEAL2;PAK2;RHOBTB3;EZR;RAC1;CACUL1;HDAC9;DUSP6;PPP1R15A;RHOA;LATS1;RNF13;DIRAS1;OXSR1;SPRED3;GSKIP;RPS3;DAXX;IL31RA;NR3C1;CYLD;PTPN1;CEP250;TRIM14;PRKAR2A;YWHAZ;PRKAG1;FOXO3;DUSP1;PPP1CB;MAP2K3;CASS4;PPM1D;CCND2;MVP;CSK;RNF138;HCLS1;DNAJC3;KAT2B;MAPKAP1;PTPRJ;USP37;MAP3K13;ADAM9;RB1CC1;GSTP1;FBXO7;RHOG;RELA;SPRED1;MAML1;IRAK3;DUSP22;APC;EXOC2
prerank,phosphatidylinositol binding (GO:0035091),0.440853525514424,1.3361820269679066,0.06818181818181818,0.5510478866335925,1.0,26/91,13.72%,ITPR1;FRMPD2;PLEKHF1;MYO1E;DENND1A;CCDC88A;PICALM;DPEP1;MITD1;ESYT3;SCARB1;SNX1;DENND1B;ESYT1;SESTD1;PITPNB;ZFYVE9;PHF12;BCAS3;PITPNM1;HIP1;SNX9;ING2;ESYT2;NCF1;ANKFY1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.6111277493669256,1.3338679610065858,0.15755627009646303,0.5520524946875798,1.0,6/12,20.96%,PNLDC1;CNOT6;CNOT2;CNOT8;CNOT6L;PARN
prerank,DNA replication origin binding (GO:0003688),0.5459804436428577,1.327820195216735,0.15994020926756353,0.5631577923146458,1.0,9/23,17.75%,CDC45;KAT7;ORC5;MCM6;ORC4;MCM2;MCM9;HSPD1;ORC2
prerank,alpha-actinin binding (GO:0051393),0.5407391954294467,1.32632989048133,0.14883720930232558,0.5618217463813319,1.0,4/24,2.28%,RARA;PDLIM5;PPARG;PDLIM1
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.42022579744633154,1.325279709041938,0.0763888888888889,0.5591441233466576,1.0,22/100,14.35%,MYO1G;IQGAP2;IQGAP1;DAPP1;RACGAP1;PLEKHF1;DENND1A;GOLPH3L;ARAP1;KCNH1;DENND1B;SESTD1;GBF1;CYTH3;SNX20;HIP1;WIPI2;SNX3;BTK;AKT1;ANKFY1;MAPKAP1
prerank,ADP binding (GO:0043531),0.5243494078840367,1.324189892028123,0.14420062695924765,0.5565374329470643,1.0,11/25,14.77%,LONP1;PRKAG2;ERN1;MYH9;TAP1;COQ8A;MSH6;GLUD1;PRKAG1;ABCD1;ABCG1
prerank,G protein-coupled receptor activity (GO:0004930),0.39678014042713317,1.3239407610480058,0.03225806451612903,0.5518094545711629,1.0,22/239,11.27%,GPR141;FFAR4;CRHR2;CYSLTR2;FPR1;ADGRG5;LTB4R;FPR3;ADGRG6;ADGRE5;RXFP2;LPAR3;GPR35;ADRA2A;P2RY14;CYSLTR1;OPRM1;HRH1;S1PR5;TAPT1;GPR88;GLP2R
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5493686488564165,1.3194708151461751,0.15749235474006115,0.5599248724248724,1.0,2/20,1.57%,CARD11;CASK
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.5083659311571765,-1.318326914606452,0.14435695538057744,0.6607573512791196,1.0,11/14,34.16%,POP1;RPP30;TSEN2;RPP14;TSEN34;ELAC2;RPP40;POP4;POP5;RPP21;POP7
prerank,carboxypeptidase activity (GO:0004180),-0.4142443901924384,-1.3175070854109496,0.09375,0.6496725748844606,1.0,17/35,29.41%,CTSA;FOLH1;NAALAD2;MINDY2;CTSZ;BLMH;MINDY1;AEBP1;AGBL1;AGBL4;CPA6;CPE;SCPEP1;PEPD;AGBL3;VASH2;CPD
prerank,mannosyltransferase activity (GO:0000030),-0.4590302097811898,-1.3164704252279502,0.12893982808022922,0.6398465546605362,1.0,13/21,30.53%,DPY19L4;ALG8;PIGB;ALG2;ALG9;POMT1;PIGV;ALG1;DPY19L3;TMTC1;ALG3;POMT2;DPM1
prerank,microtubule plus-end binding (GO:0051010),-0.46493441105284894,-1.315275689683602,0.12256267409470752,0.6308651123835881,1.0,5/20,6.89%,DST;NUMA1;CLIP1;CLASP2;CLIP2
prerank,actin monomer binding (GO:0003785),0.5375127393079956,1.308873694726808,0.17350157728706625,0.5850015953642896,1.0,4/22,4.97%,PRKCE;CORO1A;MYL4;TMSB10
prerank,GTPase regulator activity (GO:0030695),0.3928019254138519,1.3064510272942442,0.05919661733615222,0.5866918852303543,1.0,40/212,9.82%,ARHGAP15;LRRK2;VAV3;RIN2;RAP1GAP2;IQGAP2;IQGAP1;SRGAP2;TBC1D1;TBC1D8;RACGAP1;SIPA1L3;TBC1D9;ARHGAP18;ARHGEF10L;ARHGAP30;RAPGEF2;RGS2;ARHGAP26;RGS3;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;OCRL;BCR;RP2;TAGAP;DLC1;ARAP1;TBC1D8B;RABGAP1L;RABGAP1;PLCB1;SOS1;RGS12;DEPDC5;TBC1D5;ARHGEF6;ARFGEF1
prerank,chemokine receptor binding (GO:0042379),0.4902356964324235,1.306016586524739,0.14600550964187328,0.5822892768319141,1.0,5/35,6.59%,ITCH;CXCL10;CKLF;CXCL16;CCRL2
prerank,sterol transfer activity (GO:0120015),-0.4792066003209192,-1.305474975517892,0.15,0.6490182333823676,1.0,4/17,16.71%,ABCA1;GRAMD1A;MTTP;STARD5
prerank,actin binding (GO:0003779),0.39847877140744103,1.305216762423597,0.06535947712418301,0.579082202786866,1.0,22/170,8.00%,LRRK2;FXYD5;IQGAP2;PHACTR2;PRKCE;LCP1;PDLIM5;EPS8;UTRN;PDLIM1;MSRB1;HPCA;CORO1A;MYL4;CCDC88A;FHL3;MYH9;TMSB10;FLNB;CAPZB;PAWR;EZR
prerank,nucleotide diphosphatase activity (GO:0004551),-0.5100456952417707,-1.3049743637939009,0.16296296296296298,0.6380350011309436,1.0,4/14,20.75%,FHIT;ENPP1;NUDT6;NUDT3
prerank,titin binding (GO:0031432),-0.5273516909006225,-1.3049303732132773,0.14893617021276595,0.6261456973344227,1.0,4/13,18.89%,CAPN3;CALM1;ACTN2;MYBPC1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.45169307776498124,-1.3048403434417186,0.11271676300578035,0.6148012606086108,1.0,10/22,22.04%,IKBKE;ZRANB1;MINDY2;RNF169;OPTN;OTUD7A;OTUD7B;SQSTM1;SPRTN;WDR81
prerank,cAMP response element binding (GO:0035497),0.6183396558654833,1.2993236726447883,0.17967332123411978,0.590334910485122,1.0,3/10,9.33%,CREB1;ATF2;E4F1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.6199396882894626,1.2982553098504461,0.18003273322422259,0.5882494792998797,1.0,1/11,0.07%,ITPR1
prerank,hyaluronic acid binding (GO:0005540),0.6189296649759926,1.2976316600405364,0.1702127659574468,0.5847027980482679,1.0,1/10,0.26%,CD44
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.4879799008762272,1.2967672009468911,0.14444444444444443,0.5818069137369656,1.0,13/35,18.06%,FOXP1;FOS;H3-3A;STAT1;KLF10;GTF2A1;SNAPC3;NR3C1;BAZ2A;RELA;TAF1;TAF1C;HDAC1
prerank,phospholipase inhibitor activity (GO:0004859),0.6234732308025991,1.2958536369804559,0.1968365553602812,0.5795611847012646,1.0,4/10,15.06%,ANXA2;ANXA4;ANXA1;ANGPTL3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.41955405033075055,-1.2958077122356282,0.10839160839160839,0.6320493711501203,1.0,9/28,18.59%,GABRG3;GABRG2;GRID2;GRIK4;GRIK1;GABRA4;CHRNA7;GABRA2;GABRA5
prerank,histone demethylase activity (GO:0032452),0.5047162160219523,1.2911248467236522,0.16515151515151516,0.5879333172079286,1.0,4/27,7.21%,JARID2;KDM6A;KDM7A;KDM3B
prerank,androgen receptor binding (GO:0050681),0.5109786782570548,1.2899035844612414,0.1495601173020528,0.5864580179515975,1.0,5/25,13.25%,FOXP1;PKN1;PRPF6;DAXX;NSD1
prerank,protein tyrosine kinase activity (GO:0004713),0.4051797893665223,1.288099594747403,0.10859188544152745,0.5864828904627011,1.0,16/108,7.20%,FGR;HCK;LYN;FLT3;FYN;RET;LMTK2;SYK;JAK2;SLA;ZAP70;HIPK2;STYK1;HIPK1;PTK2B;DYRK1A
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4340838792509088,1.2836743933943233,0.135,0.5941232728797495,1.0,25/71,18.42%,PTPRC;CDC14A;PTPN22;PTPRE;PTPRU;PTPRO;PTPN6;PTPN7;PTPN12;TNS2;PTEN;MTMR3;PTPN1;PTP4A2;PTPDC1;DUSP1;TIMM50;PTPRJ;PTPRG;DUSP26;DUSP22;EYA3;PTPN4;PTPRA;PTP4A3
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.535372666336707,-1.2830699290333636,0.176056338028169,0.6607963804200389,1.0,5/11,19.06%,CTC1;NABP2;TERF2IP;TERF1;HNRNPA2B1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5893932305560184,1.2801823785100244,0.18729096989966554,0.5985275714572282,1.0,4/12,16.95%,NAPSA;SPPL2A;BACE2;PSEN1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5919591567351873,1.2800948928008296,0.19015280135823429,0.5937822800059923,1.0,7/12,18.06%,FOS;H3-3A;STAT1;GTF2A1;RELA;TAF1;HDAC1
prerank,retinoid X receptor binding (GO:0046965),0.590209261483848,1.2789359967664153,0.1992818671454219,0.5922100503706721,1.0,5/11,13.25%,PPARG;RARG;TACC1;NRIP1;NSD1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.42471739682812104,1.2770721956340096,0.12360939431396786,0.5927845021323376,1.0,11/72,9.46%,MYO1G;SVIL;STXBP6;ANXA2;KCNQ1;PICALM;SESTD1;TIRAP;PLCB1;SNX20;HIP1
prerank,cation:chloride symporter activity (GO:0015377),0.6073756528539836,1.2741372743993513,0.20137693631669534,0.5960383852807194,1.0,3/10,11.22%,SLC12A7;SLC12A6;SLC12A9
prerank,MAP-kinase scaffold activity (GO:0005078),0.594774157338635,1.2738350040011115,0.19487179487179487,0.591949082913319,1.0,1/11,0.55%,IQGAP1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.6018587826827728,1.2722805430982762,0.22262118491921004,0.5914732576315395,1.0,3/10,13.97%,HEXIM1;CDKN2C;KAT2B
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5477069319056379,1.2715087840602743,0.19249592169657423,0.5889146159819735,1.0,6/16,11.50%,SLC25A13;SLC25A30;SLC1A5;SLC25A12;SLC1A4;SLC25A18
prerank,cadherin binding (GO:0045296),0.37705251148847385,1.271186118307643,0.04396728016359918,0.5852179310728535,1.0,74/315,14.84%,FXYD5;IQGAP1;AHNAK;ZC3HAV1;PDLIM5;STK24;SLK;STXBP6;CNN2;ANXA2;PTPRO;PDLIM1;SHTN1;WASF2;HSPA1A;ARHGAP18;EPS15;BMPR2;PRDX6;STK38;SND1;CTNNA1;KIF5B;ABI1;MRE11;CBL;MYH9;PICALM;LRRFIP1;CHMP4B;CD2AP;RPL6;STAT1;SNX1;FLNB;AFDN;CAST;CAPZB;FLNA;PKN2;PAK2;GIGYF2;PHLDB2;TRIM25;F11R;EZR;STX5;CAPZA1;IDH1;EPS15L1;EEF1G;RTN4;ANXA1;PTPN1;SNX9;VASP;YWHAZ;BZW2;TBC1D2;CDH9;S100A11;RPL34;TLN1;ESYT2;PACSIN2;LRRC59;SWAP70;TMOD3;KTN1;RPS2;PTPRJ;TAGLN2;EIF3E;EHD1
prerank,DNA-binding transcription factor binding (GO:0140297),0.3860177730109963,1.2703754333969755,0.07783783783783783,0.5828820575668929,1.0,47/189,18.06%,CIITA;SIK1;KLF4;CREB1;PPARG;STAT3;FOS;MAD2L2;RBBP8;TAF9;SPI1;SCX;MTA3;ATF2;RBPJ;STAT1;HIPK2;CGGBP1;CREM;NFE2L2;PURB;HDAC9;ID2;WWP2;PSMD9;SPEN;YWHAZ;TXLNG;NLRP3;CHD4;TLE1;HCLS1;CRTC3;DUSP26;CREBBP;RELA;MIER1;TAF1;BHLHE40;RBL2;RB1;DAPK3;CHCHD2;SIRT1;BBS10;HDAC7;HDAC1
prerank,1-phosphatidylinositol binding (GO:0005545),0.559154544092341,1.268981433628125,0.20064724919093851,0.5824185050423717,1.0,6/15,10.56%,FRMPD2;PICALM;SCARB1;SESTD1;ZFYVE9;SNX9
prerank,sterol binding (GO:0032934),-0.34921698649440835,-1.2675360419066883,0.09821428571428571,0.700793559910044,1.0,26/56,32.81%,ABCA1;OSBPL11;OSBPL8;GRAMD1A;APOD;OSBPL1A;ERLIN2;STARD3;VDAC1;SIDT1;NPC1;GPR183;STARD5;OSBPL6;PTCH1;OSBPL7;SOAT2;OSBP;OSBPL5;RORA;NR1H3;CAV1;PROM1;OSBPL2;STARD4;STAR
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5347859438411428,-1.2655436544452174,0.2033096926713948,0.6954061181649838,1.0,3/10,3.49%,CACNA1D;CACNB2;CACNA1C
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5404914973881823,-1.2645328461831995,0.18421052631578946,0.6871208999019128,1.0,4/11,12.80%,KCNMA1;KCNN2;KCNMB2;KCNN3
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.4976988813810846,-1.262557543640992,0.18181818181818182,0.6822538014996616,1.0,7/13,24.61%,TRMT1;TRMT1L;METTL1;THUMPD2;TRMT10A;WDR4;TRMT5
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5249526596497301,1.2615276904716792,0.2087087087087087,0.598640633644851,1.0,8/18,15.36%,RPS6KA3;DPEP1;BIRC3;SERPINB9;TNFAIP8;RPS6KA1;XIAP;PRDX5
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5155625629308931,1.2608515527709725,0.20209580838323354,0.5957782123585231,1.0,5/22,11.47%,DUSP16;MTMR3;DUSP6;DUSP12;DUSP1
prerank,ATP hydrolysis activity (GO:0140603),0.4607282993771105,1.2602032288928986,0.16198125836680052,0.593052768783497,1.0,8/41,7.91%,DNA2;HSPA1A;MYO1E;ATP2B1;ABCA3;RNF213;SMCHD1;RHOBTB3
prerank,serine-type peptidase activity (GO:0008236),0.4102729747434424,1.2598226604788334,0.125,0.5896636637922554,1.0,10/96,10.47%,DPP4;PRSS53;HP;HPR;FAP;PARL;C1RL;HGF;RHBDL2;MBTPS1
prerank,kinesin binding (GO:0019894),-0.4018429509481949,-1.2593597621908967,0.16352201257861634,0.6809883254905817,1.0,11/27,26.50%,PLEKHM2;NEK6;KIF1B;AP1AR;TOR1B;CROCC;NEFH;ATCAY;KLC2;PRC1;SPTBN5
prerank,double-stranded RNA binding (GO:0003725),0.42374499376803454,1.2566959167054266,0.1546134663341646,0.5939439948166427,1.0,13/70,8.53%,MBNL1;OAS2;MSN;VIM;DHX58;EIF2AK2;LRRFIP1;DGCR8;RC3H1;IFIH1;PRKRIP1;OASL;TLR3
prerank,alanine transmembrane transporter activity (GO:0022858),-0.510763918097416,-1.256518801659613,0.1891891891891892,0.6785255855872259,1.0,4/12,12.67%,SLC36A4;SLC36A1;SLC7A8;SLC3A2
prerank,protein phosphatase regulator activity (GO:0019888),0.4387371529476902,1.2555185924660544,0.16026490066225166,0.5929276324644045,1.0,19/53,16.22%,LMTK2;PPP2R5A;EIF2AK2;PPP1R9B;SHOC2;PPP2R2A;PPP4R2;PPP1R15A;PPP1R2;ANKLE2;PPP4R1;DMPK;PPP2R3A;PPP1R15B;LGALS3;PPP6R2;PPP2R5C;PPP2R5E;PPP1R7
prerank,GTPase inhibitor activity (GO:0005095),0.5768929523726625,1.2554629069598675,0.2058319039451115,0.5886678639701092,1.0,2/13,0.55%,IQGAP2;IQGAP1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4658610945346559,1.2537491292362068,0.189873417721519,0.5889561945642409,1.0,15/34,21.01%,BIRC6;UBE2E1;UBE2QL1;UBE2D3;UBE2N;UBE2W;UBE2Z;UBE2S;UBE2G1;UBE2J2;TAF1;UBE2Q2;AKTIP;UBE2E3;CDC34
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4466901215909931,1.2513958666171197,0.17744154057771663,0.590921232973349,1.0,12/42,14.76%,CCNJL;CCND3;HEXIM1;CDKN2C;CCND1;CCNH;CCNT2;CCNT1;CCNL1;CCND2;KAT2B;CDK5R2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3660084196963237,1.2511638373440905,0.05737704918032787,0.5872045220997688,1.0,95/346,18.61%,TRAF1;NEURL3;NEURL1B;DTL;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CUL5;RSPRY1;BIRC6;CBLB;UBE2E1;MALT1;RNF38;TRIM7;CBL;ANKIB1;CDC42;RNF146;CBLL1;TRIM62;PEX12;BIRC3;ARIH1;TRAF3IP2;RNF213;RNF20;PELI1;RC3H1;UBE2QL1;UBE2D3;FBXW11;UBE2N;RNF217;UBR5;HLTF;FBXW2;HECTD1;MYCBP2;TRAF3;TRIM25;FBXO4;UBR2;COP1;ARIH2;RNF130;RNF141;WWP2;RNF13;TRIM71;UBE2W;KCMF1;UBE2Z;FANCL;TRIM14;RNF31;UBE2S;MEX3C;RCHY1;TRIM17;UBE2G1;SH3RF1;AREL1;RNF138;UBE2J2;RNF150;UHRF2;FBXO7;KCTD13;RMND5B;XIAP;RNF166;RNF122;TAF1;TRIM35;RNF41;HACE1;TRIM36;UBR3;MAEA;MSL2;RNF144A;UBE2Q2;TRAF2;TSPAN17;RNF19B;NEURL4;SMURF2;ANAPC11;FBXO3;FBXL14;ANAPC4
prerank,death receptor binding (GO:0005123),0.5507726902842481,1.2473180124258787,0.21788617886178863,0.5931976650096455,1.0,9/15,24.84%,NGF;PIDD1;RIPK1;MYD88;FEM1B;BID;MADD;CASP8AP2;BDNF
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.52634694836423,1.2467664098326146,0.20443740095087162,0.5904980143322112,1.0,5/18,17.80%,HSD17B14;HSD17B7;DHRS9;RDH5;HSD17B2
prerank,nuclear receptor binding (GO:0016922),0.3921334287567816,1.2462013525845481,0.14285714285714285,0.5877366628110758,1.0,33/111,18.18%,FOXP1;PKN1;NCOA3;STAT5B;CRY1;MED30;PRPF6;MED13;STAT1;BUD31;TADA3;OASL;BCAS3;LATS1;NCOA2;SMARCE1;NCOA1;DAXX;MED12;TAF7;BAZ2A;MED14;TACC1;NRIP1;NSD1;TAF1;MED1;PROX1;SIRT1;NR4A1;PADI2;SMARCD3;NCOA7
prerank,ribonuclease P RNA binding (GO:0033204),-0.532620920963214,-1.2443451728728405,0.2222222222222222,0.7054013511722871,1.0,8/10,34.16%,POP1;RPP30;RPP14;RPP40;POP4;POP5;RPP21;POP7
prerank,vitamin D receptor binding (GO:0042809),0.5548175731392609,1.2432703819867976,0.21273031825795644,0.5914878841610214,1.0,6/14,15.79%,MED30;MED13;MED12;TAF7;MED14;MED1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.5280832666796981,-1.2418680641711348,0.20963855421686747,0.7017698480613944,1.0,5/11,31.13%,AKR1A1;AKR1B1;RDH13;DHRS13;RDH11
prerank,potassium channel regulator activity (GO:0015459),0.4383176963564808,1.240494396322857,0.17716535433070865,0.5947331027406392,1.0,6/49,6.98%,KCNE3;SGK3;NEDD4L;SUMO1;KCNIP3;FLNA
prerank,voltage-gated anion channel activity (GO:0008308),-0.4636270624582006,-1.2402684950031022,0.2103825136612022,0.6959750310046632,1.0,7/15,21.10%,CLCN6;CLCN4;VDAC1;CLCN3;GPR89B;GPR89A;CLCN2
prerank,acetylcholine receptor activity (GO:0015464),-0.4231384364527288,-1.240065944892744,0.1671388101983003,0.6859601688409029,1.0,4/22,9.50%,CHRM3;CHRM2;CHRFAM7A;CHRNA7
prerank,protein kinase C binding (GO:0005080),0.44791849670531886,1.23830578739473,0.18096514745308312,0.5964319536210728,1.0,6/43,8.51%,GRK5;PDLIM5;PKN1;CCDC88A;TIRAP;HDAC9
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.36809467041463995,-1.2337767510865771,0.13438735177865613,0.6947101049234152,1.0,16/40,22.24%,DNMT3A;COMT;SETD3;HNMT;DPH5;METTL2B;METTL2A;AS3MT;METTL8;PCMT1;SUV39H1;THUMPD2;LCMT1;METTL9;PCMTD2;N6AMT1
prerank,MHC class I protein binding (GO:0042288),0.5536262795501936,1.232423435782914,0.25254237288135595,0.6081550210369221,1.0,3/13,6.29%,LILRB1;PILRA;TAP1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.35690934763278154,1.232325809931607,0.035140562248995984,0.6042985975025155,1.0,72/597,12.31%,CIITA;NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;GLI1;KLF4;CREB1;PPARG;BCL6;NFKB1;PITX3;STAT3;FOXJ1;ELF4;RFX7;FOS;ZBTB20;CDC45;TAF9;SPI1;TBL1XR1;KAT7;ATF6;ATF2;IRF2;RFX3;ORC5;HIVEP1;KLF5;MCM6;IRF4;BBX;RFX5;KLF13;KLF10;AHR;ARID4A;MBD4;CREM;NFE2L2;THRA;CRY2;ORC4;CLOCK;ZBED4;RARG;E2F2;GABPB1;GABPB2;CTCF;NFYC;ELF1;PKNOX1;IRF7;MEF2B;SMAD4;BNC2;NR3C1;GMEB2;PBX1;FOXO3;TAF7;ETS2;REST;MBD2;ATF6B;NFYA;TFAM
prerank,acylglycerol lipase activity (GO:0047372),-0.5088473233009203,-1.225757206019262,0.228287841191067,0.7090627123608828,1.0,3/11,10.35%,ABHD12;MGLL;ABHD3
prerank,5'-3' exonuclease activity (GO:0008409),0.5473494296304097,1.2207512000296599,0.2157190635451505,0.6310523275734231,1.0,6/14,15.39%,MRE11;FEN1;XRN2;DCP2;EXOG;CPSF3
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5876757544569836,1.219824103877824,0.23508137432188064,0.6294431597260333,1.0,7/10,20.54%,NSD3;SETD5;ASH1L;SETD2;NSD1;SETMAR;PRDM9
prerank,syntaxin-1 binding (GO:0017075),0.4923628182828276,1.2182155326223414,0.22740963855421686,0.6295083742313983,1.0,2/22,1.36%,LRRK2;DAPK1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5364282375471864,1.2174960950740432,0.23854660347551343,0.6229632507984085,1.0,5/16,3.76%,PTPRC;PTPRE;PTPRU;PTPRO;PTPN6
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5364282375471864,1.2174960950740432,0.23854660347551343,0.6229632507984085,1.0,5/16,3.76%,PTPRC;PTPRE;PTPRU;PTPRO;PTPN6
prerank,aspartic-type peptidase activity (GO:0070001),0.5891298987233041,1.2149616555777356,0.2535211267605634,0.6256608317046004,1.0,1/10,0.17%,NAPSA
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.47353344892076243,1.2139861633710287,0.22986822840409957,0.6240534818712203,1.0,8/29,15.33%,PRKAG2;PKIB;HEXIM1;CDKN2C;CIB1;PRKAR2A;KAT2B;SPRED1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.39263164756505897,1.2114261114186338,0.1799761620977354,0.626946986932856,1.0,13/91,9.46%,MYO1G;SVIL;STXBP6;ANXA2;KCNQ1;PICALM;KCNH1;SESTD1;TIRAP;PLCB1;GBF1;SNX20;HIP1
prerank,calcium-release channel activity (GO:0015278),0.5167213711737394,1.2106454331016174,0.23244929797191888,0.6250488724331278,1.0,2/17,3.72%,ITPR1;RASA3
prerank,endonuclease activity (GO:0004519),0.42468242548439034,1.2101139809946757,0.2129032258064516,0.6223074545613406,1.0,15/49,18.78%,ZC3H12D;ERN1;SND1;MRE11;FEN1;MBD4;KHNYN;RPS3;INTS11;EXOG;ERCC4;CPSF3;SMG6;NYNRIN;SETMAR
prerank,kinase binding (GO:0019900),0.35312043059654247,1.2076731257236262,0.07092198581560284,0.6252525811121237,1.0,100/435,15.94%,FGR;PTPRC;RND3;SP100;IQGAP1;TIAM1;CD226;PTPN22;SIK1;PLCG2;VRK1;STAP1;PPP2R5A;UTRN;PPP1R12A;MSN;RACGAP1;PRKAG2;JAK2;STAT3;CRK;KIF20A;RCC2;PTPN6;RAC2;BCL2L14;IKBKB;VRK2;SLC12A7;CDC42;AXIN1;IBTK;ATF2;CCND3;BTG1;ADRA2A;BCAR1;ITGB2;CAV2;TNS2;PRKRIP1;IRAK4;FAF1;TEX14;CDKN2C;AP2A2;MAP3K1;CCND1;PRKAB2;GRB2;FLNA;NBEAL2;PAK2;MOB1B;RHOBTB3;CARD16;RAC1;CACUL1;PPP1R15A;RHOA;LATS1;OXSR1;SPRED3;GSKIP;RPS3;DAXX;IL31RA;NR3C1;CYLD;PTPN1;CEP250;TRIM14;YWHAZ;PRKAG1;FOXO3;HTT;PPP1CB;MAP2K3;EIF4ENIF1;CCND2;PIP5K1A;MVP;RNF138;HCLS1;DNAJC3;KAT2B;MAPKAP1;PTPRJ;USP37;MAP3K13;AURKB;RB1CC1;FBXO7;RHOG;RELA;SPRED1;MAML1;IRAK3;APC;EXOC2
prerank,phospholipase activator activity (GO:0016004),0.5748734812030134,1.2073660960406813,0.26362038664323373,0.6220091658046665,1.0,4/10,16.87%,FYN;PDPK1;BTK;ARHGAP6
prerank,ATP binding (GO:0005524),0.3596290919632156,1.2066209469564089,0.09700722394220847,0.6200538917324527,1.0,75/266,18.87%,MAP4K1;RUNX3;SIK1;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;ERN1;STK38;MYH9;ZAP70;SIK3;MCM6;RPS6KA5;SMARCA5;DARS2;STK4;TAP1;GSS;MKNK2;ATP7A;RHOBTB3;SIK2;STK38L;MINK1;MSH6;SMC4;LATS1;OXSR1;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;PRKAG1;DMPK;NLK;LATS2;MAP4K3;CAD;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TLK1;HASPIN;MYO1F;ABCG1;BRSK1;PAPOLA;SRR;IRAK3;DYRK2;INSR;DAPK3;MVK;GCK;PI4K2A;PRPS2;ABCB8;HSPA5;PTPA;PYGL;MTHFD1L;STK3;PINK1;ABCE1
prerank,muscle alpha-actinin binding (GO:0051371),0.5426787184755818,1.206241372293646,0.282793867120954,0.6172359889328801,1.0,2/15,2.28%,PDLIM5;PDLIM1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.4377206681641553,-1.205938945087803,0.23756906077348067,0.7627378423454073,1.0,5/17,25.89%,SLC2A3;MFSD4A;SLC2A5;SLC2A8;SLC5A11
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5133015915213447,1.204619624465193,0.23410852713178296,0.6173488110861394,1.0,6/17,16.32%,ACOT11;ACOT2;ACAA2;ABCD1;PLA2G6;PPT1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.48173059608917235,1.203928283038582,0.2451708766716196,0.6152728459867205,1.0,4/23,7.83%,PLCG2;CCR1;PLCB1;PLCD4
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4425183938134584,-1.2022939696110062,0.2154255319148936,0.7640169638549202,1.0,5/18,13.74%,TGFBR2;TGFBR1;SMAD7;SMAD3;TGFB2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.399016736789377,1.20162092007334,0.20532319391634982,0.6177663638167786,1.0,11/69,10.07%,CERS6;HHAT;NAA16;CERS1;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC17;KAT6A;NAA15;MOGAT3
prerank,kinase activity (GO:0016301),0.3874443019554025,1.200794168728715,0.19466975666280417,0.6160570502950131,1.0,24/109,16.98%,LRRK2;LYN;DGKG;CERKL;NADK;ITPKC;PIK3C2A;IP6K3;PANK1;PANK4;PKN2;PAPSS1;COQ8A;PAPSS2;CSNK2A1;PIK3CA;PGM2L1;AKT1;STK39;TAF1;IPMK;SEPHS1;MVK;GK
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5024095925049179,-1.1993288658198986,0.2540415704387991,0.7623346018924915,1.0,4/10,14.69%,DLG4;SQSTM1;GNAS;IGSF11
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5263868171349185,1.199241407014751,0.2564885496183206,0.6161457993770758,1.0,4/15,10.65%,PIK3C2A;PI4K2B;PIKFYVE;PIK3CA
prerank,metal ion binding (GO:0046872),0.34962637156547255,1.1990985243077565,0.07615230460921844,0.6128247762088826,1.0,80/477,12.88%,ITPR1;LRRK2;IQGAP1;LCP1;PADI1;SIK1;RET;MAP3K5;ACER3;TNNC1;ANXA2;EFCAB9;TPM4;PLSCR1;TRIM26;HPCA;C2CD5;ERN1;RASGRP2;RAPGEF2;SELL;MCTP2;DYSF;STK38;CLGN;FEN1;RP2;ESYT3;PPP3CA;SIK3;SLC25A13;S100A4;STIM2;ESYT1;STK4;PRNP;GSS;IMPA1;ANXA4;ATP2A1;WRN;NUCB2;CIB1;S100A10;PDE2A;MAPK12;SIK2;STK38L;CABYR;RPE;MSH6;IDH1;PGM1;CPNE1;LATS1;PITPNM1;OXSR1;BRAF;FBN1;CAMKK2;NLRC4;PAPOLG;ANXA1;SLC25A12;TDG;MTPAP;CALB2;LETM1;NLK;TPD52;RHEB;EFCAB11;CDH9;S100A11;GNAI1;EXD2;ESYT2;XXYLT1;MAP3K20;MICU3
prerank,vinculin binding (GO:0017166),0.5695663628703981,1.1977174845116534,0.2857142857142857,0.612459032489438,1.0,4/11,12.51%,UTRN;CTNNA1;PXN;TLN1
prerank,Toll-like receptor binding (GO:0035325),0.5643336990327472,1.1946496385750582,0.27304347826086955,0.616573554073554,1.0,6/11,22.34%,CD36;TIRAP;TLR2;MYD88;TLR1;UNC93B1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.567576698000818,1.1944890168286726,0.287215411558669,0.6133812560675853,1.0,1/10,1.14%,GDA
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3477166061241974,1.192410899191632,0.09778225806451613,0.615069977017554,1.0,102/431,17.20%,LRRK2;RND3;MAP4K1;RUNX3;SIK1;RAP1A;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;RABL3;ERN1;NOA1;STK38;RAC2;MYH9;ZAP70;CDC42;SIK3;RAB7A;MCM6;RPS6KA5;SMARCA5;DARS2;ARF4;RAB6A;STK4;TAP1;GSS;RAB39A;GNL1;MKNK2;ARF1;ATP7A;RHOBTB3;RAC1;SIK2;STK38L;MINK1;RALB;MSH6;RHOA;SMC4;LATS1;DIRAS1;OXSR1;ATL3;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;GLUD1;PRKAG1;DMPK;NLK;RHEB;LATS2;MAP4K3;CAD;GNAI1;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TUBD1;ARL8B;GBP5;MMAA;TLK1;HASPIN;RRAD;MYO1F;RAB29;GBP2;ABCG1;BRSK1;ATL1;GBP3;RHOG;DRG2;PAPOLA;SRR;IRAK3;SEPHS1;DYRK2;TUBA1B;INSR;DAPK3;RAB35;MVK;GCK;PI4K2A;PRPS2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.4890215857324943,-1.1922768402607757,0.27941176470588236,0.7758442803778589,1.0,7/12,18.59%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABRA2;GABRA5
prerank,adenyl ribonucleotide binding (GO:0032559),0.3538946002999867,1.1920832548561604,0.1105424769703173,0.6122426191965326,1.0,80/291,18.87%,MAP4K1;RUNX3;SIK1;DAPK1;MAP3K5;LMTK2;AKT3;OAS2;LONP1;PIM1;STK17B;PRKAG2;HSPA1A;ERN1;RAPGEF2;STK38;MYH9;ZAP70;SIK3;MCM6;RPS6KA5;SMARCA5;DARS2;STK4;TAP1;GSS;MKNK2;PDE2A;ATP7A;RHOBTB3;SIK2;COQ8A;STK38L;MINK1;MSH6;SMC4;LATS1;OXSR1;TLK2;NLRC4;PIP4K2B;TDG;MTPAP;GLUD1;PRKAG1;DMPK;NLK;LATS2;MAP4K3;CAD;MAP3K20;HSPA9;BTK;ABCD1;AKT1;PDK3;TLK1;HASPIN;MYO1F;ABCG1;BRSK1;PAPOLA;SRR;IRAK3;DYRK2;INSR;DAPK3;MVK;GCK;PI4K2A;PRPS2;ABCB8;HSPA5;PTPA;PYGL;PDE4B;MTHFD1L;STK3;PINK1;ABCE1
prerank,sodium channel regulator activity (GO:0017080),0.43598034228341853,1.1895334368367545,0.24390243902439024,0.6153774188477165,1.0,3/37,2.59%,FXYD5;SGK3;NEDD4L
prerank,tau protein binding (GO:0048156),-0.349362741927499,-1.1874050767747484,0.1992619926199262,0.7802314327362678,1.0,9/40,12.13%,LGMN;BIN1;APOE;MAP2;MARK1;STUB1;MAP1A;CDK5;CLU
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3517614301876845,1.1870379263611144,0.1409185803757829,0.6182097518765284,1.0,76/269,17.99%,TRAF1;PTPN22;RPL5;NGFR;CD40;ITCH;DTX3L;HSPA1A;CUL3;CUL5;LAPTM5;PRDX6;NFKBIA;FBXW7;SUMO1;AXIN1;TRAF4;ARIH1;STAT1;RNF20;SPOP;FAF1;GLMN;UBE2N;HLTF;TSG101;NEDD8;WFS1;ELOB;TRAF3;UBXN7;ATXN3;RALB;WRAP53;PARP9;TANK;UBE2W;CAMLG;RTN4;FANCL;DAXX;SUMO2;SNX9;RIPK1;PRKAR2A;YWHAZ;STAM;RNF31;GPI;NLK;NDUFS2;SLC25A5;UBE2G1;DNM1L;RPL11;HSPA9;STAT2;TNFRSF1B;VCP;UBE2J2;TRIOBP;USP7;FBXO7;RELA;TCP1;APC;TUBA1B;RB1;CCDC50;SMAD5;AMBRA1;TRAF2;HSPD1;SMC6;BECN1;HSPA5
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.4561328753580175,-1.1850043549218712,0.24371859296482412,0.777665937806861,1.0,5/15,27.32%,ALDH9A1;ALDH7A1;ALDH3B1;ALDH1L1;ALDH1A2
prerank,single-stranded DNA helicase activity (GO:0017116),0.4986251343301988,1.1839410615444417,0.26810477657935283,0.6227057453607391,1.0,4/19,12.95%,DNA2;MCM6;CHTF18;MCM2
prerank,neuropeptide binding (GO:0042923),0.50479819593894,1.1837669634815966,0.2703125,0.6196308252266801,1.0,2/18,9.07%,SORL1;OPRM1
prerank,solute:proton symporter activity (GO:0015295),-0.43980095073090963,-1.1818223535410934,0.24871794871794872,0.7774265417656679,1.0,5/16,12.90%,SLC11A2;SLC36A1;SLC25A3;SLC2A9;SLC15A2
prerank,lipase activator activity (GO:0060229),0.5588343111218231,1.1812156041858808,0.2879858657243816,0.622689785019036,1.0,4/10,16.87%,FYN;PDPK1;BTK;ARHGAP6
prerank,calcium channel activity (GO:0005262),-0.3052856646459189,-1.178252271114962,0.12962962962962962,0.7786490587625947,1.0,21/84,15.00%,CACNA1D;SLC24A3;CACNB2;CACNA2D3;CACNA2D1;TRPV2;PKD2;CACNA1C;TRPC4;P2RX4;CACHD1;TPCN2;TRPC1;MCOLN1;CHRNA7;CACNG2;TRPC7;TRPM2;TRPV4;TRPC3;NCS1
prerank,PDZ domain binding (GO:0030165),-0.31999633476353123,-1.1767791575444488,0.19811320754716982,0.7731547267811344,1.0,17/61,14.75%,PRKN;CADM1;DOCK4;NLGN1;DLG4;GRIA1;ATP2B2;GRID2;TBC1D10A;SLC22A5;GNG12;ATP2B3;CLCN3;ADRB1;CXADR;SLC22A4;ERC1
prerank,translation elongation factor activity (GO:0003746),-0.45730683960067153,-1.1767742243549368,0.2639593908629442,0.7632424866941968,1.0,6/14,25.76%,GFM2;EEF1A1;EIF5A;EIF5AL1;GTPBP2;EEF1B2
prerank,ion channel activity (GO:0005216),-0.30436444312508565,-1.175561753252241,0.16417910447761194,0.7571106094287877,1.0,15/80,9.50%,GRIA4;TRPV2;TRPM3;PKD2;GRIA2;GRIA1;UNC80;GRID2;GRIK4;GABRB1;GRIK1;TMEM63B;TRPC1;MCOLN1;CHRNA7
prerank,tau-protein kinase activity (GO:0050321),0.48983663439009295,1.1744688802732273,0.2676056338028169,0.6357614630206182,1.0,7/20,14.86%,FYN;SIK3;DYRK1A;PRKAA1;MARK3;ROCK1;BRSK1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.34052275806036564,-1.1697036377676728,0.20955882352941177,0.7651014593024844,1.0,9/46,13.71%,HEXB;LARGE1;B3GALNT1;MGAT5;PIGP;MGAT4C;HEXA;MGAT4A;PIGA
prerank,lipoprotein particle binding (GO:0071813),0.49058517075450625,1.1675712972641545,0.2879019908116386,0.6496737347147779,1.0,4/20,5.03%,LDLR;CD36;SORL1;SCARB1
prerank,protein kinase regulator activity (GO:0019887),0.37648384011932046,1.1668383348776739,0.20677570093457945,0.647987168046797,1.0,24/95,13.93%,PRKAG2;GPRC5C;CXCL10;CCNJL;GMFG;CCND3;TAOK3;HEXIM1;PRKRIP1;FAF1;CCND1;CCNH;MBIP;GSKIP;DAXX;PRKAR2A;PRKAG1;CCNT2;CCNT1;SH3BP5;CCNL1;CCND2;KIDINS220;DNAJC3
prerank,voltage-gated cation channel activity (GO:0022843),-0.2867409825545662,-1.1656882957215913,0.16083916083916083,0.7678779249297031,1.0,16/97,10.51%,CACNA1D;KCNMA1;KCNQ5;CACNB2;CACNA2D3;KCND2;CACNA2D1;KCNQ3;PKD2;CACNA1C;CACHD1;TPCN2;KCNA2;HCN1;CACNG2;HCN2
prerank,cell adhesion mediator activity (GO:0098631),0.47444228029677393,1.1653914961421998,0.2854938271604938,0.6481156733747407,1.0,4/24,6.70%,CD47;EMB;NPTN;IGSF9
prerank,ion channel inhibitor activity (GO:0008200),0.43766941357655514,1.164747801926798,0.2832618025751073,0.64618111942991,1.0,6/35,11.64%,ITPR1;NEDD4L;MCUB;SLC30A1;STX7;FKBP1B
prerank,cholesterol binding (GO:0015485),-0.3363010456409741,-1.163374453820612,0.22267206477732793,0.7656170100896436,1.0,22/47,32.81%,ABCA1;OSBPL8;GRAMD1A;APOD;OSBPL1A;ERLIN2;STARD3;VDAC1;SIDT1;NPC1;STARD5;OSBPL6;PTCH1;OSBPL7;SOAT2;OSBPL5;NR1H3;CAV1;PROM1;OSBPL2;STARD4;STAR
prerank,ion gated channel activity (GO:0022839),-0.38744679024385476,-1.1631371059904534,0.24719101123595505,0.7570591340573268,1.0,6/24,18.02%,TTYH3;ANO10;TTYH2;TMEM63B;KCNT2;ANO8
prerank,receptor ligand activity (GO:0048018),0.34813165019787273,1.1629866056579286,0.16371220020855057,0.647221925719335,1.0,18/245,9.48%,DPP4;IL1B;NGF;TNFSF13B;METRNL;SEMA4A;FGF5;FGF22;CXCL10;GDF1;GDNF;VEGFC;IL33;OSGIN2;BMP3;IL6;HGF;PGF
prerank,transferrin receptor binding (GO:1990459),0.5702856159683032,1.161866342965035,0.2952029520295203,0.6463406566184108,1.0,2/10,5.33%,IKBKB;SNX1
prerank,histone methyltransferase binding (GO:1990226),-0.4819859763797595,-1.1613268302722644,0.28078817733990147,0.7535563534908079,1.0,5/11,25.85%,CTNNB1;CBX1;PHF1;HSP90AB1;NOP56
prerank,hexose transmembrane transporter activity (GO:0015149),-0.467466276608806,-1.1611727576485282,0.2892768079800499,0.7449698752114573,1.0,4/12,21.79%,SLC2A3;MFSD4A;SLC2A5;SLC2A8
prerank,low-density lipoprotein particle binding (GO:0030169),0.5152564715140225,1.1601932630135277,0.2884310618066561,0.647359065992204,1.0,4/16,5.03%,LDLR;CD36;SORL1;SCARB1
prerank,ubiquitin protein ligase activity (GO:0061630),0.345308556591141,1.1563671354673142,0.1890179514255544,0.6535081987819699,1.0,59/228,18.25%,NEURL3;NEURL1B;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CBLB;RNF38;TRIM7;CBL;ANKIB1;CDC42;CBLL1;TRIM62;BIRC3;ARIH1;TRAF3IP2;PELI1;RC3H1;UBE2D3;RNF217;UBR5;HLTF;HECTD1;MYCBP2;TRIM25;UBR2;COP1;ARIH2;RNF130;WWP2;RNF13;TRIM71;KCMF1;FANCL;TRIM14;MEX3C;RCHY1;TRIM17;SH3RF1;AREL1;RNF138;RNF150;UHRF2;XIAP;RNF166;RNF122;TRIM35;RNF41;HACE1;UBR3;MSL2;RNF144A;RNF19B;NEURL4;SMURF2;ANAPC11
prerank,thyroid hormone receptor binding (GO:0046966),0.44771010971249875,1.1552209200385748,0.2837209302325581,0.6530722637608815,1.0,9/28,15.79%,NCOA3;MED30;MED13;OASL;MED12;TAF7;TACC1;NSD1;MED1
prerank,guanyl ribonucleotide binding (GO:0032561),0.34630097095439655,1.1498116138660188,0.2165058949624866,0.6637443625473882,1.0,41/196,16.79%,LRRK2;RND3;RAP1A;RABL3;NOA1;RAPGEF2;RAC2;CDC42;RAB7A;ARF4;RAB6A;RAB39A;GNL1;ARF1;PDE2A;RHOBTB3;RAC1;RALB;RHOA;DIRAS1;ATL3;PIP4K2B;GLUD1;RHEB;GNAI1;TUBD1;ARL8B;GBP5;MMAA;RRAD;RAB29;GBP2;ATL1;GBP3;RHOG;DRG2;SEPHS1;TUBA1B;INSR;RAB35;RAB9B
prerank,double-stranded DNA binding (GO:0003690),0.33293922843647883,1.1492844694075484,0.12386706948640483,0.661468729129406,1.0,55/531,10.95%,NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;KLF4;CREB1;PPARG;BCL6;POLR3F;PITX3;ELF4;RFX7;FOS;RBBP8;ZBTB20;MRE11;FEN1;CRY1;MBD1;CAMTA2;ATF6;ATF2;IRF2;RFX3;HIVEP1;STAT1;KLF5;RBMS1;IRF4;BBX;RFX5;KLF13;KLF10;AHR;CGGBP1;CREM;MECP2;MSH3;CLOCK;RARG;E2F2;ELF1;MSH6;PKNOX1;IRF7;MEF2B;RPS3;NR3C1;MAU2;TDG;GMEB2;PBX1
prerank,aminopeptidase activity (GO:0004177),-0.38538639357343174,-1.1480232570273725,0.2610062893081761,0.7761975906869194,1.0,7/26,9.28%,METAP1D;MMP16;LTA4H;METAP2;MMP14;BLMH;TRHDE
prerank,phosphatase activity (GO:0016791),0.3783010038382722,1.1474175296011817,0.2642424242424242,0.6627730392842656,1.0,16/73,17.30%,PTPN22;DUSP16;PTPRO;ARMT1;OCRL;PXYLP1;DUSP12;PGAM5;HDDC2;ACP5;PPP1CB;PTPRJ;DUSP28;DUSP26;LHPP;PLPPR2
prerank,protein homodimerization activity (GO:0042803),0.3330292964351958,1.1452366053405054,0.12424849699398798,0.6644297022808067,1.0,90/590,11.62%,DPP4;JAML;LRRK2;STK10;SRGAP2;EXT1;KYNU;PECAM1;LILRB1;SLK;PIP4K2A;MAP3K5;MCL1;NECTIN1;TNNC1;PTPRO;TPM4;STAT3;RABL3;ERN1;UPB1;RBPMS;ABCB7;CORO1A;GLIPR2;SLC8B1;CCDC88A;EIF2AK1;INPP5F;IL6R;MYH9;IKBKB;PANK1;LRRFIP1;CHMP4A;CHMP4B;AXIN1;GDNF;DGCR8;ADRA2A;STAT1;SNX1;CAV2;EXD1;SMCHD1;FAP;PRMT8;DARS2;STK4;TAP1;TSG101;GSS;AHR;IMPA1;FLNA;ATP2A1;WRN;IKZF3;S100A10;CPQ;PDE2A;F11R;MSH3;PSAP;FBXO4;PAPSS1;TOX3;PDCD6IP;RPE;MSH6;SPPL2A;SNF8;IDH1;HIP1;NQO2;SMAD4;NLRC4;KYAT1;PIP4K2B;SNX9;NUDT21;RIPK1;TDG;B2M;TRIM14;MTPAP;SCARB2;TPD52;TPST1;S100A11
prerank,peptidase activator activity (GO:0016504),0.4608653845120895,1.1440703059811486,0.29984544049459044,0.6640661063388459,1.0,8/22,18.81%,PSME3;PSME2;PSME4;TANK;NLRC4;VCP;MAL;PINK1
prerank,GTP binding (GO:0005525),0.34807233791670295,1.1436300239577608,0.25301204819277107,0.6616208029744299,1.0,38/172,16.58%,LRRK2;RND3;RAP1A;RABL3;NOA1;RAC2;CDC42;RAB7A;ARF4;RAB6A;RAB39A;GNL1;ARF1;RHOBTB3;RAC1;RALB;RHOA;DIRAS1;ATL3;PIP4K2B;GLUD1;RHEB;GNAI1;TUBD1;ARL8B;GBP5;MMAA;RRAD;RAB29;GBP2;ATL1;GBP3;RHOG;DRG2;SEPHS1;TUBA1B;INSR;RAB35
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4103071710636828,1.142852871975438,0.27956989247311825,0.660116430083409,1.0,21/44,21.36%,NSD3;KMT2C;SETD7;SETDB2;DOT1L;SETD5;ASH1L;SETD2;KMT5B;NSD1;EZH2;KMT2E;KMT2A;ASH2L;SETMAR;EHMT1;WDR5;TTLL12;PRDM9;SMYD5;RBBP5
prerank,exoribonuclease activity (GO:0004532),-0.47050946036010677,-1.139438563558216,0.30617283950617286,0.7939009001967104,1.0,6/12,22.70%,EXOSC1;EXOSC9;EXOSC5;EXOSC10;EXOSC3;CNOT7
prerank,DNA binding (GO:0003677),0.32885881716353615,1.138349250142855,0.12012012012012012,0.6684194294765311,1.0,127/694,15.73%,CIITA;NFE2;HIVEP2;DNA2;GLI1;SAMHD1;MLH1;PPARG;BCL6;LONP1;POLR3F;STAT3;EHF;FOXJ1;TRIM26;RBBP8;POLL;CRLF3;CDC45;TAF9;MRE11;MYRF;SLPI;FEN1;CRY1;SCX;FAM111A;ZEB2;MBD1;CAMTA2;ATF6;LRRFIP1;RYBP;PARP4;IRF2;RFX3;RPL6;RBPJ;STAT1;NUFIP1;MCM6;RBMS1;IRF4;RFX5;SMARCA5;TSHZ1;TRIM16;CDC5L;SMC1B;TSG101;SETX;AHR;PHF19;CGGBP1;ARID4A;MBD4;CBFB;CREM;WRN;IKZF3;NFE2L2;OASL;PURB;MECP2;MSH3;NABP1;CRY2;CLOCK;RARG;GTF2A1;E2F2;CTCF;NFYC;BRIP1;MSH6;KAT6A;EZH1;SNAPC3;ZNF496;IRF7;CHTF18;SMAD4;RPS3;CSRNP1;MAU2;TDG;PBX1;ING2;SRRT;AIFM1;FOXO3;DEDD2;NLRP3;ETS2;RPA3;GTF3C6;APP;CCNT1;BCLAF3;NFYA;XRCC4;LIN9;TFAM;PQBP1;MSL3;TEAD1;MCM2;ERCC3;ERCC4;CHD4;JUNB;RNF138;CHRAC1;RPL7;SLTM;MAFK;SP4;CENPC;CREBBP;RELA;WBP11;STN1;TAF1;INO80;ENDOV;MCM9;ZNF148
prerank,poly-purine tract binding (GO:0070717),-0.3684551454103637,-1.1378668609687472,0.26791277258566976,0.7894972925151263,1.0,13/27,24.03%,ATXN1;RBMS3;ZC3H14;HNRNPDL;TIA1;PATL1;ELAVL4;KHDRBS2;PPIE;DDX3X;DAZAP1;HNRNPU;MCRS1
prerank,CoA hydrolase activity (GO:0016289),0.5006176635758852,1.1375801200394455,0.2983606557377049,0.6670402276619892,1.0,5/16,14.45%,ACOT11;ACOT2;ACAA2;ABCD1;HIBCH
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3393465238252399,1.1367652685809604,0.21390937829293993,0.6659244715314293,1.0,59/232,18.25%,NEURL3;NEURL1B;ITCH;RNF149;DTX3L;NEDD4L;TRIM26;CUL3;CBLB;RNF38;TRIM7;CBL;ANKIB1;CDC42;CBLL1;TRIM62;BIRC3;ARIH1;TRAF3IP2;PELI1;RC3H1;UBE2D3;RNF217;UBR5;HLTF;HECTD1;MYCBP2;TRIM25;UBR2;COP1;ARIH2;RNF130;WWP2;RNF13;TRIM71;KCMF1;FANCL;TRIM14;MEX3C;RCHY1;TRIM17;SH3RF1;AREL1;RNF138;RNF150;UHRF2;XIAP;RNF166;RNF122;TRIM35;RNF41;HACE1;UBR3;MSL2;RNF144A;RNF19B;NEURL4;SMURF2;ANAPC11
prerank,phosphatase activator activity (GO:0019211),0.506043888747063,1.1363104177305812,0.3178036605657238,0.6639325855548469,1.0,5/14,15.69%,PPP2R5A;PPP1R15A;PPP2R5C;FRS2;PPP2R5E
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5298972599097436,1.1341846931143997,0.33222591362126247,0.6660718762697095,1.0,4/12,15.46%,PIK3C2A;PIK3R6;PIK3CA;IPMK
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.44059255458692975,-1.1335004657737158,0.30077120822622105,0.7934750510490435,1.0,7/14,30.13%,BLVRB;QDPR;DHFR;ALDH1L1;MTHFD1;PYCR3;NOXRED1
prerank,phosphatidylglycerol binding (GO:1901611),-0.4442499282128916,-1.1313625698953407,0.3089622641509434,0.7912435781890568,1.0,3/13,14.79%,PITPNC1;PLEKHN1;STOML2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3259747288888959,1.1312606824694786,0.112,0.6699561895229352,1.0,85/830,9.97%,BCL11A;TRPS1;NFE2;ZBTB46;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;ETV6;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;SCX;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;ZNF319;RBPJ;KCNIP3;HIVEP1;DEAF1;STAT1;KLF5;IRF4;BBX;RFX5;KLF13;KLF10;CDC5L;CREBRF;CREM;IKZF3;NFE2L2;PURB;THRA;CLOCK;ZFP3;RARG;GTF2A1;E2F2;CTCF;NFYC;ELF1;ZBTB11;BACH1;NFE2L1;ZNF182;RBAK;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;RPS3
prerank,calcium ion binding (GO:0005509),0.33394182182963555,1.131222030965186,0.2,0.6667239012446267,1.0,45/323,11.62%,ITPR1;IQGAP1;LCP1;PADI1;RET;ACER3;TNNC1;ANXA2;EFCAB9;TPM4;PLSCR1;HPCA;C2CD5;RASGRP2;RAPGEF2;SELL;MCTP2;DYSF;CLGN;ESYT3;PPP3CA;SLC25A13;S100A4;STIM2;ESYT1;PRNP;ANXA4;ATP2A1;NUCB2;CIB1;S100A10;CABYR;CPNE1;PITPNM1;BRAF;FBN1;CAMKK2;ANXA1;SLC25A12;CALB2;LETM1;TPD52;EFCAB11;CDH9;S100A11
prerank,chloride channel activity (GO:0005254),-0.3069613047377273,-1.130197259014378,0.22807017543859648,0.7864189121392322,1.0,11/59,9.20%,TTYH3;CLCN6;GABRG3;GABRG2;CLCN4;TTYH2;CLCN7;GLRA3;GABRB1;GLRA2;GABRA4
prerank,mechanosensitive ion channel activity (GO:0008381),0.5122575767302775,1.1288865824665433,0.32605042016806723,0.6695936450789131,1.0,6/12,22.03%,TMC8;PIEZO1;TMC6;TMC4;PIEZO2;TMEM63A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.48508008164814453,1.1287432575678913,0.32608695652173914,0.6666371195304659,1.0,5/15,11.50%,SLC25A13;SLC1A5;SLC25A12;SLC1A4;SLC25A18
prerank,RNA cap binding (GO:0000339),-0.4282265883521802,-1.1282445845239968,0.30434782608695654,0.7838218454838963,1.0,2/16,1.51%,LARP1;EIF4A1
prerank,pentosyltransferase activity (GO:0016763),0.4245145113012254,1.1262230186996207,0.3069306930693069,0.6697058999185138,1.0,7/36,9.68%,ZC3HAV1;PARP8;PARP4;TIPARP;PARP14;TNKS;PARP9
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.46541226317323725,-1.1237382950837798,0.3263888888888889,0.7893039105907914,1.0,5/11,26.10%,SLC25A25;LRRC8A;SLC17A9;SLC35B2;SLC25A42
prerank,beta-tubulin binding (GO:0048487),0.4276108412724194,1.1237203091194277,0.3124087591240876,0.6730164400082108,1.0,9/31,13.63%,UXT;RACGAP1;PEX14;BCAS3;SPAST;HTT;ARL8B;EML4;TBCD
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.29215912540067024,-1.1236588315314227,0.22099447513812154,0.7812072846390404,1.0,15/85,13.24%,ABHD12;PON3;PNPLA7;MGLL;PLA2G15;GDE1;ENPP2;LIPA;PLA2G4A;DDHD2;ABHD3;CA2;ABHD4;PTRH2;LYPLAL1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3343107949689073,1.1220157768470898,0.23739495798319327,0.6740571632142465,1.0,70/254,17.99%,TRAF1;PTPN22;RPL5;NGFR;CD40;HSPA1A;CUL3;CUL5;LAPTM5;PRDX6;NFKBIA;FBXW7;SUMO1;AXIN1;TRAF4;ARIH1;RNF20;SPOP;FAF1;GLMN;UBE2N;HLTF;TSG101;NEDD8;WFS1;ELOB;TRAF3;UBXN7;ATXN3;RALB;WRAP53;TANK;UBE2W;CAMLG;RTN4;FANCL;DAXX;SUMO2;SNX9;RIPK1;PRKAR2A;YWHAZ;RNF31;GPI;NLK;NDUFS2;SLC25A5;UBE2G1;DNM1L;RPL11;HSPA9;TNFRSF1B;VCP;UBE2J2;TRIOBP;USP7;FBXO7;RELA;TCP1;APC;TUBA1B;RB1;CCDC50;SMAD5;AMBRA1;TRAF2;HSPD1;SMC6;BECN1;HSPA5
prerank,cardiolipin binding (GO:1901612),-0.47916572116418704,-1.1212936630240165,0.3393258426966292,0.7799115803656089,1.0,7/10,46.73%,PLEKHN1;STOML2;UQCC3;GSDME;OPA1;NME4;MME
prerank,single-stranded RNA binding (GO:0003727),-0.33426589071497226,-1.1210582420202913,0.2831541218637993,0.7724695106223505,1.0,20/43,22.20%,AGO3;AGO1;ADARB2;JMJD6;CNBP;FXR1;STRBP;PTBP1;DHX9;LACTB2;HNRNPF;EIF4H;ZFR2;SNRPC;TLR7;DDX3X;EXOSC10;DDX11;SRA1;HNRNPU
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.4438326662756127,-1.1187239761433996,0.324582338902148,0.7714535278169007,1.0,5/13,27.32%,ALDH9A1;ALDH7A1;ADH5;ALDH1L1;ALDH1A2
prerank,cation channel activity (GO:0005261),-0.27336147535157956,-1.1161104043406878,0.18620689655172415,0.7704582793544194,1.0,19/94,14.97%,CACNA1D;SLC24A3;CACNB2;TRPV2;TRPM3;PKD2;UNC80;ANO10;TMEM63B;TRPC1;MCOLN1;KCNA2;CHRNA7;HCN1;TMEM38A;TRPM2;TRPV4;TRPC3;KCNA1
prerank,cysteine-type peptidase activity (GO:0008234),-0.29480570848830673,-1.1155437171075084,0.24623115577889448,0.7640441668498876,1.0,20/73,11.73%,LGMN;CTSB;USP35;CAPN3;USP46;USP2;USP29;USP12;CTSZ;USP28;USP20;CASP4;BLMH;CTSF;OTUD7B;OTULIN;ATG4A;USP16;USP21;CASP3
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.4433899322710305,-1.1132419887739022,0.3422330097087379,0.7629397252542173,1.0,4/13,10.42%,SLC7A6;SLC7A1;SLC7A7;SLC7A2
prerank,tRNA methyltransferase activity (GO:0008175),-0.4235886464212909,-1.1128879780765948,0.329700272479564,0.7564700027860534,1.0,10/16,25.13%,ALKBH8;METTL2B;METTL2A;THUMPD2;TRMT44;TRMT12;LCMT2;TRMT9B;TRMT5;BCDIN3D
prerank,epidermal growth factor receptor binding (GO:0005154),0.4431918377489773,1.1106844173493011,0.32732732732732733,0.6993437446428039,1.0,6/25,9.46%,PLSCR1;CCDC88A;SNX1;ARF4;GRB2;HIP1
prerank,protease binding (GO:0002020),0.36032787846402525,1.1103245314652164,0.28805620608899296,0.6968189389905993,1.0,15/99,10.33%,DPP4;LDLR;ANXA2;SELL;CD177;SUMO1;FAP;PTEN;PRNP;SERPINB9;PSAP;CARD16;SPATA2;NLRC4;FN1
prerank,chemokine activity (GO:0008009),0.42392460894199635,1.1093137247404106,0.3371104815864023,0.6958367771191606,1.0,3/31,6.24%,CXCL10;CKLF;CXCL16
prerank,hydro-lyase activity (GO:0016836),-0.32079097939564255,-1.1092886783074847,0.24315068493150685,0.7590250753409779,1.0,13/41,21.84%,ECHS1;HACD2;ECHDC1;ENO2;TGDS;HADHB;CA2;HADHA;TBXAS1;ECI1;PCBD2;ENO3;NAXD
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3301635589227826,1.1082262647834218,0.2712041884816754,0.6952327947444095,1.0,46/248,15.05%,LRRK2;RND3;GNA14;DNA2;RAP1A;RAB19;HSPA1A;RABL3;MYO1E;RAC2;MYH9;ATP2B1;ABCA3;CDC42;RAB7A;RNF213;SMCHD1;ARHGDIB;RAB6A;GNL1;RHOBTB3;RAC1;GNG10;GNB1;RALB;RHOA;DIRAS1;ATL3;GPR88;RHEB;GNAI1;DNM1L;ABCD1;ARL8B;GBP5;MMAA;GNAI2;VCP;RAB29;KIF5A;GBP2;GNA11;ATL1;GBP3;RHOG;DRG2
prerank,DNA secondary structure binding (GO:0000217),-0.3491754888377395,-1.1064689755301051,0.31,0.7602701763202675,1.0,17/31,27.82%,MEF2C;RAD51B;HMGB1;BLM;MSH2;HMGB2;FANCM;RAD51C;HMGA2;CLSPN;XPC;NEIL3;GEN1;MEN1;RAD51AP1;ABL1;RAD51D
prerank,phosphatidate phosphatase activity (GO:0008195),-0.4290196605014467,-1.1060261428818707,0.3501259445843829,0.754392648235903,1.0,7/13,31.26%,PLPP3;PLPP1;PLPPR1;PLPPR4;PLPP4;PLPP5;PLPP2
prerank,microtubule binding (GO:0008017),-0.24455047264752294,-1.1056359642226157,0.10416666666666667,0.7483260483087515,1.0,71/222,20.81%,DST;NAV3;KIF13B;CAMSAP1;STARD9;FMN1;GAS2L3;NUMA1;TUBGCP5;MTUS2;IRAG2;MAP2;MAP1B;FGF13;CLIP1;RMDN1;MAST2;CEP57;KIF1B;CLASP2;KIF1A;CKAP5;CCDC66;GOLGA2;CLIP2;DCX;KIF5C;CEP57L1;MAP1A;MTUS1;MTCL1;DNM1;CDK5;EML2;SNPH;MAP1LC3B;MAPRE1;CAMSAP2;CHP1;EML3;TRPV4;HOOK1;CCDC88B;REEP1;MACF1;TUBGCP6;TPPP;CETN3;CCDC181;HAUS4;WHAMM;MAP6D1;CENPE;NEFH;TERF1;KIF15;RAB11A;HDAC6;VAPB;FAM161A;KIF3A;ARL3;MAST1;KIF21B;KIF18A;NDEL1;MAP9;CEP290;TUBGCP2;NEFM;SUN2
prerank,P-type ion transporter activity (GO:0015662),0.5125549696416932,1.1046093897132756,0.3407534246575342,0.7015006123814415,1.0,4/12,7.74%,ATP2B1;ATP2A3;ATP2A1;ATP7A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3370316716969709,1.1040328596284699,0.2838847385272145,0.69962374189715,1.0,30/173,15.73%,BCL11A;TRPS1;FOXP1;PPARG;ETV6;BCL6;NFKB1;ZBTB20;ZEB2;LRRFIP1;KLF8;KCNIP3;DEAF1;CREM;CTCF;BACH1;E4F1;NR3C1;FOXO3;IKZF5;ETS2;REST;SREBF2;NFIL3;ZNF436;MAFK;RELA;ZBTB25;BHLHE40;ZNF148
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.27932850810626014,-1.1040151976951105,0.24019607843137256,0.745717843223104,1.0,18/78,11.73%,LGMN;CTSB;USP35;CAPN3;CFLAR;USP46;USP2;USP29;USP12;CTSZ;USP28;USP20;CAPNS1;CASP4;PYCARD;CTSF;USP16;CASP3
prerank,growth factor activity (GO:0008083),0.37130229043445456,1.1037825394747358,0.303970223325062,0.6969665143240272,1.0,9/74,9.48%,NGF;FGF5;FGF22;GDNF;VEGFC;OSGIN2;IL6;HGF;PGF
prerank,water transmembrane transporter activity (GO:0005372),-0.4440050219711236,-1.1032977540414226,0.3325,0.7401938584244917,1.0,6/11,55.61%,AQP4;PDPN;AQP11;AQP1;SLC5A1;SLC4A11
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3170424772389286,-1.1028161732406945,0.2981132075471698,0.7346049336636243,1.0,10/47,14.59%,SLC38A6;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SLC7A2;SLC7A8;SLC3A2;SLC22A4
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3177142698938716,1.1026317323241392,0.1891891891891892,0.6964744792957592,1.0,91/731,13.25%,BCL11A;NFE2;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;ZNF319;RBPJ;KCNIP3;HIVEP1;STAT1;KLF5;IRF4;RFX5;KLF13;TIPARP;KLF10;AHR;CREM;IKZF3;NFE2L2;THRA;CLOCK;RARG;E2F2;CTCF;NFYC;ELF1;ZBTB11;BACH1;NFE2L1;ZNF182;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;NR3C1;GMEB2;PBX1;FOXO3;IKZF5;ZNF260;ETS2;REST;ZNF418;ATF6B;NFYA;TEAD1;KLF9;MYB;NRIP1;STAT2;NSD1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.31324063427206295,-1.1025102859032567,0.2905982905982906,0.7286110965184853,1.0,12/53,12.67%,SLC38A6;SLC1A3;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SLC17A6;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.31716683103473464,1.1004438185220549,0.19519519519519518,0.6988551815315652,1.0,91/730,13.25%,BCL11A;NFE2;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP3;RUNX3;STAT4;GLI1;KDM6A;HNF4G;KLF4;CREB1;PPARG;STAT5A;BCL6;NFKB1;PITX3;FOSL2;STAT3;EHF;FOXJ1;ELF4;RFX7;FOS;CIART;REL;ZBTB20;SPI1;STAT5B;SCX;ZEB2;PGBD1;ATF6;LRRFIP1;KLF8;ATF2;IRF2;RFX3;H3-3A;ZNF319;RBPJ;KCNIP3;HIVEP1;STAT1;KLF5;IRF4;RFX5;KLF13;KLF10;AHR;CREM;IKZF3;NFE2L2;THRA;CLOCK;RARG;E2F2;CTCF;NFYC;ELF1;ZBTB11;BACH1;NFE2L1;ZNF182;E4F1;SNAPC3;PKNOX1;ZNF496;IRF7;MEF2B;SMAD4;NR3C1;GMEB2;PBX1;FOXO3;IKZF5;ZNF260;ETS2;REST;ZNF418;ATF6B;NFYA;TEAD1;KLF9;MYB;NRIP1;STAT2;NSD1
prerank,four-way junction DNA binding (GO:0000400),-0.40190499687887526,-1.0997287393212372,0.33421750663129973,0.7292119534857161,1.0,11/17,27.82%,RAD51B;HMGB1;BLM;MSH2;HMGB2;FANCM;RAD51C;GEN1;MEN1;ABL1;RAD51D
prerank,FMN binding (GO:0010181),-0.46698038347312876,-1.0988599169249982,0.3395348837209302,0.7248086343191352,1.0,2/11,7.07%,PPCDC;DUS2
prerank,nucleosomal DNA binding (GO:0031492),0.4545970586496822,1.098759327983375,0.3597560975609756,0.6998234988595272,1.0,10/21,20.27%,GATAD2B;H3-3A;RBBP4;SMARCE1;MBD2;CHD4;SMARCC2;HDAC1;ACTB;HNRNPC
prerank,protein phosphatase binding (GO:0019903),0.346317225972878,1.0979201940327843,0.31645569620253167,0.6986549274977599,1.0,27/117,15.48%,IQGAP1;LILRB1;MAP3K5;STAT3;KCNQ1;AKAP11;PPP1R9B;MAPK14;STX17;MTMR3;SHOC2;STRN4;TRAF3;MTMR4;KCNN4;PXN;PPP1R15A;ANKLE2;SNX3;LGALS3;EIF2AK3;MVP;GRIN3A;STRN3;VCP;ANAPC7;TBK1
prerank,poly-pyrimidine tract binding (GO:0008187),-0.3731852922883082,-1.0963166223255352,0.34870317002881845,0.7248884487384402,1.0,7/23,14.32%,ATXN1;RBMS3;HNRNPH1;PATL1;SSB;PTBP1;DIS3L2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3819398322300762,-1.0959661591404977,0.33513513513513515,0.7193226362879148,1.0,6/21,8.76%,PDE3B;PDE1B;PDE8B;PDE1A;PDE1C;PDE4A
prerank,palmitoyltransferase activity (GO:0016409),0.42574174043006746,1.0957794380177284,0.342143906020558,0.7008973750574954,1.0,6/28,9.01%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17
prerank,retinoic acid receptor binding (GO:0042974),0.46445253491840766,1.0940639350682893,0.36065573770491804,0.7018904272909121,1.0,6/17,15.79%,PPARG;RARG;TACC1;NRIP1;NSD1;MED1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.46420180455201027,-1.0938495745412524,0.3685393258426966,0.718736219868177,1.0,4/11,7.06%,ATP8A2;ABCB4;ATP8A1;ATP8B1
prerank,ribonuclease P activity (GO:0004526),-0.4534051677624464,-1.09062428372173,0.35294117647058826,0.7212422337630879,1.0,8/11,34.16%,POP1;RPP30;RPP14;RPP40;POP4;POP5;RPP21;POP7
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5083654105525831,1.0897729186510676,0.38344594594594594,0.7090505548877328,1.0,3/12,5.52%,SULF2;ARSI;ARSJ
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4646950114472962,-1.0897634255884123,0.3756345177664975,0.7172920453935459,1.0,5/10,28.03%,CLCN6;CLCN4;CLCN3;CLCN2;CLCN1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.44873028683988225,-1.0879913095232485,0.36674816625916873,0.7159082730377349,1.0,3/12,6.11%,TGFBR2;TGFBR1;ACVR1
prerank,nuclear receptor coactivator activity (GO:0030374),0.37788498651347247,1.087042262402245,0.34600262123197906,0.7127746189215808,1.0,16/52,18.18%,PKN1;NCOA3;MED30;MED13;HELZ2;BUD31;CNOT6;NCOA2;NCOA1;MED12;MED14;TACC1;ZMIZ2;MED1;SS18;NCOA7
prerank,clathrin adaptor activity (GO:0035615),0.4775540592695963,1.0846079542253337,0.3696682464454976,0.7157547085922581,1.0,7/15,17.19%,AP2A2;HIP1;AP1G1;AP2B1;STON1;AP2S1;AP1M1
prerank,endopeptidase activity (GO:0004175),0.32657715065338966,1.083636949484296,0.31584362139917693,0.7149566531305783,1.0,48/257,16.05%,DPP4;NAPSA;ACE;PRSS53;ACE2;MALT1;MMP1;PSMB7;HP;HPR;FAP;PARL;USP49;ADAM17;C1RL;ADAMTS6;HGF;USP48;CPNE1;RHBDL2;USP15;PIDD1;PSMB8;ADAM19;PSMA5;MBTPS1;CASP2;USP42;PSMB3;USP40;THSD4;TPP2;PSMB1;CAPN7;BACE2;CORIN;CASP7;PCSK5;ADAMTS12;USP37;ADAM9;USP7;CASP6;USP9X;MIPEP;ADAMTS19;PROC;USP47
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3403083813364922,-1.0809051390039455,0.2893081761006289,0.7280749356616668,1.0,11/32,11.84%,PHYHD1;KDM2A;EGLN3;ALKBH5;KDM2B;TYW5;EGLN2;KDM4A;TET1;PHF8;TET3
prerank,motor activity (GO:0003774),0.37569066403765167,1.0803114528774858,0.34571062740076824,0.7206231100722144,1.0,12/60,10.97%,DNAH2;DNAH8;MYO1E;KIF20A;KIF5B;KIF6;MYH9;KIF23;KIF24;KIFC3;KIF3B;GPR88
prerank,phospholipase C activity (GO:0004629),0.430417510541828,1.0801245909193,0.3819548872180451,0.717896994127564,1.0,4/25,7.83%,PLCG2;CCR1;PLCB1;PLCD4
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.37045721127247316,-1.0775855987539398,0.3323943661971831,0.7302190296312067,1.0,6/23,8.76%,PDE3B;PDE1B;PDE8B;PDE1A;PDE1C;PDE4A
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5193830418331795,1.075117368574867,0.386986301369863,0.7267334126401483,1.0,1/11,3.56%,CHRNA4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.33702651989082494,-1.074625167060297,0.3503184713375796,0.7319228866817786,1.0,7/32,12.67%,SLC38A6;MFSD12;SLC36A4;SLC36A1;SFXN1;SLC7A8;SLC3A2
prerank,transaminase activity (GO:0008483),-0.45655314893042,-1.074367974276173,0.38028169014084506,0.7264057061486048,1.0,2/11,7.12%,GOT1;PSAT1
prerank,rRNA binding (GO:0019843),0.38615803742324856,1.0714385534865964,0.3902439024390244,0.7329795771035627,1.0,11/42,16.42%,RPL5;MRPL18;RPS14;RPF2;ERI1;RPS3;RPLP0;PTCD3;RPL11;MRPS6;MRPS27
prerank,protein phosphatase activator activity (GO:0072542),0.4768051178274325,1.0706062460827592,0.3733108108108108,0.7318250882994897,1.0,5/13,18.02%,PPP2R5A;PPP1R15A;PPP2R5C;PPP2R5E;PTPA
prerank,proton transmembrane transporter activity (GO:0015078),-0.320789520526851,-1.0701971809079172,0.32677165354330706,0.730814708446189,1.0,9/39,19.88%,ATP6V1B2;SLC11A2;CLCN4;CLCN3;COX10;NNT;UQCRC1;UQCR10;COX5B
prerank,insulin-like growth factor binding (GO:0005520),-0.4058323722307919,-1.069570355117822,0.38903394255874674,0.7264792026692559,1.0,8/15,30.33%,ITGA6;ITGB3;IGFBP5;IGFBP2;IGFBP4;IGF2R;ITGB4;IGFBP3
prerank,phospholipase activity (GO:0004620),0.36241546121088797,1.0683256561061378,0.3555276381909548,0.734271467466177,1.0,4/67,5.04%,PLBD1;PLD4;PRDX6;SMPDL3A
prerank,3'-5' exonuclease activity (GO:0008408),0.379449854727461,1.067659483165676,0.3673740053050398,0.7328012653939754,1.0,15/45,20.96%,MRE11;EXD1;XRN2;PNLDC1;WRN;CNOT6;ERI1;EXD2;PNPT1;POLD1;CNOT8;DIS3L;APEX1;CNOT6L;PARN
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.4124835336818475,1.06723737126014,0.3708029197080292,0.7306450217240935,1.0,7/29,13.59%,SLC25A13;SLC25A30;SLC1A5;SLC25A12;SLC1A4;SLC25A18;SLC26A7
prerank,histone methyltransferase activity (GO:0042054),0.40109076842931185,1.0664417969146969,0.3715469613259669,0.7294229741238691,1.0,13/32,20.54%,NSD3;PRMT8;KMT2C;SETD7;DOT1L;SETD2;KMT5B;EZH2;KMT2E;NTMT1;EHMT1;TTLL12;PRDM9
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.38890815957695296,-1.0659104974886628,0.359375,0.7303249064608046,1.0,6/17,13.28%,ABCA1;PITPNC1;ABCB4;ATP8B1;MTTP;ABCA7
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.4009058475854218,1.0631924258275247,0.3944055944055944,0.7343372861060908,1.0,11/34,20.96%,XRN2;PNLDC1;CNOT6;ERI1;CNOT2;EXD2;PNPT1;CNOT8;DIS3L;CNOT6L;PARN
prerank,ubiquitin binding (GO:0043130),-0.2772372898878434,-1.0629716786413694,0.2975609756097561,0.7324293608382568,1.0,31/73,27.10%,PRKN;BIRC2;MVB12B;BUB3;VPS36;PLAA;NBR1;UCHL3;GGA3;AUP1;NPLOC4;DNAJB2;SMAD3;ASCC2;TOM1L1;USP16;UCHL1;SQSTM1;OTUB1;TRIM32;SPRTN;SHARPIN;USP5;RAD23A;UBE2L6;CKS2;MDM2;VPS28;UBXN2A;WDR48;USP33
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.33186845306657553,-1.0626399423003035,0.35987261146496813,0.7273062778083398,1.0,21/35,32.31%,DUS2;QTRT1;DTWD2;PTRH2;GATB;GATC;DUS3L;TARS2;DUS1L;TRMT12;LCMT2;ELAC2;TRMT9B;TRMT5;BCDIN3D;DTWD1;QRSL1;QTRT2;FTSJ1;ALKBH1;AARS2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.37353059829985374,-1.0605621966854701,0.35755813953488375,0.7268947954739338,1.0,4/21,10.34%,GRIA1;CHRFAM7A;CHRNA7;GRM5
prerank,disordered domain specific binding (GO:0097718),0.4322914265161137,1.0599389949415297,0.3911764705882353,0.7393627103093625,1.0,5/23,11.67%,FYN;HSPA1A;NCOA3;FN1;DFFB
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3916437211766154,-1.0592923852715517,0.3649025069637883,0.7240644942510948,1.0,6/18,17.00%,TGFBR2;TGFBR1;ACVR1;ACVR2B;BMPR1B;ACVR1B
prerank,potassium channel activity (GO:0005267),-0.26539722298412494,-1.058227278679029,0.3018867924528302,0.7211730650306208,1.0,15/89,10.61%,KCNMA1;KCNK13;KCNQ5;KCND2;KCNQ3;PKD2;GRIK4;GRIK1;KCNN2;KCNMB2;KCNA2;KCNK6;HCN1;HCN2;TMEM38A
prerank,tubulin binding (GO:0015631),-0.22849296423499157,-1.0576538950542824,0.22580645161290322,0.7170496585810614,1.0,87/296,20.81%,DST;NAV3;PRKN;DIP2B;KIF13B;CAMSAP1;STARD9;FMN1;GAS2L3;NUMA1;TUBGCP5;MTUS2;IRAG2;MAP2;MAP1B;FGF13;CLIP1;RMDN1;RAB11FIP5;MAST2;CEP57;IFT74;KIF1B;DIXDC1;CLASP2;KIF1A;CKAP5;CCDC66;GOLGA2;CLIP2;TTLL11;TRAPPC14;DCX;CDK5R1;KIF5C;CEP57L1;MAP1A;MTUS1;MTCL1;DNM1;WASHC1;CDK5;EML2;SNPH;MAP1LC3B;TTLL5;CHP1;GJA1;EML3;TRPV4;HOOK1;NCALD;CCDC88B;REEP1;TUBGCP6;TPPP;CETN3;CCDC181;TPR;WHAMM;TBCA;MAP6D1;CENPE;NEFH;TERF1;KIF15;BRCA1;RAB11A;PDCD5;HDAC6;VAPB;DDX3X;ARL4C;AGBL1;FAM161A;KIF3A;ARL3;MAST1;AGBL4;KIF21B;ATF5;KIF18A;NDEL1;MAP9;TUBGCP2;NEFM;SUN2
prerank,insulin-like growth factor I binding (GO:0031994),-0.4117420479545012,-1.057123420730249,0.3844221105527638,0.7128513309664511,1.0,7/13,30.33%,ITGA6;ITGB3;IGFBP5;IGFBP2;IGFBP4;ITGB4;IGFBP3
prerank,GTPase activity (GO:0003924),0.3189156329033591,1.0567261199637632,0.3655913978494624,0.7440037504804343,1.0,34/192,15.05%,LRRK2;RND3;GNA14;RAP1A;RAB19;RABL3;RAC2;CDC42;RAB7A;ARHGDIB;RAB6A;GNL1;RHOBTB3;RAC1;GNG10;GNB1;RALB;RHOA;DIRAS1;ATL3;RHEB;GNAI1;DNM1L;ARL8B;GBP5;MMAA;GNAI2;RAB29;GBP2;GNA11;ATL1;GBP3;RHOG;DRG2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.37324605351933743,1.053987619004429,0.4070221066319896,0.7474253660561675,1.0,6/55,6.98%,ITPR1;ANXA2;CUL5;ATP2B1;ATP2A3;ATP2A1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.45712401692528526,1.0533521119962517,0.41033925686591277,0.7460386220705006,1.0,3/15,12.72%,PLEKHF1;SESTD1;SNX3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.4351283853135954,-1.0496344289797301,0.4067796610169492,0.7265044410255477,1.0,5/11,20.29%,PPP1R14C;PPP1R8;PPP1R11;PPP1R14A;PPP1R14B
prerank,tRNA binding (GO:0000049),-0.3070129819504499,-1.0490266071675955,0.34210526315789475,0.7226546342551236,1.0,19/43,24.73%,ALKBH8;NSUN2;TRNT1;EIF2AK4;PSTK;EEF1A1;DALRD3;ELP5;TYW5;ELP1;PTCD1;SSB;IGHMBP2;KARS1;TRMT10A;NSUN6;TRMT9B;CARS1;NAT10
prerank,calcium-dependent phospholipid binding (GO:0005544),0.36911706109269027,1.0487527200807112,0.3891156462585034,0.7542811239604051,1.0,11/49,12.57%,ANXA2;C2CD5;MCTP2;DYSF;ESYT3;ESYT1;ANXA4;CPNE1;ANXA1;CPNE2;ESYT2
prerank,poly(U) RNA binding (GO:0008266),-0.37177661224357833,-1.0485524809076598,0.3655913978494624,0.7183231384657276,1.0,6/20,14.32%,ATXN1;RBMS3;HNRNPH1;PATL1;SSB;DIS3L2
prerank,endopeptidase activator activity (GO:0061133),0.4974849379975884,1.0479552998893205,0.4270650263620387,0.7532445155883133,1.0,3/10,10.13%,PSME3;PSME2;NLRC4
prerank,ribonuclease activity (GO:0004540),0.3647595485006104,1.0463325777381411,0.38722294654498046,0.7542065831245705,1.0,14/56,16.35%,ZC3H12D;SAMHD1;ERN1;SND1;CNOT6;RNASE1;KHNYN;RNASE6;INTS11;EXOG;RNASEH2A;RNASEH1;CPSF3;SMG6
prerank,TBP-class protein binding (GO:0017025),0.4319454143237912,1.0460058586259748,0.42073170731707316,0.7519178357585093,1.0,4/21,7.94%,TAF13;AHR;THRA;GTF2A1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3119834269434496,1.044997134588956,0.38396624472573837,0.7511925500982324,1.0,31/254,10.43%,HNF4G;KLF4;CREB1;NFKB1;FOSL2;PLSCR1;STAT3;EHF;FOXJ1;ELF4;REL;SCX;ATF6;ATF2;IRF2;ZNF319;RBPJ;KLF5;IRF4;RFX5;KLF10;CDC5L;CREBRF;CLOCK;E2F2;NFYC;ELF1;E4F1;MEF2B;SMAD4;NR3C1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.37352977053967806,-1.0408516566069748,0.4012345679012346,0.7318246355452652,1.0,6/22,12.12%,SCN1A;PKD2;SCN3A;HCN1;HCN2;SCN1B
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.47836625665484367,1.0390806545564593,0.39419795221843,0.7627624091354662,1.0,2/11,3.49%,MARVELD3;STK38
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.45133252078275343,-1.0374459340191635,0.43424317617866004,0.734511478264688,1.0,1/10,0.11%,SLCO2B1
prerank,single-stranded DNA binding (GO:0003697),0.3325853093571151,1.0352196199352284,0.40211019929660025,0.7690190146532498,1.0,19/93,15.71%,SAMHD1;MLH1;LONP1;RBBP8;CDC45;FAM111A;MCM6;RBMS1;PURB;MSH3;NABP1;CRY2;RPA3;MCM2;ERCC4;RNF138;WBP11;STN1;MCM9
prerank,zinc ion binding (GO:0008270),0.3071452766981831,1.0339251783146566,0.40537745604963804,0.7688720279393854,1.0,41/293,11.68%,SAMHD1;GDA;ACE;KLF4;ACER3;LNPEP;PPARG;ACE2;TET2;PLSCR1;KDM7A;MSRB1;UPB1;DHX58;CBLB;SMPDL3B;DPEP1;MBD1;PEX12;SMPDL3A;ARIH1;RC3H1;IFIH1;CRIP1;MYCBP2;PDE2A;ARIH2;CTCF;KAT6A;TNKS;RBAK;NQO2;SLU7;RASSF1;CYLD;PTPN1;RNPEP;DUSP12;TAB3;IKZF5;CAD
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.3812869088627141,-1.0322767054880626,0.39420289855072466,0.741625030010222,1.0,9/17,42.24%,AK3;DTYMK;AK1;CMPK2;AK4;NME2;AK9;NOL9;NME4
prerank,I-SMAD binding (GO:0070411),-0.4154795133309647,-1.0317844316414952,0.4268292682926829,0.7373879584555225,1.0,4/13,9.97%,TGFBR1;CTNNB1;SMAD7;SMAD3
prerank,endoribonuclease activity (GO:0004521),0.3927201792288255,1.031035374170159,0.4119318181818182,0.7725704094319935,1.0,10/32,17.82%,ZC3H12D;ERN1;SND1;KHNYN;INTS11;EXOG;CPSF3;ENDOV;SMG6;NYNRIN
prerank,MAP kinase activity (GO:0004707),0.4619580720492646,1.0307122937802342,0.4342948717948718,0.770239910073096,1.0,5/14,15.13%,MAPK14;MAPK12;NLK;MAPK8;MAPK1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.41308835690452195,1.028215726076451,0.4306784660766962,0.7732368568201674,1.0,2/24,2.90%,ITPKC;IP6K3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.4772133751696915,1.0279437681254011,0.43389830508474575,0.7708542429731632,1.0,4/11,9.48%,SAMD8;SGMS1;SGMS2;PIGF
prerank,exonuclease activity (GO:0004527),0.36237189982373613,1.027894834298094,0.41184387617765816,0.7679094373956725,1.0,10/46,12.46%,MRE11;FEN1;APEX2;EXD1;XRN2;WRN;CNOT6;ERI1;EXOG;EXD2
prerank,sequence-specific DNA binding (GO:0043565),0.29602626372364077,1.024126762089276,0.4172517552657974,0.7739401917225751,1.0,89/590,17.60%,NFE2;BACH2;FOXP1;RUNX2;RARA;SP3;RUNX3;KLF4;CREB1;PPARG;BCL6;LONP1;PITX3;ELF4;RFX7;FOS;ZBTB20;MYRF;SCX;ZEB2;MBD1;ATF6;ATF2;IRF2;RFX3;RBPJ;HIVEP1;KLF5;IRF4;BBX;RFX5;KLF13;KLF10;AHR;CBFB;CREM;IKZF3;NFE2L2;MECP2;CLOCK;RARG;E2F2;CTCF;ELF1;PKNOX1;IRF7;MEF2B;SMAD4;CSRNP1;NR3C1;UPF2;GMEB2;PBX1;FOXO3;NLRP3;ETS2;MBD2;ATF6B;SMG1;TFAM;TEAD1;JUNB;SREBF2;SLTM;MAFK;SP4;KMT2A;STN1;TAF1;HSF5;BHLHE40;ZNF148;FOXN2;ELF2;SMG6;IRF5;BPTF;HOXC9;PROX1;CREB3L4;CREB3;SMAD5;ELK4;FOXK1;CHCHD2;LRWD1;NR4A1;ERH;NFATC3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4176881306757182,-1.0232375281932595,0.4241645244215938,0.7532061763081457,1.0,9/12,36.24%,SDHB;FXN;ISCA2;FDX1;ISCU;CIAPIN1;AOX1;ISCA1;CISD3
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.3698434253260019,-1.0194668173850474,0.4603174603174603,0.7516732331824271,1.0,4/17,11.76%,EPHA6;EPHA5;EFNB3;EPHA7
prerank,ephrin receptor activity (GO:0005003),-0.3698434253260019,-1.0194668173850474,0.4603174603174603,0.7516732331824271,1.0,4/17,11.76%,EPHA6;EPHA5;EFNB3;EPHA7
prerank,G protein-coupled receptor binding (GO:0001664),0.3214461267829145,1.0173605258602683,0.4489795918367347,0.7872102463168251,1.0,6/132,2.62%,GRK3;GNA14;FPR1;ACE;HSPA1A;CCDC88C
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4426373760871689,-1.0171180521684597,0.45323741007194246,0.7520796211170543,1.0,2/10,1.04%,SLC8A1;SLC24A3
prerank,protein kinase inhibitor activity (GO:0004860),0.37140176174944356,1.0153602368673653,0.44630404463040446,0.7890434677999445,1.0,11/42,15.33%,IBTK;GMFG;TAOK3;HEXIM1;PRKRIP1;CIB1;MBIP;GSKIP;SH3BP5;DNAJC3;SPRED1
prerank,transcription coactivator binding (GO:0001223),-0.36883204301491157,-1.0087477424599582,0.4462809917355372,0.7673605264436146,1.0,13/20,28.66%,VGLL4;THRB;PGR;SMAD3;MED25;ESR1;ZBTB49;AR;CDK9;ZBTB17;CIT;RORA;PPARD
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4879746393231733,1.0079122013499637,0.44939965694682676,0.8043483124992064,1.0,4/10,22.61%,B4GALT5;B3GALT2;B4GALT7;B3GALT5
prerank,3'-5' DNA helicase activity (GO:0043138),-0.37310731369647687,-1.0069756555722535,0.4358288770053476,0.7663510256184611,1.0,1/16,0.02%,NAV2
prerank,microtubule motor activity (GO:0003777),0.35710576180404524,1.0046726821372376,0.4553686934023286,0.808945354424935,1.0,9/51,10.57%,DNAH2;DNAH8;KIF20A;KIF5B;KIF6;KIF23;KIF24;KIFC3;KIF3B
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.3796254568649187,-1.0042967204252242,0.43989071038251365,0.7679089693093497,1.0,7/17,28.95%,BLVRB;DPYD;PECR;TECR;PTGR2;DECR2;PTGR1
prerank,solute:sodium symporter activity (GO:0015370),0.39525228713795657,1.003930012350474,0.45427728613569324,0.807487030406872,1.0,3/27,12.21%,SLC4A7;SLC4A8;SLC28A2
prerank,GABA receptor activity (GO:0016917),-0.34654543128969917,-1.0036591841273008,0.43258426966292135,0.7641028972926353,1.0,8/21,18.59%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABBR1;GABRA2;GABRA5
prerank,amino acid:sodium symporter activity (GO:0005283),-0.42055223765827554,-1.0017890654299515,0.45901639344262296,0.7637428163068372,1.0,2/11,5.53%,SLC1A3;SLC6A15
prerank,telomerase RNA binding (GO:0070034),0.40188211944499175,1.00045861428785,0.4628224582701062,0.8127114801742393,1.0,9/22,20.96%,TEP1;SNRPB;DCP2;NHP2;WRAP53;TENT4B;SMG6;HNRNPC;PARN
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3770272965997513,0.9998270255150942,0.481638418079096,0.811019437156007,1.0,11/33,20.96%,XRN2;PNLDC1;DCP2;CNOT6;ERI1;EXD2;PNPT1;CNOT8;DIS3L;CNOT6L;PARN
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.3577787880374727,-0.9993677232860105,0.44668587896253603,0.7593475806464917,1.0,11/21,20.51%,CDK8;CDK11B;CDKL3;CDK5;CCNK;CDK10;CDK4;CDKL1;CDK9;CDK20;CDK7
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.3577787880374727,-0.9993677232860105,0.44668587896253603,0.7593475806464917,1.0,11/21,20.51%,CDK8;CDK11B;CDKL3;CDK5;CCNK;CDK10;CDK4;CDKL1;CDK9;CDK20;CDK7
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.3594154433584504,-0.9979232875124608,0.44692737430167595,0.7578975605463356,1.0,6/19,10.75%,GAS6;ERCC6;NRG3;DGKQ;GRM5;EFNA5
prerank,cyclic nucleotide binding (GO:0030551),0.406704428614671,0.9932559127444384,0.488822652757079,0.8235890015923756,1.0,3/21,7.50%,RAPGEF2;KCNH1;PDE2A
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3703547397795579,0.99322124237993,0.48614958448753465,0.8204853327385186,1.0,13/34,21.30%,NSD3;SETD7;CAMKMT;DOT1L;SETD2;KMT5B;EZH2;EEF1AKMT1;KMT2E;EHMT1;TTLL12;PRDM9;ATPSCKMT
prerank,solute:anion antiporter activity (GO:0140323),-0.3850334931026247,-0.9922473662995759,0.48936170212765956,0.7668879839309305,1.0,6/14,29.39%,SLC26A11;SLC26A2;SLC4A2;SLC26A8;SLC26A6;SLC4A3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4368389027121266,0.9900033530904047,0.4867549668874172,0.8252142818204994,1.0,2/14,6.14%,CAPN13;CAPN2
prerank,NF-kappaB binding (GO:0051059),0.40237087029607677,0.9898606498734186,0.4823529411764706,0.8224378812193712,1.0,12/24,26.22%,NFKBIA;FAF1;ANXA4;CPNE1;HDAC3;RELA;HDAC1;GSK3B;HIF1AN;PSMA6;SETD6;HDAC2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3863947964700848,0.9884936374461082,0.462882096069869,0.8225096737041523,1.0,4/27,7.52%,SLC9A7;SLC23A1;SLC8B1;SLC4A8
prerank,transforming growth factor beta binding (GO:0050431),-0.3322228428987736,-0.9869470949726755,0.468944099378882,0.7750100259068475,1.0,3/23,6.11%,TGFBR2;TGFBR1;ACVR1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3256067157670064,-0.9859392305172313,0.47962382445141066,0.7723793599784752,1.0,4/26,10.66%,SLC16A6;ABCG2;SLC27A1;MPC2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.3450670388052652,-0.9855961211820198,0.4672897196261682,0.7682288670936517,1.0,8/22,17.60%,RBMS3;CPEB2;CPEB1;ELAVL1;EXOSC9;ELAVL4;CPEB3;ELAVL3
prerank,NAD+ binding (GO:0070403),0.45290484791216656,0.9851410353502209,0.5077989601386482,0.8274950623007125,1.0,6/12,21.21%,ZC3HAV1;PARP9;GLUD1;SIRT1;HPGD;SIRT3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3150955630457194,-0.9834120948981621,0.4672897196261682,0.7686327346217922,1.0,10/27,27.66%,ANKH;SLC26A11;SLC25A11;SLC25A14;GET3;LRRC8A;SLC26A2;SLC26A8;SLC26A6;SLC25A10
prerank,E-box binding (GO:0070888),0.37865473188202736,0.9828581132861144,0.49712643678160917,0.8297403514078031,1.0,5/34,7.79%,PPARG;CIART;SCX;AHR;CLOCK
prerank,histone deacetylase binding (GO:0042826),0.32003033168195927,0.9766181049099945,0.5194647201946472,0.8416589582588215,1.0,20/88,16.30%,PKN1;HSPA1A;NIPBL;SPI1;MTA3;CAMTA2;RBBP4;CCND1;IKZF3;PKN2;HDAC9;MEF2B;NUDT21;MAPK8;CHD4;KAT2B;HDAC3;RELA;MIER1;KPNA2
prerank,carboxy-lyase activity (GO:0016831),-0.32959135524105154,-0.9705924905363473,0.49411764705882355,0.7943290819655218,1.0,9/23,22.64%,PPCDC;ECHDC1;PCK2;UMPS;GGCX;MLYCD;ODC1;GAD1;DDC
prerank,signaling receptor complex adaptor activity (GO:0030159),0.36216627399403023,0.9694609240724252,0.5106382978723404,0.8553784350757354,1.0,6/38,12.71%,LRRK2;STAP1;AXIN1;SPATA2;DEDD2;RGS14
prerank,chloride channel regulator activity (GO:0017081),-0.3710173341432575,-0.9694151115294112,0.5145118733509235,0.7920090822330238,1.0,8/14,17.78%,WNK1;WNK2;SGK1;VTI1B;CHRNA7;STX1A;VAMP8;STX8
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.47258851135875823,0.9685531745533963,0.5393634840871022,0.8543186817041389,1.0,2/10,10.65%,PIK3C2A;PIK3CA
prerank,sulfotransferase activity (GO:0008146),-0.29707620214410924,-0.9673716421269206,0.5,0.7921190267752166,1.0,13/33,26.40%,TPST2;CHST11;CHST9;CHST1;HS6ST1;CHST8;CHST3;GAL3ST4;CHST2;HS3ST2;HS3ST1;SULT1A1;HS3ST3A1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.39393306072115086,0.964009357864402,0.5176110260336907,0.8617999612508932,1.0,6/23,14.35%,SESTD1;GBF1;HIP1;WIPI2;SNX3;MAPKAP1
prerank,metalloexopeptidase activity (GO:0008235),0.3437244425626514,0.9628823889447542,0.5274431057563588,0.8612483461087964,1.0,6/51,7.40%,ACE;LNPEP;ACE2;DPEP1;RNPEPL1;CPQ
prerank,O-methyltransferase activity (GO:0008171),-0.4148831313082307,-0.9624211067585285,0.5160550458715596,0.7990787414833657,1.0,5/10,25.63%,COMT;COQ3;FTSJ3;BCDIN3D;ASMT
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3909584971794454,-0.9611648416415441,0.48258706467661694,0.7971605961018509,1.0,4/12,8.76%,PDE3B;PDE1B;PDE8B;PDE4A
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4240001188205171,0.9595212477386769,0.5146103896103896,0.8656755436548181,1.0,5/14,15.34%,MINDY3;ATXN3;USP15;USP7;USP9X
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4387645135715673,0.9591860141816689,0.5333333333333333,0.8632580946501754,1.0,4/13,13.34%,KCNQ1;EZR;PRKAR2A;CSK
prerank,hexosyltransferase activity (GO:0016758),-0.23378358846699632,-0.9573696688568704,0.6075949367088608,0.801204973580701,1.0,20/101,20.21%,HEXB;LARGE1;DPY19L4;B3GALNT1;CHPF2;GYG1;B4GALT4;MGAT4C;PIGB;ALG9;HEXA;MGAT4A;POMT1;PIGV;GCNT1;ALG1;POGLUT2;GBA2;DPY19L3;HYAL1
prerank,damaged DNA binding (GO:0003684),0.34059604270772714,0.9548136747627988,0.5188172043010753,0.8701887212154661,1.0,16/44,22.09%,RBBP8;FEN1;CRY2;RPS3;TDG;RPA3;ERCC3;ERCC4;CREBBP;POLD1;SMC6;FANCG;APEX1;XPA;POLQ;SDE2
prerank,GABA-A receptor activity (GO:0004890),-0.35043636205284845,-0.9543446421960449,0.5561643835616439,0.8036385513543136,1.0,7/18,18.59%,GABRG3;GABRG2;GABRB1;GABRA4;GABRB3;GABRA2;GABRA5
prerank,transition metal ion binding (GO:0046914),0.27970048341338966,0.9540605329131352,0.5995934959349594,0.86878813821819,1.0,56/397,12.65%,SAMHD1;GDA;ACE;KLF4;ACER3;LNPEP;PPARG;PIM1;ACE2;TET2;PLSCR1;KDM7A;MSRB1;UPB1;DHX58;CBLB;ETHE1;FEN1;SMPDL3B;DPEP1;MBD1;PEX12;HEPH;SMPDL3A;ARIH1;RC3H1;IFIH1;PRNP;IMPA1;CRIP1;WRN;MYCBP2;PDE2A;ATP7A;GALNT2;ARIH2;CTCF;KAT6A;TNKS;RBAK;NQO2;SLU7;RASSF1;ARG2;ATOX1;CYLD;PTPN1;MTPAP;RNPEP;DUSP12;TAB3;IKZF5;CAD;RCHY1;EXD2;XXYLT1
prerank,glutamate receptor binding (GO:0035254),-0.3453272173201116,-0.9526755886758129,0.5392953929539296,0.8025518594993896,1.0,7/17,23.45%,DLG4;SQSTM1;GNAS;IGSF11;CAMK2A;AKAP5;HOMER3
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4504909516654547,0.9505415332012637,0.5497553017944535,0.8735245494728873,1.0,1/11,3.90%,HCN4
prerank,adenylate cyclase binding (GO:0008179),-0.4129104955418026,-0.9492975135617266,0.5250596658711217,0.8053398884967939,1.0,6/10,34.72%,AKAP12;AKAP6;CALM1;AKAP5;ADCY2;CALM2
prerank,phosphatase binding (GO:0019902),0.30272943544812014,0.9492750673353352,0.563719862227325,0.87339692452269,1.0,28/105,18.89%,IQGAP1;MAP3K5;STAT3;CRY1;MAPK14;STX17;MTMR3;SHOC2;TRAF3;CRY2;MTMR4;KCNN4;PXN;SNX3;LGALS3;EIF2AK3;MVP;VCP;ANAPC7;MAPK1;SPRED1;TBK1;ELL;PIK3R2;TRAF2;CTSC;ANAPC4;BAD
prerank,RNA stem-loop binding (GO:0035613),-0.3928875064573459,-0.9484670311312604,0.5255474452554745,0.8022993965987403,1.0,5/12,21.35%,RC3H2;DHX9;CPEB3;DDX3X;MYH10
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3683302431227917,0.9479848162127205,0.5366568914956011,0.873321308160236,1.0,4/27,8.98%,POLR3F;POLR3A;POLR2C;TENT2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.27434726757923006,-0.9466442690439293,0.5535055350553506,0.8017164290177543,1.0,19/49,22.60%,IKBKE;AGAP3;ZRANB1;MINDY2;RNF169;UBQLN4;OPTN;OTUD7A;MINDY1;OTUD7B;SQSTM1;UBL7;UBQLN2;HDAC6;SPRTN;SHARPIN;WDR81;RAD23A;ZFAND2B
prerank,ATPase regulator activity (GO:0060590),-0.2870024711041691,-0.9455777767073572,0.5201238390092879,0.7993153678259839,1.0,9/38,9.87%,FNIP2;FNIP1;ATP1B3;ATP1B1;PFN1;BAG4;BAG1;DNAJA2;DNAJB2
prerank,peptidase inhibitor activity (GO:0030414),-0.29398491404768057,-0.9448113784105142,0.556390977443609,0.7963247148523034,1.0,4/33,4.28%,TIMP2;RENBP;PROS1;CST3
prerank,protein heterodimerization activity (GO:0046982),-0.21151562223661907,-0.9444364087168672,0.6351351351351351,0.7925144726583931,1.0,51/178,21.26%,MEF2C;RALGAPA2;NPAS3;BCL2L1;TENM4;UBA3;IRAK2;TENM2;USF2;ATF3;ATP1B1;RALGAPB;HIF1A;RALGAPA1;ATF4;SAE1;ATP1A2;FXR1;NAE1;QTRT1;PDGFA;ALG2;IRAK1;FXR2;HEXA;MIGA2;TLR4;MTTP;ADD2;P4HB;PRMT5;ADRA1B;BHLHE41;ADRB1;BAX;TENM1;RRAGC;BMP6;PAFAH1B2;SMC1A;ZHX2;RAN;ADCY8;TCF4;VAPB;YWHAH;GCA;TCF3;TCOF1;BCL2L2;PPP2R1A
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3766511004587264,0.9434721526668748,0.5290423861852434,0.8803416073388577,1.0,3/24,5.85%,PLEKHF1;GOLPH3L;SESTD1
prerank,gated channel activity (GO:0022836),0.4159316305020802,0.9433983165159656,0.5367047308319739,0.8773236786059688,1.0,7/14,24.26%,TMC8;PIEZO1;TMC6;TMC4;PIEZO2;TMEM63A;PACC1
prerank,anion:anion antiporter activity (GO:0015301),-0.34708051598309964,-0.9422219461306265,0.5287671232876713,0.7927929703293191,1.0,8/17,29.39%,SLC26A11;SLC25A11;SLC26A2;SLC4A2;SLC26A8;SLC26A6;SLC25A4;SLC4A3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.42627259376922166,0.9388081732716186,0.5340136054421769,0.8845387179834782,1.0,5/13,16.28%,CCDC88A;ARHGDIB;SH3BP4;RGS14;GPSM2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.3245676052306484,-0.9349154078688513,0.5552238805970149,0.8046272973940308,1.0,3/21,9.50%,P2RX7;P2RX4;CHRNA7
prerank,anion channel activity (GO:0005253),0.3173710705865917,0.9348928374158177,0.5684754521963824,0.8903460202683,1.0,6/61,5.20%,LRRC8C;GABRB2;LRRC8D;CLIC4;GABRR2;LRRC8B
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.26857067522468697,-0.9344316177007727,0.5627906976744186,0.8010452593575715,1.0,13/51,18.42%,SLCO2B1;ANKH;CLCN4;SLC25A3;SLC35C2;SLC25A11;SLC7A8;SLC25A14;CLCN3;SLC22A4;SLC35E1;SLC35D2;SLC35E3
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3650951670089577,0.9322274085728137,0.5516739446870451,0.8931316060001547,1.0,3/27,4.13%,POLR3F;POLR3A;POLR2C
prerank,alpha-tubulin binding (GO:0043014),0.35331001219376057,0.9307523672930322,0.5414781297134238,0.8931809386279677,1.0,9/31,16.40%,FYN;RACGAP1;SPAST;SETD2;ARL8B;EML4;EFHC2;INO80;TRIM36
prerank,DNA polymerase activity (GO:0034061),0.37912056396991656,0.9293694753765579,0.5729323308270676,0.8929476080742124,1.0,9/22,21.13%,POLI;POLL;POLD4;CHRAC1;POLB;POLD1;PRIMPOL;POLK;POLQ
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4294244896050709,0.9289321367545322,0.534453781512605,0.8907400580574338,1.0,4/12,15.60%,CCDC88A;VEGFC;PGF;ITGA5
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3862126747993839,0.9282259370806307,0.5688073394495413,0.8892273958267959,1.0,9/21,21.13%,POLI;POLL;POLD4;CHRAC1;POLB;POLD1;PRIMPOL;POLK;POLQ
prerank,N-acetyltransferase activity (GO:0008080),0.38615818823005016,0.9271469944758426,0.5405819295558959,0.8883431752013947,1.0,4/19,13.97%,ATAT1;SMARCE1;NAT2;KAT2B
prerank,ankyrin binding (GO:0030506),0.3862871807352419,0.9266280342106655,0.5725190839694656,0.8863483219606055,1.0,1/19,0.30%,PTPRC
prerank,kinase activator activity (GO:0019209),-0.2989945172923044,-0.9245259082211842,0.6098360655737705,0.81862639106385,1.0,9/30,13.71%,TREM2;WNK1;RPTOR;FGF13;STRADA;CDK5R1;NCKAP1L;GPRC5B;RPLP1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3760545557788291,0.9232389793903705,0.5596184419713831,0.8908522644759691,1.0,5/21,9.91%,WASF2;KCNQ1;EZR;ARFGEF1;GSKIP
prerank,protein tyrosine kinase binding (GO:1990782),0.31211283104743537,0.921840260067675,0.5774473358116481,0.8906448454201112,1.0,12/71,13.27%,NEDD9;ITGAX;CRK;BMPR2;CBLB;CBL;ELMO2;PITPNM1;PTPN1;MAP3K7;CASS4;LRP4
prerank,voltage-gated potassium channel activity (GO:0005249),0.306047152636715,0.9217249521590194,0.5928659286592866,0.8878135034022117,1.0,6/80,5.68%,KCNE3;KCNG4;KCNA6;KCNQ1;HCN4;KCNH1
prerank,adrenergic receptor binding (GO:0031690),-0.35536473964033305,-0.9201034659979254,0.5962059620596206,0.8242953181797587,1.0,9/16,23.61%,MAGI2;DLG4;SAV1;ADRB1;UCHL1;GNAS;APLP1;AKAP5;C1QBP
prerank,SH2 domain binding (GO:0042169),0.35242658652763986,0.9198663005018978,0.5581061692969871,0.8887613861974205,1.0,8/31,11.17%,LILRB1;JAK2;CRK;CCDC88A;DLC1;AFAP1L2;AFAP1;NLK
prerank,estrogen receptor binding (GO:0030331),-0.28670773455470755,-0.9182586390284719,0.57,0.823958518926975,1.0,8/32,14.48%,CTNNB1;MMS19;DCAF1;NCOA6;RERG;PPARGC1B;ESR1;PRMT2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.38304608476961144,-0.9167361570221376,0.5804878048780487,0.8227468454056344,1.0,4/11,11.73%,CFLAR;CASP4;PYCARD;CASP3
prerank,RNA binding (GO:0003723),0.2627655137690205,0.9148601292978342,0.836,0.8963403077162039,1.0,275/1321,16.84%,TENT5A;MBNL1;AHNAK;DNA2;ZC3H12D;ZC3HAV1;SAMHD1;CDK13;RPL5;PTBP3;OAS2;ANXA2;LONP1;MSN;DHX40;FASTKD1;MEX3D;STAT3;VIM;SEPSECS;VIRMA;HSPA1A;TCF20;DHX58;NOA1;IFIT2;RBPMS;EIF4G3;ANKRD17;RCC2;SND1;CORO1A;CTNNA1;NOL6;GTF2E2;RPS10;CRNKL1;RBM27;EIF2AK2;SLPI;FARS2;MYH9;XPO5;STAU1;MBNL3;SUMO1;ZMAT3;LRRFIP1;SNRPD2;RPL37A;PRPF6;DGCR8;RPL6;DIAPH1;S100A4;NUFIP1;RC3H1;EXD1;FLNB;RBMS1;IFIH1;RPS18;HEXIM1;DDX42;HELZ2;PRKRIP1;XRN2;TEP1;UBE2N;SNRPB;DARS2;DBR1;POLR1G;CAST;DEK;KMT2C;HLTF;CDC5L;CLUH;DHX37;GRB2;SETX;LGALS1;PNLDC1;RPS14;FNDC3A;RBM34;FLNA;SRSF10;RPL35A;SAMSN1;BUD13;OASL;PKN2;GIGYF2;NUP98;PURB;DDX41;FNDC3B;HTATSF1;DCP2;MECP2;PUM2;TRIM25;ARF1;RBMS2;FIP1L1;IMMT;RPL22L1;YTHDF3;TUT1;DNAJC21;SAP18;ZBED4;NHP2;EZR;UTP6;RBM10;KHNYN;LSM5;MAGOHB;DDX46;RPL13;MRPL13;TLR3;RPF2;ZFP36L2;ERI1;PRPF3;ASCC3;ACAA2;SF3B6;SEC63;SCAF8;ETF1;NSA2;RBM22;RP9;WRAP53;DDX49;SRSF4;NAA15;DHX34;DHX8;MDH2;RPS3;RTN4;IGF2BP3;NOC4L;RPS21;CELF2;PIN4;SUMO2;ALG13;YTHDC1;PTPN1;FDPS;NUDT21;RBM15;SPEN;YWHAZ;MTPAP;DCP1A;CACTIN;SRRT;SRP72;PRPF38B;SCAF4;FRG1;TUT7;NOL11;EIF4A2;NAP1L1;MAK16;SRP19;MEX3C;DYNC1H1;SLC25A5;ZCCHC7;RPL34;RPLP0;BAZ2A;UTP20;SMG1;PTCD3;NMD3;TFAM;DDX23;SNRPA1;AGFG1;SF3A1;OTUD4;RPL19;LRRC59;LGALS3;MAP3K20;RPL11;EIF4ENIF1;NSRP1;HSPA9;HNRNPLL;IREB2;RPL30;NOP58;METTL3;RRP36;RNASEH1;API5;KTN1;TNRC6B;RBM38;IFIT1;PNPT1;NUFIP2;GPATCH4;SECISBP2;RPS2;TNRC6A;RPL4;RPL7;LARP4B;VCP;CANX;SYNCRIP;AQR;UTP18;TRMT10C;ZCCHC9;SLTM;MRTO4;EIF3E;DDX10;U2SURP;TENT4B;MAZ;FAM133B;ASS1;DRG2;RRP8;RPS15A;CPSF3;WBP11;SLC16A3;NCBP1;TBL3;PHF5A;ENDOV;LRRC47;CELF1;SIDT2;TCP1;RBM39;PTBP2;RPS4X;TFB1M;TPD52L2;PPHLN1;PABPC1;PUM1;TNPO1;KPNB1;TUBA1B;NPM3;PARP12;KPNA2;SMG6;PUS1;MRPS27;PPIB;NCOA5;EIF1AX;EIF1;ACIN1;SYF2;LLPH
prerank,N-acyltransferase activity (GO:0016410),0.35018357348130186,0.9148247239771157,0.5662824207492796,0.8933709495257887,1.0,4/32,12.42%,CERS6;CERS1;SMARCE1;NMT2
prerank,fibroblast growth factor binding (GO:0017134),0.37366134437908405,0.9138503682290571,0.5786163522012578,0.8923656153485909,1.0,9/21,20.76%,KL;API5;RPS2;FGFR3;THBS1;GLG1;FGFR1;GPC1;ITGAV
prerank,general transcription initiation factor binding (GO:0140296),0.3647876129916892,0.9070343642838912,0.5678092399403875,0.9040228497416518,1.0,6/25,15.44%,TAF13;AHR;THRA;GTF2A1;RELA;TAF1
prerank,methylated histone binding (GO:0035064),0.30801750952351614,0.9038642130288177,0.5893536121673004,0.9075356060634733,1.0,24/62,21.84%,KDM7A;MBTD1;PHF19;MSH6;ING3;ING2;TAF7;MSL3;ATRX;MORC3;L3MBTL2;CDYL;KMT2E;RRP8;TAF1;BPTF;LRWD1;PHF13;CBX8;WDR5;TTLL12;RBBP5;GLYR1;KDM5A
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.3524510878724073,-0.9027917993127372,0.605,0.8489982394104507,1.0,2/14,8.62%,AKR1A1;DHRS3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.36845450199725904,0.9002162999570529,0.5854037267080745,0.9120500980290587,1.0,5/20,17.41%,SLC30A4;SLC30A1;SLC39A11;SLC39A13;SLC39A12
prerank,diacylglycerol kinase activity (GO:0004143),0.41958510629823514,0.8954120840271009,0.5865546218487395,0.9189913864080155,1.0,1/11,1.04%,DGKG
prerank,SUMO binding (GO:0032183),-0.3660374570586331,-0.8950509692393346,0.6004784688995215,0.8612753817030285,1.0,7/13,30.49%,HERC2;SIMC1;HABP4;RNF4;UBA2;CBX4;USP25
prerank,RNA polymerase II complex binding (GO:0000993),0.33832394134392796,0.8942496255388098,0.6161616161616161,0.9184075809441884,1.0,7/32,11.19%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.3491415298309165,-0.8941483958671654,0.5796703296703297,0.858456604928348,1.0,7/14,42.24%,DTYMK;AK1;CMPK2;AK4;NME2;AK9;NME4
prerank,lipid phosphatase activity (GO:0042577),-0.3427024697571823,-0.8938351336973834,0.5773195876288659,0.8543458932272464,1.0,5/14,19.90%,PLPP3;PLPP1;PLPPR1;PLPP7;PLPPR4
prerank,ATPase binding (GO:0051117),-0.23671581282248397,-0.8917239183590119,0.7246376811594203,0.8545652172054279,1.0,20/71,15.86%,ABCA1;TCIRG1;ATP1B3;PKD2;ATP1B1;ANK2;PGR;TRPC1;SNTA1;RALA;ATP6V0A1;DERL1;NR1H2;ESR1;SRC;PIH1D1;PTPN3;AR;CLPP;SNU13
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3333124900890136,0.889455773723769,0.6203059805285118,0.9253096006982017,1.0,7/33,11.19%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.25216762684847616,-0.8894072986512392,0.6628787878787878,0.8551356697232324,1.0,9/48,13.66%,TRPV2;TRPM3;ATP6V1B2;PKD2;UNC80;TRPC1;MCOLN1;TRPM2;TRPV4
prerank,"DNA binding, bending (GO:0008301)",-0.3448197806158425,-0.8888909967486116,0.5979643765903307,0.8515361231948998,1.0,7/14,33.91%,HMGB1;HMGB2;TERF1;HMGA2;HHEX;LEF1;HMGB3
prerank,cytokine activity (GO:0005125),0.27681849342741727,0.8843332378974351,0.6886160714285714,0.9329152147564004,1.0,8/131,8.62%,IL1B;CXCL10;GDF1;IL33;CKLF;CXCL16;BMP3;IL6
prerank,poly(A) binding (GO:0008143),-0.30688304041758585,-0.8838766839290506,0.6017699115044248,0.8577549168190854,1.0,8/21,18.25%,RBMS3;ZC3H14;HNRNPDL;TIA1;ELAVL4;KHDRBS2;PPIE;DDX3X
prerank,phospholipase binding (GO:0043274),0.39012318495990617,0.8836569600715166,0.6114864864864865,0.9312982513322219,1.0,4/13,7.28%,FYN;SYK;PDPK1;PAFAH1B1
prerank,adenyl nucleotide binding (GO:0030554),-0.3792007224607208,-0.8834786824584182,0.6196868008948546,0.8493571361378401,1.0,6/11,22.29%,PFN1;BAG4;BAG1;GRPEL1;HSPH1;BAG5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.3792007224607208,-0.8834786824584182,0.6196868008948546,0.8493571361378401,1.0,6/11,22.29%,PFN1;BAG4;BAG1;GRPEL1;HSPH1;BAG5
prerank,R-SMAD binding (GO:0070412),-0.32330549131442887,-0.8775424860723847,0.6434108527131783,0.8572263540698246,1.0,4/18,11.91%,LDLRAD4;DDX5;SMAD3;TRIM33
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.43025675888835313,0.8764402518500769,0.6138433515482696,0.9431024113474222,1.0,2/10,11.68%,DPEP1;CAD
prerank,methylation-dependent protein binding (GO:0140034),0.3023949163938178,0.8749072027187247,0.6380208333333334,0.9431229322574427,1.0,21/57,21.84%,KDM7A;MBTD1;PHF19;MSH6;ING3;ING2;MSL3;ATRX;MORC3;L3MBTL2;CDYL;KMT2E;RRP8;BPTF;LRWD1;PHF13;CBX8;WDR5;RBBP5;GLYR1;KDM5A
prerank,chemoattractant activity (GO:0042056),0.34436164528925006,0.8748700309189087,0.6304985337243402,0.9400923614208249,1.0,6/26,12.85%,CXCL10;GDNF;VEGFC;HGF;PGF;LGALS3
prerank,Hsp70 protein binding (GO:0030544),0.3302540482306373,0.8692231187934703,0.6338235294117647,0.9486004873843946,1.0,7/31,10.82%,ERN1;RNF207;SPN;DNAJC8;RPS3;HIKESHI;DNAJB12
prerank,cation transmembrane transporter activity (GO:0008324),-0.25038047310752387,-0.8689147827791671,0.732824427480916,0.8710583715182956,1.0,9/48,12.67%,SLC38A6;MFSD12;SLC7A1;SLC36A4;SLC36A1;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,endopeptidase inhibitor activity (GO:0004866),0.2900896496248977,0.8687854424120753,0.6825208085612366,0.9463249952440008,1.0,10/82,12.10%,NGF;ANXA2;BIRC6;SLPI;CAST;PRNP;SERPINB9;CARD16;UBE2Z;APP
prerank,endopeptidase regulator activity (GO:0061135),0.31543911493408133,0.8681369090829408,0.6557591623036649,0.9444854215815119,1.0,5/40,10.13%,PSME3;SLPI;PSME2;CAST;NLRC4
prerank,deubiquitinase activity (GO:0101005),0.2871150408232817,0.8675299890733329,0.69559902200489,0.9427003408843542,1.0,26/88,18.07%,MINDY3;USP3;EIF3F;OTUD1;USP49;USP45;JOSD1;ATXN3;USP32;USP48;USP31;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47;EIF3H;USP14;USP38
prerank,protein phosphatase 2A binding (GO:0051721),-0.29266869213653046,-0.8652746765639593,0.683377308707124,0.8741902337175763,1.0,8/23,22.58%,CTTNBP2NL;ENSA;MFHAS1;DAB2IP;SMG7;ADCY8;IGBP1;BOD1
prerank,pre-mRNA binding (GO:0036002),0.33515642027755976,0.8624904643452181,0.6398809523809523,0.9496075900555259,1.0,5/28,10.31%,RNPC3;ERI1;RBM22;SLU7;CELF2
prerank,AMP binding (GO:0016208),0.4092354130621588,0.8616623217905612,0.6328671328671329,0.9483192240135412,1.0,4/11,19.95%,PRKAG2;PRKAG1;PYGL;ACSS2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3481878265396324,-0.8615956638200566,0.6410256410256411,0.877158420827438,1.0,5/12,26.10%,SLC25A25;LRRC8A;SLC17A9;SLC35B2;SLC25A42
prerank,death receptor activity (GO:0005035),0.40611171134213053,0.8614420843824478,0.6422338568935427,0.9456502931243864,1.0,3/11,15.21%,NGFR;TNFRSF1B;TNFRSF4
prerank,O-acyltransferase activity (GO:0008374),-0.27949524936699455,-0.8603391886391148,0.6888888888888889,0.8751428033385036,1.0,5/30,9.66%,LPCAT2;PLA2G15;LPCAT1;PLA2G4A;GPAM
prerank,telomeric DNA binding (GO:0042162),-0.26802506896965556,-0.8603102153644325,0.6964856230031949,0.8706200442433568,1.0,10/32,19.06%,CTC1;BLM;UPF1;TERF2IP;XRCC5;TEN1;SMG7;TERF1;ZBTB48;HNRNPA2B1
prerank,phosphatase inhibitor activity (GO:0019212),0.3533948160887145,0.8578406052515639,0.6615853658536586,0.949388816113973,1.0,4/20,12.85%,LMTK2;PPP1R9B;PPP1R2;LGALS3
prerank,metalloendopeptidase activity (GO:0004222),-0.2226665292612613,-0.857500038381418,0.7752808988764045,0.871870252316564,1.0,17/76,18.62%,ADAM33;MMP16;MMP14;AFG3L2;IDE;ADAMTSL1;ADAMTS16;SPG7;ADAMTSL4;ZMPSTE24;MBTPS2;ADAMTS5;NLN;SPRTN;NRDC;ADAMTS2;ADAMTS1
prerank,G protein-coupled amine receptor activity (GO:0008227),0.34416894809238685,0.8539335523502436,0.6422155688622755,0.9481985607780845,1.0,3/22,9.67%,HTR1D;HTR4;HRH1
prerank,serotonin receptor activity (GO:0099589),0.34416894809238685,0.8539335523502436,0.6422155688622755,0.9481985607780845,1.0,3/22,9.67%,HTR1D;HTR4;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.34416894809238685,0.8539335523502436,0.6422155688622755,0.9481985607780845,1.0,3/22,9.67%,HTR1D;HTR4;HRH1
prerank,kinase inhibitor activity (GO:0019210),0.32112547117538226,0.8534167160674642,0.6548672566371682,0.946221467347307,1.0,8/33,13.93%,GMFG;TAOK3;HEXIM1;PRKRIP1;MBIP;GSKIP;SH3BP5;DNAJC3
prerank,GABA receptor binding (GO:0050811),-0.3507792895333257,-0.8532264922904521,0.6133909287257019,0.8762904429675804,1.0,5/11,22.30%,JAKMIP1;ARFGEF2;LHFPL4;GABARAP;AKAP5
prerank,protein kinase activator activity (GO:0030295),0.29446213097733576,0.8527571297263402,0.6798516687268232,0.944584901203339,1.0,7/60,7.57%,IQGAP1;PRKAG2;GPRC5C;ABI1;STK4;PAK2;AFAP1L2
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.35785200593874844,-0.8521112436695334,0.6113744075829384,0.8739559195739156,1.0,2/10,2.73%,NAA50;NAA40
prerank,receptor tyrosine kinase binding (GO:0030971),0.29719982045197213,0.850129475850532,0.6829268292682927,0.9463971898961423,1.0,12/56,17.10%,STAP1;ITGAX;CBLB;CBL;ELMO2;PITPNM1;PTPN1;MAP3K7;LRP4;FRS2;RNF41;PIK3R2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2843324965353097,0.8497236794299148,0.7007481296758105,0.9442445234624638,1.0,22/83,16.05%,MINDY3;USP3;OTUD1;USP49;USP45;JOSD1;ATXN3;USP32;USP48;USP31;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47
prerank,sequence-specific mRNA binding (GO:1990825),-0.3529587989763824,-0.8487228766454281,0.6485849056603774,0.8758495815051102,1.0,3/10,14.03%,SHFL;SSB;DHX9
prerank,mRNA 3'-UTR binding (GO:0003730),0.2800186931330337,0.8479698323268333,0.7335722819593787,0.9445678570660412,1.0,20/79,17.97%,RPL5;MEX3D;RNF20;RC3H1;RBMS1;PUM2;RBMS2;TUT1;ZFP36L2;IGF2BP3;CELF2;NUDT21;SECISBP2;LARP4B;CELF1;PABPC1;PUM1;BOLL;YBX3;AUH
prerank,potassium:proton antiporter activity (GO:0015386),0.4086408452945317,0.8471577129298937,0.6797274275979557,0.9432982878578735,1.0,1/10,2.03%,SLC9A7
prerank,myosin binding (GO:0017022),0.29304712825451706,0.8463444087849665,0.677336747759283,0.9419754690211386,1.0,17/55,22.77%,LMTK2;RAB3D;CORO1A;SPATA6;RAB6A;RHOA;ARFGEF1;USH2A;TRIOBP;SHROOM1;RAB10;RAB3B;TRAK1;LLGL2;TRAK2;RAB8A;RAB11B
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.22813317906640437,-0.8438639582438086,0.7970297029702971,0.8806922448062162,1.0,3/70,2.74%,HEXB;LARGE1;B3GALNT1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.4095739146138121,0.8438094910019258,0.6666666666666666,0.9439535115269139,1.0,1/10,0.77%,CD47
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3169302722948885,0.8431398348550773,0.6830985915492958,0.9422174585905156,1.0,7/33,11.19%,NCOA3;WAC;ELOF1;SCAF8;RPRD2;RPRD1B;RECQL5
prerank,ferrous iron binding (GO:0008198),0.33899685924413714,0.8420882423364847,0.68125,0.9412647688101452,1.0,3/21,4.94%,TET2;HEPH;HAAO
prerank,NADPH binding (GO:0070402),-0.32945522689278467,-0.8417177998149403,0.6691919191919192,0.880474614231567,1.0,3/13,13.10%,QDPR;DUS2;CBR4
prerank,ribosomal small subunit binding (GO:0043024),-0.3032269614778166,-0.8391891633100769,0.711484593837535,0.8807073044906272,1.0,6/17,18.25%,LARP1;CPEB2;DHX29;NPM1;EIF4H;DDX3X
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4095234600709411,0.8375461421558011,0.6839285714285714,0.9467279034945527,1.0,3/10,12.77%,ATXN3;CYLD;OTUD4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.3817054491169117,0.8369003158741197,0.6786324786324787,0.9449820765298461,1.0,4/13,15.60%,ERN1;PDGFD;PTPRJ;ITGA5
prerank,neurexin family protein binding (GO:0042043),-0.36058731159883906,-0.8354669477471733,0.6884057971014492,0.8835509390333829,1.0,4/10,23.22%,NLGN1;NLGN2;NLGN3;CPE
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4087271129539721,0.8350935407781128,0.6724137931034483,0.9452867352216926,1.0,3/10,10.50%,SETDB2;SETD5;ASH1L
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4026909864732675,0.8346393964074028,0.67008547008547,0.943196969504082,1.0,4/10,20.00%,FEN1;EXD2;POLD1;APEX1
prerank,channel activity (GO:0015267),0.2968870483578361,0.8295456442115716,0.702557200538358,0.94966165431704,1.0,2/41,2.86%,SLC14A1;MCUB
prerank,glutathione transferase activity (GO:0004364),-0.28315502722151525,-0.827711913301531,0.7333333333333333,0.8937683427337899,1.0,2/23,5.81%,HPGDS;LTC4S
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.36323091526136086,0.8256877896179233,0.6734006734006734,0.9537941648326191,1.0,3/14,11.50%,SLC25A13;SLC25A12;SLC25A18
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3730011447537042,0.8249608805334222,0.6830427892234548,0.9521944638174857,1.0,1/14,1.01%,NGF
prerank,phosphatidic acid binding (GO:0070300),0.34605344837048774,0.8243254051484077,0.6925566343042071,0.9503876487836029,1.0,5/19,14.35%,RAPGEF2;SESTD1;PITPNM1;PACSIN2;MAPKAP1
prerank,phospholipase A2 activity (GO:0004623),-0.27690444990056223,-0.8233700090814898,0.7538461538461538,0.8975753584170674,1.0,4/26,10.35%,PLA2G15;PNPLA8;PLA2G4A;ABHD3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.32784018307437696,0.8232060287047415,0.7031484257871065,0.9494754461578374,1.0,4/24,9.01%,ZDHHC7;ZDHHC6;ZDHHC23;ZDHHC17
prerank,omega peptidase activity (GO:0008242),0.27161802325104245,0.8206710569692282,0.7734470158343484,0.951173094145892,1.0,22/89,16.05%,MINDY3;USP3;OTUD1;USP49;USP45;JOSD1;ATXN3;USP32;USP48;USP31;USP15;TANK;CYLD;USP42;USP40;USP4;OTUD4;USP37;USP7;VCPIP1;USP9X;USP47
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3235991349248919,-0.8190709561164335,0.710594315245478,0.9008777591725096,1.0,7/14,27.66%,SLC26A11;SLC25A11;SLC25A14;SLC26A2;SLC26A8;SLC26A6;SLC25A10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.25587358045216496,-0.8177146854042664,0.7313915857605178,0.8987636457625463,1.0,13/29,31.07%,GALC;NEU1;GAA;ABHD10;HEXD;GANAB;GLA;GBA2;ACER2;ENGASE;MOGS;OVGP1;PGGHG
prerank,mRNA binding (GO:0003729),0.2419527469579327,0.815975240702321,0.8471933471933472,0.9564363490194888,1.0,66/249,20.53%,ZAR1;ZC3H12D;RPL5;PTBP3;RBPMS;EIF4G3;SLPI;XPO5;RNF20;RC3H1;RBMS1;CLUH;RPS14;NUP98;PURB;PUM2;RBMS2;YTHDF3;TUT1;KHNYN;MRPL13;SF3B6;SCAF8;ETF1;SRSF4;RPS3;IGF2BP3;CELF2;YTHDC1;NUDT21;RBM15;DCP1A;EIF4ENIF1;NSRP1;HNRNPLL;IREB2;METTL3;SECISBP2;RPS2;RPL7;LARP4B;SYNCRIP;AQR;MARF1;NCBP1;CELF1;PTBP2;PABPC1;PUM1;BOLL;DDX6;NYNRIN;YBX3;AUH;SHMT1;CSTF3;PUM3;SF3B1;RPS13;UPF3B;N4BP1;PARK7;HNRNPC;LUC7L3;EDC3;LUC7L
prerank,sodium:proton antiporter activity (GO:0015385),0.3855416743874772,0.8159117714242445,0.6978297161936561,0.9537596047161612,1.0,1/11,2.03%,SLC9A7
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.30176916362138234,-0.8128038219475427,0.7368421052631579,0.9033000446074995,1.0,5/16,14.59%,SLC25A26;SLC22A5;SLC7A8;SLC5A7;SLC22A4
prerank,acetyltransferase activity (GO:0016407),0.3108436648822436,0.8109692898878638,0.7253218884120172,0.9595303977210529,1.0,7/31,15.26%,NAA16;KAT6A;NAA15;SMARCE1;ACAT1;KAT2B;CREBBP
prerank,miRNA binding (GO:0035198),0.3162647987725566,0.8090487922195388,0.7130307467057101,0.9601335063694101,1.0,7/30,16.03%,RC3H1;PUM2;RBM10;TRIM71;TUT7;PNPT1;PUM1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.30279870262190156,0.8089535157522317,0.7214673913043478,0.9574391483436809,1.0,5/35,5.58%,PLD4;SMPDL3B;APEX2;SMPDL3A;GPCPD1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.30516823306361857,0.8084372064066405,0.7262411347517731,0.9555603214588763,1.0,7/33,11.52%,ANKIB1;ARIH1;DCUN1D1;RNF217;ARIH2;RPS3;DCUN1D3
prerank,ubiquitin-specific protease binding (GO:1990381),-0.29150421455968745,-0.8059545551162823,0.7401574803149606,0.9105268307436618,1.0,2/19,5.45%,PRKN;DERL2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.3343133542824078,-0.8057011914203385,0.7220902612826603,0.9065153380444094,1.0,6/11,29.18%,KCND2;PKD2;KCNT2;KCNK2;KCND1;KCNT1
prerank,NADP binding (GO:0050661),-0.24765018301819883,-0.80195794383956,0.7859531772575251,0.9083657268746529,1.0,7/32,17.07%,ME3;QDPR;DPYD;DUS2;CBR4;PGD;NNT
prerank,glucuronosyltransferase activity (GO:0015020),0.3369035580265236,0.8006157143693126,0.7231012658227848,0.9661309157449581,1.0,1/19,0.85%,EXT1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.3123340926504139,0.8005886234410088,0.7230989956958394,0.9633633814559227,1.0,5/31,11.22%,KCNK7;SLC12A7;TMEM38B;SLC12A6;SLC12A9
prerank,nuclear localization sequence binding (GO:0008139),0.3408510319654784,0.8005373547649721,0.6912225705329154,0.9606527578593359,1.0,6/18,16.30%,NFKBIA;KPNA4;NUP153;TNPO1;KPNB1;KPNA2
prerank,iron ion binding (GO:0005506),0.27820257527971326,0.7991088430638569,0.7698519515477793,0.9601962756594522,1.0,5/48,4.94%,TET2;KDM7A;ETHE1;HEPH;HAAO
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2958994070061419,0.7983189656814135,0.7577903682719547,0.958799774361734,1.0,7/38,12.72%,PLEKHF1;DENND1A;SESTD1;SNX20;HIP1;WIPI2;SNX3
prerank,cAMP binding (GO:0030552),0.37281056554371506,0.7967819958755169,0.71875,0.958707769767266,1.0,2/11,7.50%,RAPGEF2;PDE2A
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3020346673611845,0.795024418854549,0.7489539748953975,0.9588990827986031,1.0,9/34,20.85%,IQGAP1;STK4;CCNT2;CCNT1;CDK5R2;STK3;MAP2K1;CAB39L;RICTOR
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3770008160190823,0.7942782973811392,0.6919014084507042,0.9573356405998893,1.0,10/10,62.32%,SLC6A11;SLC6A1;SLC10A5;SLC10A4;SLC10A2;SLC6A13;SLC6A12;SLC10A3;SLC10A6;SLC10A1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.3270378138239927,-0.7935387719483876,0.7555012224938875,0.9180354946068309,1.0,3/12,10.53%,BLNK;IRS1;PIK3R1
prerank,hormone receptor binding (GO:0051427),0.34977270926564535,0.7933608878777028,0.7111853088480802,0.9561265554357091,1.0,1/14,2.34%,JAK2
prerank,leak channel activity (GO:0022840),-0.28441511993446156,-0.7918052965054443,0.8022284122562674,0.9165128813366817,1.0,7/18,28.37%,KCNK13;KCNK6;KCNK2;PANX1;KCNK1;KCNK9;KCNK12
prerank,gamma-tubulin binding (GO:0043015),0.3253926254792625,0.7911322105290337,0.7092511013215859,0.9570926138798843,1.0,2/22,2.18%,PAK1;RACGAP1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.33124229413360806,-0.7875807744401127,0.7434052757793765,0.9192311736311216,1.0,2/11,2.73%,NAA50;NAA40
prerank,potassium ion antiporter activity (GO:0022821),-0.3044851812281276,-0.7872634022793281,0.7605263157894737,0.9154223258388039,1.0,3/15,7.08%,SLC24A3;SLC9A9;SLC9A6
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.36614559947030295,0.7867882392886437,0.7353433835845896,0.9613549759009108,1.0,2/12,11.10%,SLC9A7;LETM1
prerank,Notch binding (GO:0005112),0.3226026610914445,0.7859941106083198,0.7386018237082067,0.9599217462350861,1.0,3/22,11.98%,CUL3;ADAM17;MEGF10
prerank,antiporter activity (GO:0015297),0.33089872984546476,0.7858422339673249,0.7370078740157481,0.9574269113640055,1.0,2/20,5.59%,SLC25A16;SLC25A30
prerank,myosin V binding (GO:0031489),0.34256243203232395,0.7837526462323059,0.7327044025157232,0.9580325852375686,1.0,2/15,6.12%,RAB3D;RAB6A
prerank,lysine-acetylated histone binding (GO:0070577),0.33016806195633525,0.7834744547497106,0.7468152866242038,0.953074278066318,1.0,8/20,20.90%,PSME4;BAZ2A;KMT2A;TAF1;BRD7;BRD2;BRD4;PHIP
prerank,acetylation-dependent protein binding (GO:0140033),0.33016806195633525,0.7834744547497106,0.7468152866242038,0.953074278066318,1.0,8/20,20.90%,PSME4;BAZ2A;KMT2A;TAF1;BRD7;BRD2;BRD4;PHIP
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2645915671834051,0.7834656136890877,0.7977941176470589,0.9504299479475198,1.0,14/74,16.98%,DGKG;NADK;PIK3C2A;PANK1;PANK4;PAPSS1;PAPSS2;PIK3CA;PGM2L1;NT5C3A;GNE;IPMK;MVK;GK
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3616377710041405,0.782893423403258,0.7345132743362832,0.9486514776670217,1.0,2/12,7.21%,KDM7A;KDM3B
prerank,manganese ion binding (GO:0030145),0.27763004521545565,0.7804396233239231,0.7825520833333334,0.9500333563600539,1.0,12/48,17.11%,PIM1;FEN1;IMPA1;WRN;GALNT2;ARG2;MTPAP;EXD2;XXYLT1;PAPOLA;DYRK2;ABL2
prerank,metalloaminopeptidase activity (GO:0070006),0.3343006452617445,0.7796028779802541,0.7333333333333333,0.9486864441778133,1.0,3/16,11.35%,LNPEP;RNPEPL1;RNPEP
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.2902821111811371,0.7786488106849017,0.7920110192837465,0.9474971364664337,1.0,3/38,6.80%,ANXA2;SLPI;SERPINB9
prerank,peptide N-acetyltransferase activity (GO:0034212),0.37507953503056846,0.7781981027650007,0.7420494699646644,0.9455474332417338,1.0,2/10,9.25%,NAA16;NAA15
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.262232583180863,0.7770924648138433,0.8061728395061728,0.9446719634028883,1.0,12/75,13.12%,ME2;HIBADH;HSD17B7;MDH2;LDHD;DHRS4;BDH1;NSDHL;ABCC4;DHRS9;HSD17B11;RDH5
prerank,RNA polymerase binding (GO:0070063),0.33428536315960267,0.7757175698969706,0.7441497659906396,0.9441582498152616,1.0,6/18,12.15%,PKN2;SCAF8;STOM;CCNT2;PHRF1;CCNT1
prerank,syntaxin binding (GO:0019905),0.26723414207432206,0.7724523328315597,0.8123393316195373,0.9466618070760324,1.0,7/61,10.04%,LRRK2;DAPK1;CACNA1A;STX6;TMED10;SYP;STX7
prerank,gap junction channel activity (GO:0005243),0.31931636823111886,0.768813154441701,0.7558823529411764,0.9493790808205654,1.0,1/22,2.90%,GJA5
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2974382851450619,-0.76876479668191,0.7871794871794872,0.9403949864367471,1.0,6/15,44.93%,PLA2G4A;PLA2G3;PLA2G4C;PLA2G5;PLA2G4F;PLA2G2D
prerank,myosin II binding (GO:0045159),0.3773548095429407,0.7687326199041087,0.7472727272727273,0.9469234120440995,1.0,4/10,21.10%,MYL4;TRIOBP;SHROOM1;LLGL2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.2943148017845956,-0.7680218211707878,0.803763440860215,0.9371558350191247,1.0,6/16,26.63%,CLCN6;CLCN7;SLC26A2;SLC1A1;SLC26A8;SLC26A6
prerank,leucine zipper domain binding (GO:0043522),0.363956542485156,0.7675912805608501,0.7262773722627737,0.9460916193656705,1.0,3/10,16.39%,PAWR;MRTFA;DAPK3
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3008818830099475,0.7664759461845149,0.7922848664688428,0.9452769784180479,1.0,6/27,11.52%,ANKIB1;ARIH1;DCUN1D1;RNF217;ARIH2;DCUN1D3
prerank,metallopeptidase activity (GO:0008237),0.24507622488463807,0.7658390094495552,0.8615916955017301,0.9436682724539986,1.0,19/113,18.03%,ACE;ADAM21;LNPEP;ACE2;MMP1;DPEP1;ADAM17;ADAMTS6;ADAM11;ADAM19;RNPEP;THSD4;ADAMTS12;ADAM9;MIPEP;ADAMTS19;EIF3H;ANPEP;MMP8
prerank,alkali metal ion binding (GO:0031420),0.34612187679858575,0.7658355726780535,0.7636363636363637,0.9411383307047922,1.0,3/13,11.96%,IMPA1;TDG;ACAT1
prerank,potassium ion leak channel activity (GO:0022841),-0.2932347009263134,-0.7656393067878278,0.7974025974025974,0.9361257444551311,1.0,6/15,28.37%,KCNK13;KCNK6;KCNK2;KCNK1;KCNK9;KCNK12
prerank,peptide hormone receptor binding (GO:0051428),0.3652856246076585,0.7655273299644494,0.7408637873754153,0.9390617301869415,1.0,11/11,63.50%,ADCYAP1;GPHA2;UCN3;GPHB5;UCN2;PSMC5;GHRH;VIP;GNRH1;PTHLH;CCK
prerank,snRNA binding (GO:0017069),0.28091665583513187,0.7652724853715742,0.7850589777195282,0.9369586072176747,1.0,8/42,12.46%,RNPC3;HEXIM1;TUT1;COIL;RBM22;CCNT2;CCNT1;SNRPA1
prerank,nuclear import signal receptor activity (GO:0061608),0.3425621014169554,0.7643186906837891,0.7633711507293355,0.9359216052524397,1.0,5/15,16.30%,KPNA4;HIKESHI;TNPO1;KPNB1;KPNA2
prerank,signal sequence binding (GO:0005048),0.28684254864643366,0.7633897568881629,0.7831491712707183,0.9347330321959587,1.0,9/35,16.30%,NFKBIA;KPNA4;AP2B1;KDELR1;NUP153;PEX5L;TNPO1;KPNB1;KPNA2
prerank,copper ion binding (GO:0005507),0.2757361243613982,0.7630799322352065,0.7896138482023968,0.9327177310769712,1.0,7/42,14.34%,HEPH;PRNP;ATP7A;ATOX1;SUMF1;COX17;CUTC
prerank,mannose binding (GO:0005537),0.3490125899320519,0.7624715894312533,0.7744107744107744,0.9311272342018646,1.0,2/12,10.22%,LMAN2L;MBL2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.33417702922220827,-0.7616871845631583,0.7788461538461539,0.9376973494109146,1.0,4/10,11.66%,KDM2A;KDM2B;KDM4A;PHF8
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.33548989724693945,0.7610074023828232,0.7751196172248804,0.9308362909603706,1.0,4/14,18.89%,ATP2A3;APAF1;MAL;BAD
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.32988435621136475,0.7575087566592438,0.7741407528641571,0.9333543638549554,1.0,7/15,21.36%,KMT2C;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3135680939521396,-0.7572042016465844,0.7705314009661836,0.9396394205446796,1.0,1/12,1.08%,LARP1
prerank,translation initiation factor activity (GO:0003743),-0.22770030588278967,-0.7537033444643867,0.8402777777777778,0.9401241409757342,1.0,11/36,20.63%,EIF4A1;EIF2S2;EIF3M;EIF5;EIF2B5;EIF2B4;EIF3L;EIF4G1;EIF3K;EIF3B;EIF2D
prerank,wide pore channel activity (GO:0022829),0.3093020124863773,0.7531903764202482,0.7771260997067448,0.9369542109823693,1.0,1/23,2.90%,GJA5
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.36216730187372687,0.7531406476418796,0.7993197278911565,0.9345790258343188,1.0,5/10,18.67%,RPE;GNE;GALM;GLCE;DSEL
prerank,active ion transmembrane transporter activity (GO:0022853),-0.22814722536721999,-0.7527616278390404,0.8984962406015038,0.9371869789998067,1.0,1/37,0.11%,SLCO2B1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.346714588228749,0.7505329597293945,0.7460595446584939,0.9357312004656564,1.0,2/11,9.97%,APEX2;RPS3
prerank,metal ion:proton antiporter activity (GO:0051139),-0.29794058552232416,-0.7498672174025164,0.8273195876288659,0.9368933814553632,1.0,3/13,7.08%,SLC11A1;SLC9A9;SLC9A6
prerank,LRR domain binding (GO:0030275),-0.2919299547493676,-0.7475916565145914,0.8048192771084337,0.9356319425287011,1.0,5/14,22.04%,ROBO1;ATF4;ERC1;PMF1;POLR2J
prerank,protein phosphatase inhibitor activity (GO:0004864),0.2936206724553215,0.7442670396743425,0.823262839879154,0.9419726043371828,1.0,5/26,13.15%,LMTK2;PPP1R9B;PPP1R2;LGALS3;PABIR1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3185915479141471,-0.7380352816956266,0.8072289156626506,0.9441397481853753,1.0,3/10,11.73%,CFLAR;CASP4;CASP3
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.26642774308990347,-0.7367130268391965,0.8388888888888889,0.941718160698119,1.0,8/20,23.98%,LPCAT2;PLA2G15;LPCAT1;GPAT4;LPGAT1;AGPAT3;AGPAT2;DGAT1
prerank,histone acetyltransferase binding (GO:0035035),-0.255793279340755,-0.7367089001165233,0.8552278820375335,0.9375140617664309,1.0,5/21,13.36%,KANSL1L;ECD;HIF1A;GLI3;PCNA
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.35709387750863764,0.7366845433044832,0.7750809061488673,0.9494235607554086,1.0,2/10,10.38%,LAPTM5;DAXX
prerank,ribosome binding (GO:0043022),0.262197027190912,0.7357657854679138,0.8382352941176471,0.9481725204703877,1.0,13/46,18.76%,NAA16;MAIP1;YTHDF3;ERI1;ETF1;NAA15;SRP72;SRP19;MRPS27;EFL1;NCLN;MTIF3;RPSA
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.3294997371971921,0.7353618700749749,0.7811501597444089,0.9461527194821356,1.0,5/14,23.47%,RSAD1;IREB2;NFU1;ACO1;ETFDH
prerank,Tat protein binding (GO:0030957),-0.3171324289081127,-0.7289076656025674,0.8165829145728644,0.9433162691946273,1.0,3/10,18.22%,SMARCB1;NPM1;TRIM32
prerank,glycine binding (GO:0016594),-0.31120371318947726,-0.727380248408146,0.8066825775656324,0.9413400505336827,1.0,2/11,8.20%,GLRA3;GLRA2
prerank,pyridoxal phosphate binding (GO:0030170),-0.2538498904826812,-0.7265914048187744,0.8319559228650137,0.9380783499869202,1.0,12/20,44.75%,PYGB;PSAT1;ACCS;OAT;SHMT2;PNPO;PDXK;CBS;PYGM;THNSL2;CTH;GLDC
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2802263255439207,0.7264462232447627,0.8312056737588652,0.9554056852164129,1.0,7/30,17.41%,SLC30A4;ATP7A;SLC30A1;SLC39A11;SLC31A1;SLC39A13;SLC39A12
prerank,fatty acid synthase activity (GO:0004312),0.3530832407818081,0.7262118535342056,0.7832764505119454,0.9532620105158965,1.0,2/10,8.29%,ELOVL5;ELOVL6
prerank,histone deacetylase activity (GO:0004407),0.30623622155233055,0.7245565993115866,0.8180428134556575,0.95292023775519,1.0,8/19,24.13%,HDAC9;HDAC3;MIER1;SIRT1;HDAC1;SIRT3;HDAC5;SIRT2
prerank,neuropeptide hormone activity (GO:0005184),-0.2533805021759534,-0.7240920132451131,0.8742138364779874,0.937093044408339,1.0,16/22,57.37%,PENK;CCK;PNOC;GRP;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;CORT;NPPA;GHRH;CALCB;PPY
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.25195976603209513,0.723917974720173,0.8732394366197183,0.9512566178461811,1.0,9/57,14.10%,CYB561A3;NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9
prerank,mRNA 5'-UTR binding (GO:0048027),0.29333237946094887,0.7226519410889278,0.8125,0.9504170367200862,1.0,6/24,19.19%,RPL5;RPS14;IGF2BP3;SYNCRIP;SHMT1;RPS13
prerank,triglyceride lipase activity (GO:0004806),-0.2568745947835482,-0.7215397708769588,0.8502994011976048,0.936002966889675,1.0,3/20,17.30%,PLA2G15;DDHD2;LIPH
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.27497659768980354,0.720317761146908,0.8388017118402282,0.9484341410162884,1.0,9/34,16.22%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.27497659768980354,0.720317761146908,0.8388017118402282,0.9484341410162884,1.0,9/34,16.22%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,Hsp90 protein binding (GO:0051879),0.27650897543621117,0.7170696880328109,0.8350071736011477,0.9498938142956042,1.0,5/33,10.43%,ERN1;AHR;CSNK2A1;RPS3;NR3C1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2754976313830816,-0.7145282905683507,0.8513853904282116,0.9399236329107562,1.0,7/15,25.91%,LPCAT2;LPCAT1;ABHD4;GPAT4;AGPAT3;AGPAT2;ABHD8
prerank,store-operated calcium channel activity (GO:0015279),0.35238201784877515,0.7143873075989086,0.7979274611398963,0.9508063188712097,1.0,4/10,17.54%,STIM2;ORAI3;ORAI1;TRPC5
prerank,snoRNA binding (GO:0030515),0.27181346755854124,0.711010776815805,0.8663793103448276,0.9524203748433707,1.0,6/30,15.50%,NUFIP1;DHX37;NHP2;UTP6;NOP58;TBL3
prerank,methyl-CpG binding (GO:0008327),-0.2428561492407868,-0.7003603560744057,0.8861538461538462,0.9514385948152915,1.0,6/22,13.29%,CXXC5;ZCWPW1;TET1;TET3;ZBTB21;PRMT5
prerank,methyltransferase activity (GO:0008168),-0.20273976271253455,-0.6948118215841972,0.9717741935483871,0.9530450347395422,1.0,16/46,26.25%,COMT;MGMT;NSUN2;COQ3;NSUN3;AS3MT;PRMT5;FTSJ3;SUV39H1;LCMT1;NDUFAF7;COQ5;N6AMT1;BCDIN3D;ASMT;BUD23
prerank,mRNA methyltransferase activity (GO:0008174),0.31960146403909306,0.6884732200282746,0.8472906403940886,0.975451820556811,1.0,5/12,20.58%,CMTR1;METTL3;TRMT10C;TRMT61B;PCIF1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.29368117130242566,0.6859986682039575,0.8589540412044374,0.9758142162416774,1.0,3/16,10.70%,SMUG1;RPS3;TDG
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.2715405781504683,-0.6840691033108757,0.8900804289544236,0.9592887117942549,1.0,8/13,42.78%,PYCARD;SRC;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,galactosyltransferase activity (GO:0008378),0.32600490103978735,0.6829483934782885,0.8431703204047217,0.9766904830153444,1.0,1/11,4.27%,B4GALT5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.23882527270776757,0.6819736526435897,0.9110824742268041,0.9752990488819117,1.0,10/54,18.06%,ACER3;UPB1;NAAA;HDAC9;SIRT4;HDAC3;FAAH;MIER1;SIRT1;HDAC1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.21310305761867201,0.6811185603730856,0.9558823529411765,0.9738002344554242,1.0,28/134,19.16%,SLC23A2;SLC23A1;CD36;SLC25A13;SLCO1B1;ABCC1;SLC4A8;SLC15A4;SLC1A5;SLC25A12;SLC1A4;SLC25A18;ABCC4;SLC38A1;SLCO1C1;SLC26A7;SLC35A1;SLC66A1;SLC6A9;SLC35A3;SLCO4C1;SLC52A1;SLCO3A1;SLC25A2;SLC16A7;CTNS;SLC25A1;SLC38A2
prerank,GDP binding (GO:0019003),0.2319263898005908,0.6804896714095519,0.9319041614123581,0.9720575684511457,1.0,17/63,22.77%,RAP1A;RAB7A;RALB;DIRAS1;RHEB;GNAI1;ARL8B;RAB29;RAB35;RAB9B;RAB2A;RAB10;RAB3B;RAB21;RAB8A;RAP1B;RAB11B
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.31335673796366725,0.6802195184862224,0.8357963875205254,0.969875585534768,1.0,5/12,19.93%,CDK13;CDK12;MAPK1;BRD4;CDK19
prerank,bHLH transcription factor binding (GO:0043425),-0.2472256666923223,-0.6795783378613154,0.9146005509641874,0.9596273729295113,1.0,6/19,20.35%,LMO2;USF2;SMAD3;BHLHE41;SP1;TCF3
prerank,death domain binding (GO:0070513),0.31608409841337304,0.6752244883704588,0.8478632478632478,0.9724711967431281,1.0,2/11,10.66%,MCL1;RIPK1
prerank,BMP receptor binding (GO:0070700),-0.27156741906768633,-0.6740069450432309,0.9002557544757033,0.9603282244220152,1.0,8/12,42.78%,PYCARD;SRC;BMP6;BMP5;BMP2;BMP4;CDH5;BMP7
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.26034849568576457,0.6726451194158389,0.8746312684365781,0.9727053544382414,1.0,9/28,20.36%,FEN1;DBR1;RNASEH2A;RNASEH1;ENDOV;PRORP;RPP38;APEX1;EDC3
prerank,regulatory RNA binding (GO:0061980),0.24969787616034533,0.6720612788439374,0.8966942148760331,0.970904128478039,1.0,7/38,16.03%,RC3H1;PUM2;RBM10;TRIM71;TUT7;PNPT1;PUM1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3104955754339965,0.6705332663073417,0.8448566610455311,0.969982707469564,1.0,2/12,10.80%,ATP2A3;APAF1
prerank,U6 snRNA binding (GO:0017070),-0.26188288136596455,-0.6701578207578351,0.9135446685878963,0.9595546841500496,1.0,5/14,25.09%,DDX39B;PRPF4;EIF5A;LSM3;LSM2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3267569733829807,0.6677979268160502,0.8652246256239601,0.9702556094000553,1.0,2/10,9.35%,LAPTM5;USP15
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.24268012290206753,-0.6655182188617778,0.9185750636132316,0.9596831250401643,1.0,5/18,22.04%,WDR91;PIK3R1;SOCS2;PIK3R3;WDR81
prerank,Wnt-activated receptor activity (GO:0042813),-0.2600318687876982,-0.6652176553510986,0.9,0.9558879948603837,1.0,8/15,37.63%,RYK;ROR1;LRP5;FZD4;FZD6;FZD2;TSPAN12;FZD5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.22931527884304334,0.6578518026999307,0.9365918097754293,0.9772714340809345,1.0,4/55,6.93%,SLC23A2;SLC23A1;SLC38A10;ABCC1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3064413668613718,0.6561725518215266,0.8527397260273972,0.9764370870877738,1.0,2/11,11.99%,TAF9;MBD2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.2423903139557188,0.6532290372003662,0.9106901217861976,0.9767811382371846,1.0,4/37,6.02%,FARS2;VARS1;VARS2;DARS2
prerank,symporter activity (GO:0015293),0.3093340028874521,0.6471456315162506,0.8498233215547704,0.9797503682387665,1.0,10/10,69.09%,SLC28A2;SLC28A3;SLC5A8;SLC4A4;SLC5A12;SLC5A5;SLC28A1;MFSD2A;SLC46A2;SLC5A6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.28565018091708383,0.6458197426780679,0.8825396825396825,0.9784381814408657,1.0,2/15,13.59%,SLC4A8;SLC26A7
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2697746457115716,0.6435524349153638,0.8961038961038961,0.9780315740484135,1.0,6/20,17.21%,OTULINL;EIF3F;USP7;USP9X;USP47;EIF3H
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.2528354181577783,-0.6379459165223023,0.9367396593673966,0.9724107319602735,1.0,2/13,4.67%,LPCAT2;LPCAT1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2604074671310665,-0.6359014944693047,0.9048723897911833,0.9698500338349401,1.0,1/12,2.74%,B3GALNT1
prerank,NAD binding (GO:0051287),0.24897323362471901,0.63400162628181,0.922272047832586,0.9835821327788377,1.0,9/26,24.13%,ZC3HAV1;PARP9;GLUD1;SIRT1;HPGD;SORD;SIRT3;ALDH2;SIRT2
prerank,phosphate ion binding (GO:0042301),0.3019400401025021,0.6240857076749635,0.8678571428571429,0.9885372219395573,1.0,2/10,15.29%,PDE2A;RELA
prerank,metallocarboxypeptidase activity (GO:0004181),0.24844135478239132,0.6196840585091956,0.9290030211480362,0.9893970754519557,1.0,1/26,2.21%,ACE2
prerank,dynactin binding (GO:0034452),-0.25196383291983415,-0.6187812722756698,0.9476082004555809,0.9764115890049558,1.0,2/12,9.58%,SNX5;SNX6
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.28796633617125345,0.6186631118338572,0.8949096880131363,0.9877508000564995,1.0,3/12,18.16%,NQO2;DHRS4;AIFM2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.2577787928218961,0.6169941216529004,0.9375,0.9866079914816578,1.0,2/18,9.47%,HSD17B12;FAR1
prerank,receptor antagonist activity (GO:0048019),-0.22420949719103256,-0.616284002562338,0.9498607242339833,0.9738228687279309,1.0,3/17,22.87%,DKK2;DKK3;IL18BP
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.20328556220546112,-0.6140353407369714,0.956268221574344,0.9710185371564887,1.0,14/26,42.30%,B3GALNT1;CHPF2;GBGT1;CHSY1;B3GALT1;B3GNT7;B4GALNT3;EXTL2;B4GALNT4;B3GNT8;CHPF;B3GNT6;CSGALNACT2;B3GALT4
prerank,pseudouridine synthase activity (GO:0009982),0.27417607327552407,0.6106968720513294,0.9054054054054054,0.9883817444409738,1.0,4/13,21.47%,PUS3;PUS1;PUS7L;TRUB2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.2762434763196634,0.6092821375127571,0.9042016806722689,0.9869806417596076,1.0,2/13,13.63%,IDI1;SREBF2
prerank,acid-thiol ligase activity (GO:0016878),0.2741733054540124,0.6050667316955297,0.9144736842105263,0.9875125844612109,1.0,3/13,20.17%,AASDH;ACSS2;ACSL1
prerank,RNA methyltransferase activity (GO:0008173),0.24857594675069894,0.6006679130456866,0.9223744292237442,0.9881083727045323,1.0,5/19,17.92%,TRDMT1;METTL4;METTL3;TYW3;TRMT13
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2785817866073272,0.5988585491984997,0.9024822695035462,0.9868964999046003,1.0,2/11,14.38%,PRMT8;PRMT3
prerank,semaphorin receptor binding (GO:0030215),-0.2046913912760824,-0.5967268539124763,0.9648093841642229,0.9762871367880243,1.0,13/23,35.96%,SEMA3D;SEMA3E;SEMA6D;RIT2;SEMA7A;SEMA5B;SEMA4C;SEMA4G;PLXNB1;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,ATPase activator activity (GO:0001671),0.2516916432741689,0.5955844450842511,0.9488817891373802,0.9864849610029258,1.0,6/20,21.29%,DNAJC1;DNAJC19;TOR1AIP1;ATP1B2;DNAJC10;DNAJB4
prerank,neuropeptide receptor binding (GO:0071855),0.27148866704338537,0.5918311146950366,0.9272419627749577,0.9862510351530254,1.0,14/14,72.87%,AGRP;NMU;QRFP;UCN3;UCN2;APELA;PPY;GHRH;NPPA;GAL;APLN;SHANK1;NPY;NTS
prerank,platelet-derived growth factor binding (GO:0048407),-0.24992393027991044,-0.5901470304959737,0.9481132075471698,0.9752695353815873,1.0,1/11,8.53%,PDGFA
prerank,frizzled binding (GO:0005109),0.21968936610218193,0.5875701039817077,0.9627507163323782,0.986235109409862,1.0,6/34,18.68%,CCDC88C;DVL3;DVL2;WNT7A;WNT5B;FZD7
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.2487760570857674,0.5741728262925486,0.9376083188908145,0.9907419057919118,1.0,4/15,19.84%,PIK3R6;PIK3R2;PIK3R5;SOCS5
prerank,phospholipid transfer activity (GO:0120014),0.23830029723162552,0.5729765116590241,0.9655172413793104,0.9889775060843669,1.0,6/21,19.75%,ABCA3;PITPNB;PITPNM1;PRELID1;PITPNA;PRELID3A
prerank,carboxylic acid binding (GO:0031406),0.21091471971090975,0.5726860970511675,0.9758522727272727,0.9867969958103809,1.0,7/38,15.60%,PSAP;UBR2;GLUD1;CAD;CASTOR2;GRIN3A;SRR
prerank,CoA-ligase activity (GO:0016405),0.25127142588058016,0.5576019426904957,0.9637561779242174,0.9910889253348777,1.0,14/14,74.89%,ACSS2;ACSL1;ACSM2A;ACSM2B;ACSM1;AACS;ACSS3;ACSBG2;SLC27A5;ACSM3;ACSF3;SLC27A2;ACSBG1;ACSS1
prerank,DNA polymerase binding (GO:0070182),0.2346786283176105,0.552894276782481,0.9553846153846154,0.9906960218258898,1.0,4/18,16.35%,LONP1;FANCI;POLG2;SMG6
prerank,5'-nucleotidase activity (GO:0008253),-0.22084299387866946,-0.5502432196301367,0.967654986522911,0.9865444034833076,1.0,3/13,20.17%,NT5M;NT5DC3;NT5DC1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.2596268062506226,0.5472453117939707,0.9474605954465849,0.9905707012907298,1.0,1/11,6.03%,UBR5
prerank,amino acid binding (GO:0016597),0.20672962734574465,0.5425414598537807,0.9898697539797395,0.9900428156358184,1.0,7/31,18.37%,CAD;CASTOR2;GRIN3A;ASS1;SRR;DDAH1;SHMT1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.20513625518020848,-0.5331705066069536,0.9813333333333333,0.9871982041712859,1.0,15/15,79.51%,COX10;COX5B;COX6A1;CYB5A;COX15;COX6A2;COX8A;COX4I2;COX7A1;NDUFA4L2;COX6B1;COX4I1;NDUFA4;COX7A2L;COX5A
prerank,neuropeptide receptor activity (GO:0008188),0.19971744816911996,0.5149586281370412,0.9828815977175464,0.9962754597451838,1.0,2/29,9.07%,TACR1;OPRM1
prerank,hormone activity (GO:0005179),0.1796841992556366,0.5088899899303235,0.9948979591836735,0.995515923527138,1.0,1/54,1.96%,METRNL
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.23155844635857004,0.49225012378556504,0.9706422018348624,0.9968003125556208,1.0,1/11,7.36%,DCP2
prerank,nucleotidase activity (GO:0008252),-0.1862986240235021,-0.48207055389401343,0.9917355371900827,0.9929948018607699,1.0,3/15,20.17%,NT5M;NT5DC3;NT5DC1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.2195253634503332,0.4786461799596412,0.9769357495881383,0.9971111511031436,1.0,1/12,10.97%,GPR88
prerank,peptidoglycan binding (GO:0042834),0.23377080307194192,0.4750758922194363,0.9793459552495697,0.995397894361625,1.0,2/10,12.51%,NLRP3;TLR2
prerank,steroid hydroxylase activity (GO:0008395),0.2071341276013965,0.4748431301398373,0.9851485148514851,0.993173508260372,1.0,1/16,7.76%,CYP27A1
prerank,lysine N-methyltransferase activity (GO:0016278),0.1901639339751005,0.46229500031866616,0.9922360248447205,0.9928390472431923,1.0,6/20,23.07%,SETD7;SETD2;EEF1AKMT1;EHMT1;ATPSCKMT;ANTKMT
